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ABSTRACT 
Background: Depressive symptomology is an independent risk factor for 
cardiovascular disease, and remains under-diagnosed as well as under-treated by 
healthcare providers. Over 15% of persons with cardiovascular disease have depressive 
symptoms, and women are twice as likely to experience these symptoms when 
compared to men. Depressive symptoms significantly impact on an individual‘s overall 
quality of life. Depressive symptomology makes adherence to recommended risk 
reduction plans difficult, subsequently increasing risk for cardiovascular disease. 
Depressive symptoms are associated with greater cardiovascular morbidity and 
mortality, particularly for women. Assessment of depressive symptoms in women ―at 
risk‖ for cardiovascular disease has not been well studied, and hence was the 
justification for the research undertaken. 
Purpose: This study investigated the relationship between depressive symptoms, 
health-promoting lifestyle behaviors, heart disease risk awareness, cardiac risk, and 
quality of life in women. Whether the effect of depressive symptoms on quality of life 
was mediated by cardiac risk and/or health-promoting lifestyle behaviors was also 
examined, and is a unique contribution of this study. 
Methods: Guided by the Wilson and Cleary Health-Related Quality of Life Model and 
the Health Promotion Model, a cross-sectional correlational descriptive study was 
conducted.  Women who attended either individual or large-group cardiovascular 
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screening events in the Great Lakes region were recruited. One hundred fifty-one 
women were eligible and125 (82.8% participation rate) completed the study. The 
nonprobability convenience sample (calculated to a power of .80, an alpha of .05, and a 
.20 effect size) included women aged 30-75 years who were able to read, write, and 
speak English. The study was approved by the institutional review boards from Loyola 
University Chicago, the screening center hospital, and the university where the 
investigator is on faculty.  
Measurements: The Center for Epidemiological Studies Depression Scale, the 
Framingham risk score, the Ferrans-Powers Quality of Life Index Generic Version-III, 
the Health-Promoting Lifestyle Profile-II, and a series of heart disease risk awareness, 
demographic and health history questions comprised the study measurements. Physical 
(e.g. body mass index and percent body fat) and serum measurements (e.g., lipid 
profile) which were part of the screening event were also measured. The Functional 
Comorbidity Index was used to determine the women‘s general health history.  
Data Analysis: The SPSS version 15 was used to perform the statistical analyses. 
Spearman rho correlations determined the associations among the major variables. 
Logistic regression analyses were used to analyze the dose-response relationships 
between depressive symptoms and the study variables. Analysis for the possible 
mediation was conducted using simple linear regression analyses according to the 
methods outlined by Baron and Kenny (1986).  
Results: Study participants were predominantly urban, non-Hispanic, white, married, 
with some college education, employed full-time, and a household income between 
 xxii 
 
$25,000-49,999. The mean age was 57.7 (± 9.6). Risk awareness measurements 
identified three key findings. First, many women (67.2%) were aware of their risk of 
heart disease before attending the screening. Second, most (84.8%) said they had 
learned about heart disease risk in women either from their membership in the 
hospital‘s Heart Advantage program or the media. Third, just over half (56.8%) learned 
about their heart disease risk from their primary care provider. The cardiac risk profile 
revealed that the mean Framingham score was 3.3% (± 3.9) which placed 93.6% of the 
women in the ―low risk‖ category. Despite the low Framingham risk score, individual 
risk factors were appreciably abnormal. Most of the women (83.2%) had the total 
cholesterol greater than 160 mg/dl and 40% had the high-density lipoprotein cholesterol 
below 50 mg/dl. Seventy percent had a systolic blood pressure above the recommended 
normal of 120 mmHg. More than half (56%) of the women had a body mass index 
equal to or greater than 30. Almost all (93.5%) had greater than 30% body fat, and 
57.4% had a waist circumference equal to or greater than 35 inches. Using the 
American Heart Association‘s risk classification, 25% of the women were reclassified 
at ―low risk‖. The change in risk classification was attributable to their physical 
inactivity. A quarter (25%) of the women reported that their stress level was 
high/chronic and over half (55%) indicated that they only sometimes performed stress 
management health-promoting behaviors. 
Using the Centers for Epidemiological Studies Depression cut-score (equal to or greater 
than 16), over one third (33.6%) of the women reported significant depressive 
symptoms. Depressive symptoms were not associated with cardiac risk or with risk 
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awareness. Since these were generally ―risk aware women‖, it is not surprising that 
depressive symptoms were not associated with risk awareness. In addition, due to the 
fact that most of the depressed women were in the ―at risk and high risk‖ groups, it may 
have been difficult to detect a significant relationship between depressive symptoms 
and risk status. However, depressive symptoms were inversely associated with health-
promoting lifestyle behaviors (rS = -.37, p < .01) and quality of life (rS = -.51, p < .01). 
Furthermore, depressive symptoms had a dose-response relationship with health-
promoting lifestyle behaviors (OR= .92, 95% CI .88, .97, p < .001) and quality of life 
(OR= .85, 95% CI .79, .92, p < .001). The higher the depressive symptoms score, the 
less likely were the women to follow health-promoting lifestyle behaviors and the less 
likely were they to report a good quality of life. Health-promoting lifestyle behaviors  
(b = 2.20, SE .83, t = 2.65, p < .01) but not cardiac risk mediated the effect of 
depressive symptoms on quality of life. 
Conclusions: An inverse and dose-response relationship was found between depressive 
symptoms, health-promoting lifestyle behaviors, and quality of life. Since no 
relationship was found between depressive symptoms and cardiac risk, it was 
eliminated as a possible mediator. Health-promoting lifestyle behaviors were found to 
mediate the relationship between depressive symptoms and quality of life in these 
women being screened for cardiovascular disease risk.  
Implications for Nursing Practice: Since nurses most often manage cardiovascular 
disease risk screening programs, it is important for them to understand the impact that 
depressive symptoms have on health-promoting lifestyle behaviors and quality of life. 
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The results of this study indicate that screening for depressive symptoms is important 
for cardiovascular disease risk assessments. It is recommended that education and 
implementation of depression assessment be incorporated into cardiovascular risk 
screening events. Finally, the inverse dose-response relationship between depressive 
symptoms and adherence to treatment plans should be an important consideration when 
designing risk reduction interventions for patients in the future. 
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CHAPTER ONE 
PROBLEM STATEMENT 
Cardiovascular disease (CVD) is the leading cause of death among women 
today (Rosamond et al., 2007). Depression has been identified as an independent risk 
factor for persons with CVD (Rugulies, 2002). In the general population, women are 
twice as likely to have depression as their male counterparts (Hasin, Goodwin, Stinson, 
& Grant, 2005; NIMH, 2005). For persons at risk for CVD or with diagnosed CVD, 
women are still twice as likely to have depression (Ferketich, Schwartzbaum, Frid, & 
Moeschberger, 2000). Depression has been clearly associated with increased morbidity 
and mortality in persons with CVD (Rozanski, Blumenthal, & Kaplan, 1999).  
Depressive symptoms, a subclinical syndrome of depression (Table 1), have 
more recently been examined. Depressive symptoms have been associated with 
increased risk for CVD, nonadherence to treatment recommendations, and increased 
cardiac morbidity and mortality. A meta-analysis of the effect of depressive symptoms 
on incident CVD in healthy subjects concluded that depressive symptoms were indeed 
independent risk factors for CVD, and that there was a 64% increased risk of 
developing heart disease in depressed subjects (relative risk [RR] 1.64, 95% confidence 
interval [CI] 1.29-2.08) (Rugulies, 2002). A recent study reported that increasing 
severity of depressive symptoms was associated with higher blood-pressure, more CVD 
risk factors, greater stress and lower social support (Artinian, Washington, Flack, 
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Hockman, & Jen, 2006). In addition, the severity of depression was found to be a 
mediator between diastolic blood pressure and stress in a sample of urban African-
American women (Artinian et al.) 
Table 1. 
Depressive Symptoms 
 Persistent sad, anxious, or "empty" 
mood  
 Loss of interest or pleasure in 
activities, including sex  
 Restlessness, irritability, or 
excessive crying  
 Feelings of guilt, worthlessness, 
helplessness, hopelessness, 
pessimism  
 Sleeping too much or too little, 
early-morning awakening  
 Appetite and/or weight loss or 
overeating and weight gain  
 Decreased energy, fatigue, feeling 
"slowed down"  
 Thoughts of death or suicide, or 
suicide attempts  
 Difficulty concentrating, 
remembering, or making decisions  
 Persistent physical symptoms that 
do not respond to treatment, such as 
headaches, digestive disorders, and 
chronic pain  
   NIMH (2005), p. 3-4. 
Depressive symptoms have also been found to decrease one‘s ability to comply 
with recommendations to alter unhealthy behaviors and other aspects of a medical 
treatment plan (Barefoot & Schroll, 1996; DiMatteo et al., 2000; Katon, 2003; Vinkers, 
Gussekloo, Stek, van der Mast, & Westendorp, 2005). A meta-analysis concluded that 
there was also a dose-response relationship between depressive symptoms and 
decreased adherence, and that persons with depressive symptoms were three times more 
likely to exhibit decreased adherence (OR 3.03, 95% CI, 1.96-4.89) (DiMatteo et al.).   
Besides adversely affecting adherence to a CVD risk modification program, 
depressive symptoms have been found to be a significant predictor for myocardial 
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infarction treatment-seeking delay (Bunde & Martin, 2006). In addition, in the 
Sertraline Antidepressant Heart Attack Randomized Trial (SADHART), 53% of 
persons admitted for acute coronary syndrome (ACS) had depression prior to their 
hospitalization (Glassman, Bigger, Gaffney, Shapiro, & Swenson, 2006). Most 
compelling was that 94% of the reported pre-hospitalization depressive episodes 
actually began more than 30 days prior to hospitalization (Glassman et al.). This finding 
is contrary to previous research that had reported that depression was a consequence 
following a heart attack and during the recovery from the acute event (Lesperance, 
Frasure-Smith, Talajic, & Bourassa, 2002). Depressive symptoms have also been 
reported to more than double the risk for a heart attack- OR 2.24, 95% CI, 1.37-3.60 
(Barth, Schumacher, & Herrmann-Lingen, 2004). Depressive symptoms have been 
found to have a graded increased risk of death from heart disease;  for each one unit 
increase in depressive symptoms scores the risk of death increased by 4% (RR=1.04, 
95% CI, 1.01-1.07), (Anda et al., 1993). Furthermore, depressive symptoms can 
increase the risk of all-cause mortality by 59% (RR 1.59, 95% CI 1.26-2.00, p < 0.001; 
Barefoot & Schroll, 1996). 
Nearly all women are now considered to be at risk - classified as optimal risk, at 
risk, and high risk- for CVD (Mosca, Banka et al., 2007). A woman who has depressive    
symptoms is particularly at risk for CVD because depressive symptoms are under-
diagnosed in the overall population, and in those at risk for and with CVD (Huffman et 
al., 2006; NIMH, 2001; Ziegelstein et al., 2005). In addition to being under-diagnosed, 
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depressive symptoms have not been recognized as one of the traditionally described 
modifiable CVD risk factors - diabetes, hypertension, hyperlipidemia, obesity, smoking, 
and sedentary lifestyle, as evidenced by their absence in the most recent AHA report of  
heart disease statistics (Rosamond et al., 2007). 
 A woman‘s ability to adhere to a CVD risk modification program, therefore, 
could be diminished due to the presence of depressive symptoms. Screening for the 
presence of depressive symptoms should be part of screening for CVD risk. With an 
interest in the prevention of disease, earlier screening for depressive symptoms is 
prudent rather than waiting to screen for depressive symptoms until a woman has 
developed coronary heart disease (CHD) (Mosca, Banka, et al., 2007). In that way, we 
can tailor risk modification instructions to women with depressive symptoms. It is 
critical that we increase our understanding of the relationship of depressive symptoms 
to healthy lifestyle behaviors, to awareness of heart disease risk, and perceived quality 
of life (QOL) in women at risk for CVD. There has been no research - identified thus 
far - investigating the relationship of depressive symptoms to perceived QOL in women 
being screened for CVD risk.  
 There is also limited information regarding the dose-response relationship of 
depression and its effect on cardiac risk factors, adherence to treatment, as well as 
cardiac events. In other words, what is the level of depression that may cause these 
adverse outcomes? Most clinicians associate the concept of dose-response relationship 
to the nonlinear relationship between escalating drug dosage and the drug‘s increased 
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effect. In epidemiological studies, a dose-response relationship ―refers to changes in the 
prevalence or incidence of a given effect associated with changes in the level of a 
possible cause‖ (OECD, 2001). This means that an increased level of exposure to a risk 
factor (the dose) is associated with an increased frequency or severity of a disease 
which in turn may indicate a causal relationship (Weed, 1997). A classic example of the 
dose-response causal relationship between a risk factor and disease is the association 
between smoking and lung cancer (Hulley et al., 2001). Given the literature regarding 
depression and CVD, it is logical to determine the dose-response relationship between 
the level of depression (i.e., depressive symptoms) and cardiovascular risk (Figure 
1). In addition, since both depression and CVD impact one‘s QOL, it would be 
important to determine their effect independently and dependently on QOL. Because 
evidence indicates that depression impacts on health-promoting lifestyle behaviors, and 
health-promoting lifestyle behaviors impact on cardiovascular risk, this variable is also 
important to study.
  
Figure 1. Model of Study 
 
 
 
 
 
 
 
 
 
 
 
Note: * - Sociodemographic variables and health history were statistically controlled. Line c indicates the direct relationship 
and lines a with d1, and b with d2 indicate the mediational models that were investigated. 
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Purpose 
The purpose of this study was to investigate the relationship of depressive 
symptoms to the status of health-promoting lifestyle behaviors, the awareness of heart 
disease risk, and cardiac risk and how these relationships affect perceived QOL. No 
study – identified thus far – had examined the relationship of: depressive symptoms, 
cardiac risk, health-promoting lifestyle behaviors, awareness of heart disease risk, and 
quality of life in women at risk for CVD. 
Research Aims 
The specific aims were: 
1) To determine the relationship between depressive symptoms, the cardiac risk score, 
the health-promoting lifestyle behaviors, an awareness of heart disease risk, and the 
perceived QOL in women being screened for CVD risk.  
2) To determine whether there is a dose-response relationship between depressive 
symptoms and:  
a) The cardiac risk score (Line a in Figure 1), 
b) the health-promoting lifestyle behaviors (Line b in Figure 1), and 
c) the perceived QOL (Line c in Figure 1).  
3) To determine whether the effect of depressive symptoms on perceived QOL is 
direct or indirect (i.e., mediated by cardiac risk- d1 or health-promoting lifestyle 
behaviors-d2). (Figure 1). 
Hypotheses 
1) There is a relationship between increased depressive symptoms and:  
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a) The increased cardiac risk score, 
b) A decreased awareness of heart disease risk, 
c) Lower health-promoting lifestyle behaviors, and 
d) The lower perceived QOL in women being screened for CVD risk. 
2) There is a dose-response relationship between depressive symptoms and:  
a) The cardiac risk score, 
b) health-promoting lifestyle behaviors, and 
c) the perceived QOL. 
3) Depressive symptoms will have either a direct effect on perceived QOL or will have 
an indirect effect mediated by cardiac risk (d1) or health-promoting lifestyle 
behaviors (d2) (Figure 1). 
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CHAPTER TWO 
LITERATURE REVIEW 
 The evidence to support the aims of the study is presented in the following 
sequence: (1) the relationship between depressive symptoms, CVD risk, and ischemic 
heart disease (IHD), (2) the relationship between depressive symptoms and health 
promotion behaviors, (3) the relationship between depressive symptoms and QOL, and 
(4) variables that impact QOL. 
Methods 
 A series of searches in CINAHL, Ovid Medline, PsychInfo through December 
2009 were conducted to identify the literature to support the aims of the study. Search 
terms included: heart disease, risk factors, depression, health promotion, health-related 
quality of life, and quality of life. Searches were refined for various combinations of 
these search terms and for English, humans, studies, and reviews. ―Depressive 
symptoms‖ is not recognized as a keyword. Ancestry searches were conducted with all 
relevant references.  
Results 
 Literature that supports the relationship between depressive symptoms and CVD 
risk, IHD, and health promoting behaviors in incident CVD, yielded five systematic 
reviews and a combination of 26 prospective and observational studies. The theme of a 
dose-response relationship between depressive symptoms and incident CVD was found 
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in 20 (77%) of these prospective and observational research studies along with one 
intervention study (Iosifescu et al., 2005), and two systematic reviews (Kubzansky & 
Kawachi, 2000; Rugulies, 2002).  
 Five groups of variables were found to have a dose-response relationship with 
depressive symptoms. A dose-response relationship was found between depressive 
symptoms and cardiac risk factors such as physical activity, the metabolic syndrome, 
and the presence of unhealthy behaviors. Nonfatal IHD along with fatal IHD and all-
cause mortality were also identified as having dose-response relationships with 
depressive symptoms. Two proposed indicators of subclinical atherosclerosis, coronary 
calcium scoring and calculation of carotid intima-media thickness, were used in two 
studies that reported a dose-response relationship between depressive symptoms and 
these noninvasive cardiovascular assessments. Eight additional studies reported 
relationships between depressive symptoms and CVD albeit not a dose-response 
relationship. Lastly, a dose-response relationship was found between depressive 
symptoms and health promotion. Appendices A through E summarize the supporting 
research. Each table of studies presents the research in ascending chronological order 
listing the duration of follow-up, the samples‘ characteristics inclusive of the number of 
participants, mean age, percent female and the racial composition, the depression 
measurement instrument, and the leading findings. 
 The foundation for this study was found primarily in the literature describing the 
relationship between depressive symptoms and incident CVD. That literature summary 
is followed by a summary of the literature describing the relationship between 
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depressive symptoms and health promotion, then depressive symptoms and QOL, and 
will conclude with a summary of additional variables known to affect QOL. 
The Relationship Between Depressive Symptoms and Cardiovascular Disease Risk  
 The literature describing the relationship between depressive symptoms and 
CVD covers the continuum from depressive symptoms as independent risk factors for 
CVD to the increased risk of experiencing IHD and IHD mortality. This review begins 
with a summary of the investigation of depressive symptoms and subclinical indicators 
of atherosclerosis. The review continues with the literature describing the relationship 
between depressive symptoms and CVD risk factors, and concludes with the 
relationship of depressive symptoms to health promotion behaviors. 
Depressive Symptoms and Evidence of Subclinical Atherosclerosis 
 The noninvasive measurement of the thickness of the carotid arteries‘ intima-
media and the extent of the calcification of the coronary arteries and the aorta are being 
promoted as indicators of subclinical atherosclerosis. The current AHA heart disease 
statistics (Lloyd-Jones et al., 2009) have now added tracking of subclinical 
atherosclerosis statistics. Both intima-media thickness and vessel calcification are 
vascular changes that are part of the complex blood flow limiting atherosclerotic 
process. Two relevant studies are summarized in Appendix A. 
 Carotid intima-media thickness was measured as an indicator of subclinical 
atherosclerosis in young Finnish participants (Elovainio et al., 2005). Although more 
women than men were found to be depressed, a relationship between reduced intima-
media thickness and depressive symptoms was found at only the highest levels of 
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depressive symptoms in men. This could be because the women were still less than 30 
years old at the time of the measurement of their carotid intima-media thickness. The 
investigators posited that high levels of depressive symptoms could serve as an early 
warning sign for the development of atherosclerosis. 
 The electron beam tomography measurement of coronary artery and aortic 
calcification was used to indicate subclinical atherosclerosis in a study of the 
association of vessel calcification with depressive symptoms (Agatisa et al., 2005). A 
group of perimenopausal women without any clinical evidence of CHD were recruited 
into the Study of Women‘s Health Across the Nation (SWAN) study. Coronary artery 
and aortic calcification were identified in 45% of the women. The women with higher 
calcification scores had higher levels of CVD risk factors. Women with any coronary 
artery calcification, which was more frequent in the African-American group, tended to 
have higher depressive symptoms scores. A dose-response relationship was also 
identified; the women with a history of recurrent depression had higher calcification 
scores than those with just one episode of depression. 
 This evidence for the relationship between depressive symptoms and subclinical 
atherosclerosis is important to elucidate the role of depressive symptoms to the 
development of atherosclerosis. The next section presents the data for the relationship 
between depressive symptoms and CVD risk factors. 
The Relationship Between Depressive Symptoms and Cardiovascular Disease Risk 
 The investigation of the relationship between depressive symptoms and CVD 
risk factors is based on data that established the very concept of CVD risk factor 
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assessment. The concept of CVD risk factors was pioneered by the Framingham Heart 
Study which published in 1998 a currently used CHD risk assessment method (Redberg 
et al., 2009).The Framingham Heart Study was also a pioneer in the investigation of the 
relationship between psychological factors and CHD (Haynes, Feinleib, & Kannel, 
1980).  
 The concept of CHD and CVD risk assessments is based on decades of 
epidemiological research. This research has established a relationship pattern among a 
cluster of what are now described as ―life-habit risk factors‖ (National Cholesterol 
Education Program [NCEP], 2001) and the probability that they will increase the risk of 
developing CHD and CVD. Currently accepted life-habit risk factors are: obesity, 
physical inactivity, and a diet known to promote atherosclerosis. Additional modifiable 
CVD risk factors include: diabetes, hyperlipidemia, hypertension, and smoking. These 
risk factors are the bedrock for current CVD prevention, risk modification, and 
treatment guidelines. Non-modifiable risk factors are family history, age, gender, and 
prior heart attack. 
 The epidemiological studies of the Framingham Heart Study established the 
lexicon for heart disease assessment and validated the first global CHD risk assessment 
profile methodology (Wilson et al., 1998). The current approach to the assessment of 
CHD risk advocated by the NCEP (2001) uses the CHD risk assessment criteria 
generated by the Framingham Heart Study to calculate the gender-specific 10-year risk 
of having a cardiac event. Amid discussions of the limitations of the 1998 Framingham 
CHD risk assessment (Cooney, Dudina, & Graham, 2009; D‘Agostino et al., 2008; 
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Sacco et al., 2009) it remains one of several acceptable global risk assessments 
(Redberg et al., 2009).  
One of the points in the discussion of which is the best risk factor assessment 
method is that the 1998 Framingham risk assessment addresses ―hard‖ CHD events 
such as an MI in contrast to the expanded current interest in ―softer‖ CVD outcomes 
such as angina or stroke. Efforts to expand from CHD to CVD risk assessment have 
included the addition of diabetes and body mass index (BMI) particularly to enhance 
the ease of use in primary care (D‘Agostino et al., 2008) or the addition of waist 
circumference, alcohol consumption, and physical activity (Sacco et al., 2009). For the 
purposes of this study, the term CVD risk assessment will be used since many 
investigators identified other than cardiac events as the outcomes in their studies. 
 Continuing the line of investigation of the early cardiac risk factor 
epidemiological studies, several studies have established the data to support the 
contention that depressive symptoms are independent risk factors for CVD. 
Furthermore, these prospective studies have established that there is a dose-response 
relationship between depressive symptoms and incident CVD (Rugulies, 2002). 
Rugulies meta-analysis concluded that depressive symptoms are independent risk 
factors for CVD and that depressive symptoms increase the risk of CVD by 64%. 
 Physical activity and the metabolic syndrome are the CVD risk factors that have 
been investigated in prospective studies of the relationship of depressive symptoms to 
CVD risk factors in incident CVD. The identification of risk factor profiles further 
elucidates the relationship between depressive symptoms and CVD.  
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Physical Inactivity 
 Four longitudinal studies found an inverse relationship between depressive 
symptoms and physical activity and are summarized in Appendix B. The first study to 
describe a dose-response relationship where higher depressive symptoms were 
associated with lower levels of physical activity was the Farmer et al. (1988) study of a 
cohort from the National Health and Nutrition Examination Survey (NHANES) data. 
Both gender and racial differences were found in the relationship between depressive 
symptoms and physical activity. Women with little or no recreational physical activity 
had higher BMI, higher heart rate, and higher diastolic blood pressure. These physically 
inactive white women had twice the likelihood of depressive symptoms and black 
women had over 19 times the likelihood of having depressive symptoms. White men 
with little or no recreational physical activity were twice as likely to have depressive 
symptoms while black men with little or no recreational physical activity were more 
than 16 times as likely to have depressive symptoms. A study limitation, however, was 
the small percentage of Blacks (8%) in the sample.  
 An inverse relationship between depressive symptoms and physical activity was 
identified in postmenopausal women by the Women‘s Health Initiative Observational 
Study (WHI-OS) (Wassertheil-Smoller et al., 2004). Depressed mood was identified at 
baseline in 15.8% of the women with another 12.3% reporting a history of depressed 
mood. Exercise was defined as episodes per week of moderate or strenuous physical 
activity for  20 minutes. Women who reported more than four episodes of exercise per 
week were at half the risk of developing depression.  
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 Middle-aged women participated in the Australian Longitudinal Study of 
Women‘s Health (Brown et al., 2005) that also found an inverse relationship between 
depressive symptoms and physical activity. Regardless of exercise frequency, the 
likelihood of fewer depressive symptoms was the same with increasing levels of 
physical activity. Women who reported a high level of habitual physical activity were 
about as half as likely to develop depression compared to the women who reported a 
low level of habitual physical activity.  
 No race or gender differences were found in the inverse relationship between 
physical activity and depression in a younger cohort of African American and 
Caucasian men and women (Knox et al., 2006). Lipid profiles, however, did worsen 
only in Caucasians. Diabetes developed only in African American women, who also 
had the higher prevalence of the most frequent episodes of depression. The 
investigators concluded that even in this healthy cohort, depression was associated with 
CVD risk factors most particularly smoking, BMI, physical activity and diabetes. 
 The inverse relationship between depressive symptoms and physical activity is 
particularly relevant considering that sedentary lifestyle is frequently cited as a CVD 
risk factor. The adoption of sufficient exercise is probably the most frequently 
prescribed element to therapeutic lifestyle changes (TLC) for those identified at risk for 
CVD. Physical activity, however, is not the only CVD risk factor to be associated with 
depressive symptoms as evidenced by the findings of the following studies. 
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Metabolic Syndrome and Risk Profiles 
 Metabolic syndrome is an umbrella term for a cluster of CVD risk factors. 
Although there is some variability in the specific values for the included risk factors by 
organization or group (Johnson & Weinstock, 2006), there is consensus regarding the 
specific risk factors to be assessed. A person is considered to have the metabolic 
syndrome if they have three of the five defining risk factors: obesity, elevated 
triglycerides, decreased HDL-C, hypertension, and elevated fasting plasma glucose. 
The current guidelines for the diagnosis and management of the metabolic syndrome 
were published as a joint scientific statement by the American Heart Association and 
the NHLBI (Grundy et al., 2005). These diagnostic criteria are listed in table 2. 
Table 2. Diagnostic Criteria for Metabolic Syndrome  
Measure 
(Any 3 of 5 Criteria Constitute 
Diagnosis of Metabolic Syndrome) 
Categorical Cut Points 
(Women) 
Elevated waist circumference ≥ 35 inches 
Elevated Triglycerides ≥ 150 mg/dl or Drug treatment  
Reduced HDL-C < 50 mg/dl or Drug treatment 
Elevated BP ≥ 130 mmHg SBP or 
≥ 85 mmHg DBP or Drug treatment 
Elevated fasting glucose ≥ 100 mg/dl or Drug treatment 
  
Grundy et al., 2005, p. e286. BP – blood pressure, DBP diastolic blood pressure, HDL-
C – high density lipoprotein-cholesterol, SBP – systolic blood pressure 
 
In a study of whether psychological variables could predict the development of 
the metabolic syndrome and also if the metabolic syndrome could predict psychological 
distress, perimenopausal women were enrolled in the Healthy Women‘s Study 
(Raikkonen et al., 2002). Evidence for a dose-response relationship was found between 
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the number of metabolic syndrome risk factors and depressive symptoms. Persons with 
higher depression scores were nearly a third more likely to develop more metabolic 
syndrome risk factors than those with low depression scores. The reciprocal relationship 
hypothesis was not supported; depression scores were not increased due to the 
metabolic syndrome over the course of the follow-up.  
 A female CVD risk profile was described by the NHLBI-sponsored Women‘s 
Ischemia Syndrome Evaluation (WISE) study which reported on the association of 
depression with cardiac symptoms (Rutledge, Reis, Olson, Kelsey et al., 2006). Women 
with higher BDI scores were found to have increased CVD risk factors, lower 
socioeconomic status, and more than twice the rate of smoking (p < 0.01). Surprisingly, 
women with higher BDI scores did not have different angiogram or ischemia test 
results. Adding to the surprise, women who were treated for depression had evidence of 
less severe coronary artery disease (CAD) and were less likely to have a positive 
ischemia test, regardless of age, history of smoking, diabetes or hypertension. This 
might indicate that when depression is treated cardiac risk is reduced. This effect might 
be related to improved healthy lifestyles, improved adherence to risk modification 
treatments, or possibly to alterations in the physiological mechanisms that have been 
described as linking depression and depressive symptoms to cardiac disease. Cardiac 
symptoms, however, were increased in women with higher BDI scores. Adjusted for 
age and CAD severity, women with higher BDI scores were 30% more likely to be 
hospitalized.  
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 Whether the severity of depression was associated with high blood-pressure, 
more CVD risk factors, greater stress and lower social support was investigated in a 
sample of urban African-American women (Artinian et al., 2006). These investigators 
found that depression was a mediator between diastolic blood pressure and stress, and 
that women with more severe depression had higher diastolic blood pressures. 
 An international perspective on modifiable CVD risk factors and depression was 
provided by the INTERHEART study (Yusuf et al., 2004). This 52 country case-control 
study of myocardial infarction (MI) investigated the effect of CVD risk factors and 
whether they varied by country or ethnic group. Nine risk factors – smoking, diabetes, 
hypertension, abdominal obesity, and alcohol, physical activity, daily consumption of 
fruits and vegetables, psychosocial factors, and apolipoproteins (Apo) - accounted for 
more than 90% of the risk of an MI. The two strongest risk factors were: current 
smoking and raised ApoB/ApoA1 ratio. Adjusted for age, sex, and smoking status, 
psychosocial factors, which included depressive symptoms, increased the risk of an MI 
by two and a half times. 
 Summary. These long-term observational studies described the links between 
depressive symptoms and traditional CVD risk factors along with describing a dose-
response relationship in particular between depressive symptoms and physical activity 
and the metabolic syndrome. Some investigators have also begun to outline the risk 
profile for women. Additional evidence linking depressive symptoms and CVD risk 
factors will be addressed in the section describing the relationship between depressive 
symptoms and health promotion behaviors. The next set of studies describes the 
20 
 
relationship of depressive symptoms and IHD which includes the increased risk of IHD 
mortality.  
The Relationship Between Depressive Symptoms and Ischemic Heart Disease 
 The investigation of the relationship between depressive symptoms and IHD has 
deep historical roots. In their review of the epidemiology of comorbid coronary artery 
disease and depression, Rudisch and Nemeroff (2003) credited a report published in 
1937 as the seminal work linking depression and heart disease. They cited Malzberg‘s 
finding that in patients hospitalized with ―involutional melancholia… their age-adjusted 
mortality rate was approximately 6 times that of the general population, with 40% of 
these deaths due to ‗diseases of the heart‘ ‖ (p. 227). 
 Cassem and Hackett, working in the 1960‘s and 1970‘s, were pioneers in the 
investigation of the behavioral response to an MI (Rudisch & Nemeroff, 2003). Cassem 
and Hackett described ―a stereotyped post-MI course … which included an anxious 
response for the first 2 days post-MI, followed by a depressive response‖ (Rudisch & 
Nemeroff, 2003, p. 228). Subsequent decades of research have investigated the 
relationship between depressive symptoms and the increased risk for IHD, IHD 
mortality, and the behavioral response to acute myocardial infarction (AMI) (Barth et 
al., 2004; Carney et al., 2003), heart failure (Rutledge, Reis, Linke et al., 2006), post 
coronary artery bypass surgery (Connerney et al., 2001), and post-percutaneous 
coronary interventions (PCI) (Astin, Jones, & Thompson, 2005). 
 Because women being screened for CVD risk were the population of interest for 
this study, the investigation of the relationship of depressive symptoms to incident CVD 
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studies is relevant. A series of prospective and observational studies linking depressive 
symptoms to incident CVD continue to provide evidence for the effect of depressive 
symptoms on IHD. This literature is divided into studies of the association of depressive 
symptoms in nonfatal IHD to be followed by the literature summary of the association 
of depressive symptoms to fatal IHD and all-cause mortality. 
Depressive Symptoms and Nonfatal Ischemic Heart Disease 
 Fourteen studies, summarized in Appendix C, investigated the relationship 
between depressive symptoms and incident CVD and found an increased risk of 
experiencing nonfatal IHD. Ten of these studies reported a dose-response relationship 
between depressive symptoms and nonfatal IHD (Anda et al., 1993; Ariyo et al., 2000; 
Barefoot & Schroll, 1996; Ferketich et al., 2000; Gilmore, 2008; Hallstrom et al., 1986; 
Pratt et al., 1996; Sesso et al., 1998; Thurston & Kubzansky, 2007; Wassertheil-Smoller 
et al., 1996). Some of these studies also found an increased risk of fatal IHD and/or all-
cause mortality and their review will follow this summary of the nonfatal IHD studies. 
 Three studies used some version of the NHANES data (Anda et al., 1993; 
Ferketich et al., 2000; Thurston & Kubzansky, 2007). The depressed 10.8% of the 
nearly 3,000 adults from the National Health Examination Follow-up Study (NHEFS) 
from the NHANES data (Anda et al., 1993) were found to have a 60% increased risk of 
experiencing a nonfatal IHD event such as angina or an MI. A gender difference in 
dose-response relationship was identified in another examination of the NHANES data 
(Ferketich et al.) Nonfatal events in women were associated with higher levels of 
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depression than in men with nonfatal cardiac event risks with each 1-point CES-D score 
over 20 for women and over 12 for men. 
 Using the first NHANES through the follow-up studies, a study of the multiple 
occurrences of psychosocial risks was undertaken to identify the effect on incident 
CHD (Thurston & Kubzansky, 2007). The psychosocial risks were education, 
employment, income, being a single parent, marital status, and depressive and anxious 
symptoms. While there was a dose-response relationship between increased numbers of 
psychosocial risks and incident CHD, this was more pronounced in women. Women 
also were found to have a graded increase in BMI alone or in combination with any 
other psychosocial risks. Single parents were found to have the strongest association 
between depressive symptoms and incident CHD, especially if they were divorced or 
widowed. 
Three studies of elderly men and women free of documented CVD at baseline 
identified that more women than men were depressed at baseline (Ariyo et al., 2000; 
Barefoot & Schroll, 1996; Wassertheil-Smoller et al., 1996). These studies, however, 
reported different gender or racial patterns for an increased risk of developing CHD 
with increased depression scores. In the Ariyo et al. study, higher baseline depression 
scores were also found in nonwhite, less educated, lower income, and smoking 
participants with a history of diabetes, and those who had problems with activities of 
daily living or lower social support scores. In the Barefoot and Schroll study, depressed 
women were more likely to smoke, have higher BMI and be hypertensive. The 
participants in a randomized placebo controlled trial of the treatment of isolated systolic 
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hypertension, reported higher depressive symptom scores in Blacks and Hispanics than 
in Whites and Asians (p ≤ .001) (Wassertheil-Smoller et al., 1996).  
 A report from the Normative Aging Study of all male participants (Sesso et al., 
1998) added a unique dimension to the investigation of depression and the risk of 
incident CVD. The investigators used multiple depression scales to investigate whether 
higher depression scores were associated with increased risk of CVD. The two 
depression scales (MMPI-2 D and MMPI-2 DEP) from the revised version of the 
Minnesota Multiphasic Personality Inventory (MMPI-2), and the depression scale from 
the Symptom Checklist-90 (SCL-90) were correlated with the CES-D to test for 
convergent validity. The highest percentage of subjects across the tertiles who had a 
CES-D ≥ 16 also scored in the highest tertile of each scale. The authors reported that 
they found regardless of scale a ―strong‖ dose-response relationship between depressive 
symptoms and the incidence of both angina and nonfatal MI. 
A systematic community sample of women was recruited to investigate the 
relationships of personality factors, psychological stressors, mental disorder, and the 
experience of strain (all determined through psychiatric examinations), to the incidence 
of IHD (Hallstrom et al., 1986). High baseline passive dependency, neuroticism, strain 
experience, and the grade and severity of mental disorder including depression 
predicted IHD. A dose-response relationship was identified between depressive 
symptoms and IHD.  
 A unique sample in this group of studies recruited the Baltimore survivors of a 
national study of the prevalence and incidence of clinically defined psychiatric 
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disorders to investigate whether they had experienced an MI (Pratt et al., 1996). The 
study investigated whether the psychotropic medications they had been taking and the 
clinical diagnosis of a major depressive disorder (MDD) or dysphoria contributed to the 
incidence of an MI. Age and gender differences were found related to the severity of the 
depression, for example dysphoric participants tended to be younger and female than 
those without depression but were older than the MDD group. The dose-response 
relationship between depression and an MI was found for both dysphoria and MDD. 
The odds were similar across three models which differed by the inclusion of alcohol, 
panic disorder, phobia, and ever-use of psychotropic medications in addition to the 
covariates of age, sex, marital status and hypertension. 
 In the first ever Canadian study of the relationship between depression and the 
risk of heart disease, the risk of an incident heart disease event was significant only for 
depressed women (Gilmore, 2008). Depressed women tended to be in the low-to- 
middle income group, have high blood pressure, be diabetic, be current smokers, not 
partake in non-leisure physical activity, and be moderate to heavy drinkers.  
 Five studies found a relationship between depressive symptoms and IHD 
although not a dose-response relationship. The possible contributing factors to this 
absence of a dose-response relationship include the limited (55% was the maximum 
female enrollment in a study) to no female participants (Ford et al., 1998) and a slightly 
younger and narrower age range of the participants (age 55-66).  
 A European cohort of post-PCI patients was studied to establish the 
development of depression following a PCI (Astin et al., 2005). Compared to pre-PCI 
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baseline testing, depression scores were lower at 6-8 weeks and six months post-PCI 
but were higher at eight months post-PCI. 
 The Precursors Study enrolled male medical school graduates (Ford et al., 
1998). They were followed for a median of 37 years to investigate whether clinical 
depression was an independent risk factor for incident CVD. In the depressed men, 
there was more than twice an increased risk of CHD and of an MI. The increased risk 
for a first MI was sustained for 10 years after the first depressive episode.  
Scottish men and women were investigated to determine whether there was an 
increased risk of CHD in participants with psychological distress (Rasul, Stansfeld, 
Hart, & Davey-Smith, 2005). While there was a statistically increased risk of CHD 
events at five years in psychologically distressed men, the increased risk in 
psychologically distressed women was not statistically significant. One of the study 
limitations is that the General Health Questionnaire is a screening and not a diagnostic 
measurement. No structured interviews confirmed the specific type of mental disorder. 
 Two reports discussed the findings from the landmark INTERHEART study 
(Rosengren et al., 2004; Yusuf et al., 2004). Depression was found in 24% of the 
participants and was associated with an MI regardless of ethnicity and was increased 
with depression regardless of depression score (Rosengren et al.). Adjusted for age, sex, 
and smoking status, there was a two and a half increased likelihood of having an MI 
with the presence of depressive symptoms (Yusuf et al.).  
Summary. The evidence supporting a dose-response relationship between 
depressive symptoms and nonfatal IHD was provided by 10 out of 14 long-term 
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observational studies in a variety of participant groups. Gender and racial differences 
were generally identified with higher risks for a nonfatal IHD being found in women 
and Blacks and in people with modifiable CVD risk factors such as obesity, 
hypertension, and smoking. The relationship of depressive symptoms to nonfatal IHD 
was also supported by five studies that did not report it as a dose-response relationship. 
Two of these reports were generated from the landmark 52 county INTERHEART 
study which substantially added to the generalizability of the overall findings. The next 
section extends the link between depression to fatal IHD and all-cause mortality. 
Depressive Symptoms, Fatal Ischemic Heart Disease and All-Cause Mortality 
 Increased IHD mortality was found to be associated with depressive symptoms 
in three of the prospective studies of depressive symptoms in incident CVD and are 
summarized in Appendix D (Anda et al., 1993; Pennix et al., 2001; Wassertheil-Smoller 
et al., 1996). Increased all-cause mortality was found to be associated with depressive 
symptoms in five of these prospective studies (Ariyo, et al., 2000; Barefoot & Schroll, 
1996; Ferketich et al., 2000; Gump et al., 2004; Wulsin et al., 2005) (Appendix D). 
 The studies that found an increased risk of IHD mortality in participants with 
depressive symptoms had large sample sizes in common and just over half of the 
participants were female. Most participants were White and the mean ages were just 
over 70 in two studies (Pennix et al.; Wassertheil-Smoller et al., 1996) and a younger 
cohort – mean age 57.5 years - in the Anda et al. (1993) study. The risks for increased 
IHD mortality were 25% (Wassertheil-Smoller et al.), 50% (Anda et al.) and 60% 
(Pennix et al.). A dose-response relationship between depressive symptoms and IHD 
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mortality was reported by Anda et al. who found 4% increased risk of IHD mortality for 
each unit increase in depressive symptom scores and by Pennix et al. also reported a 5-
times increased risk with minor depression and a 10-times increased risk with major 
depression. 
 The studies that found an increased risk of all-cause mortality in participants 
with depressive symptoms also had study characteristics in common. The sample sizes 
were large, most study samples were comprised of over half female participants with 
one all male study (Gump et al., 2004). Four of the studies‘ mean ages were quite 
similar, ranging from 50 to 59.9 with one older participant group (Ariyo et al., 2000) 
with a mean age of 73. When race was reported, the racial composition was also mostly 
White. 
 The increased risks for all-cause mortality were 16% (Ariyo et al., 2000), 21% 
(Ferketich et al., 2000), and 59% (Barefoot & Schroll, 1996). A 3% increased risk of 
mortality for each higher quintile of depressive symptom scores was reported by Gump 
et al. (2004) in the unique Multiple Risk Factor Intervention Trial (MRFIT).  
 A dose-response relationship between depressive symptoms and mortality were 
also reported by a multi-generational Framingham Heart Study (Wulsin et al., 2005). 
This study, comprised of original study and offspring study participants, was designed 
to examine the relationship of depressive symptoms to CHD. Depressive symptoms 
were more likely to be seen in women, current smokers, and in younger participants 
(mean age 50 ± 13). Although depressive symptoms declined with advancing age, 
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women‘s scores were consistently higher than men‘s scores. No gender differences 
were found in the relation of depressive symptoms to IHD or all-cause mortality.  
 A narrative review of negative emotions and CHD posited that the data 
indicated that there was a dose-response relationship between depressive symptoms and 
mortality (Sirois & Burg, 2003). The reviewers suggested that mortality risk was higher 
when depression criteria included only emotional/cognitive symptoms than when 
somatic complaints were included in the depression diagnostic criteria for major 
depression. This suggestion adds a dimension to the concern for the somatic overlap 
measurement question between depression diagnostic criteria and comorbid medical 
illnesses somatic complaints.  
 Summary. While the risk percentage varied for both increased fatal IHD and all-
cause mortality, increased depressive symptoms contributed to this increased risk 
regardless of age or gender. While the sample sizes were generally large, the racial 
composition was overwhelming White, which limits the generalizability to other racial 
and ethnic groups. When gender differences were reported, women experienced higher 
risk for fatal IHD and all-cause mortality associated with their depressive symptoms. 
 Given this review of the literature supporting the relationship between 
depressive symptoms, CVD risk, nonfatal IHD, fatal IHD, and all-cause mortality, it is 
important to examine the evidence linking depressive symptoms to health promotion. 
Most of this literature supports that depressive symptoms are associated with unhealthy 
behaviors and furthermore suggests that the presence of depressive symptoms lessen the 
probability of adopting and/or being able to maintain a health promoting lifestyle. 
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The Relationship Between Depressive Symptoms and Health Promotion Behaviors 
 The examination of the literature linking depressive symptoms to health 
promotion includes data from an ongoing national survey of health behavior patterns, 
and studies that report on the relationship of depressive symptoms to decreased health 
behaviors. The concept of awareness of heart disease risk will be discussed along with 
the data to support the link between depressive symptoms and the decreased ability to 
adhere to medical treatment plans, which for the CVD risk prone person would include 
TLC prescriptions. 
 The Centers for Disease Control and Prevention (CDC) in partnership with state 
health departments conducts surveys of United States adults through the Behavioral 
Risk Factor Surveillance System (BRFSS). The BRFSS compiles ongoing patterns of 
health risks, health-related behavior, and modifiable risk factors for CHD among other 
chronic diseases (Ashaye & Giles, 2003). Based on data from the year 2000 BRFSS, a 
study was designed to examine whether persons with CHD were more or less likely to 
engage in healthy lifestyle behaviors (HLBs).  
The survey results described very low adherence to four basic HLBs: (1) 
maintaining an ideal body weight (BMI < 25.0), (2) eating five or more fruits and 
vegetables daily, (3) performing at least 30 minutes of leisure time physical activity, 
and (4) being a non-smoker (former and never smokers) (Ashaye & Giles, 2003).  
These are all key CVD health promotion behaviors. The pattern of following HLBs was 
very similar in both the CHD and non-CHD groups with less than 10% following all 
four HLBs. Coronary heart disease respondents were likely to be former smokers, 
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physically inactive, overweight or obese, and to consume fewer fruits and vegetables 
each day. 
 From the prospective literature reporting on the relationship of depressive 
symptoms to incident CVD, two studies (Appendix E) examined risk behaviors (Bonnet 
et al., 2004; Rosal et al., 2001) and one study provided a profile of participants least 
likely to participate in a healthy behavior (Farmer et al., 1988) (Appendix E). 
 Those who reported the lowest levels of non-recreational physical activity and 
depressive symptoms in the first NHANES data (Farmer et al., 1988) were more likely 
to be the less educated, lower income, black, and older participants. These older data 
present a similar profile of participants with the unhealthiest pattern from the BRFSS 
data. 
 To investigate how the co-occurrence of unhealthy behaviors can increase the 
risk of disease, Rosal et al. (2001) examined the pattern of four health risk behaviors 
(i.e., smoking, high-fat diet, sedentariness, and high-risk drinking) and psychosocial 
variables. Two or more risk behaviors were found in 43% of the participants. A high-fat 
diet and sedentariness were the most frequent risk behaviors‘ combination. 
Furthermore, a dose-response relationship was found between depressive symptoms and 
the number of risk behaviors so that as the depressive symptoms increased so did the 
number of risk behaviors.  
 Participants who were referred to a CVD risk factor prevention program were 
recruited to participate in an investigation of how adherence to heart healthy behavior 
guidelines was associated with depression and anxiety (Bonnet et al., 2004). A detailed 
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analysis was conducted of their diet, alcohol consumption, and laboratory assessment of 
dyslipidemia in addition to measurement of other CVD risk factors: BMI, blood 
pressure, smoking, recreational physical activity, and diabetes. A composite score of 0, 
1, or 2 was created from these unhealthy behaviors to indicate the degree of adherence 
to guidelines. A score of zero represented adherence to guidelines while a score of two 
indicated a maximum guidelines deviation.  
 The participant profile revealed that women were more anxious and depressed 
(Bonnet et al., 2004). Grouped by depression severity, scores for diet, smoking, 
physical inactivity and a combined score were all increased from mild to marked 
depression for both men and women. Women scored worse than men only for physical 
inactivity. There was no gender difference for the dose-response relationship between 
depression and the odds of having unhealthy behavior. Men and women were both more 
than twice as likely to have unhealthy behaviors when they were mildly depressed and 
were five times as likely to have unhealthy behaviors when they were markedly 
depressed.  
 Summary. Depressed people and particularly depressed women lead unhealthy 
lifestyles. Physical inactivity and poor nutrition most likely contributed to the increased 
obesity. Evidence was presented to support the dose-response relationship between 
depressive symptoms and CVD most likely begins with the degree of an unhealthy 
lifestyle. 
 Given these relationships between depressive symptoms and CVD risk and the 
onset of IHD, what do we know about women‘s awareness of heart disease? While we 
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know that knowledge does not mean behavior will change, if one is not aware of her 
risk of developing a disease, what is the likelihood that risk modification behavior will 
be adopted? 
Awareness of Heart Disease Risk 
 When discussing awareness of heart disease risk in women today, it is relevant 
to mention the role of health education directed to women to increase their awareness of 
heart disease. Since the early 1990‘s, government agencies such as the NHLBI and the 
National Women‘s Health Information Center (NWHIC), and professional 
organizations like the AHA, the Preventive Cardiovascular Nurses Association, and the 
Association of Women‘s Health, Obstetric, and Neonatal Nurses (AWHON) have been 
actively involved in the development and dissemination of CVD health education for 
both the professional and lay education. It remains vital to increase the awareness of 
healthcare providers to advances in CVD primary and secondary prevention because 
women depend a great deal on the health education they receive during routine 
healthcare provider visits and attendance at CVD risk screening programs (Rosenfeld, 
2006; Wenger, 2003). 
 The most recent AHA survey of women indicated that there has been an 
improvement in women‘s awareness of heart disease risk in the 12 years from the first 
survey in 1997. Despite the improvement, a large number of women (46%) remained 
unaware that heart disease is their number one killer with African-American and 
Hispanic women significantly less aware than White women (Mosca, Mochari-
Greenberger, Dolor, Newby, & Robb, 2010). In the prior survey, a majority of the 
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survey‘s respondents could not state the health levels of risk factors (Mosca, Mochari et 
al., 2007). Most significantly, they were unable to correctly classify their own CVD risk 
(Mosca, Mochari et al.). A further finding from the 2007 survey sends a strong message 
to those providing CVD risk modification education to women. A majority of the 
women reported confusion about CVD risk prevention strategies (Christian et al.) which 
extended to the 2010 findings (Mosca et al., 2010). Most women‘s perception of their 
risk was associated with risk modification strategies being provided by their healthcare 
provider (Mosca, Mochari et al.). Two barriers to heart disease prevention were 
reported by about half of the current survey respondents: busy providing care to their 
families and confusing messages in the media (Mosca et al., 2010).  
 While an in-depth discussion of risk perception is beyond the scope of this 
review, there have been studies conducted investigating the awareness of heart disease 
risk and risk perception. Risk perception is a key concept to be considered when 
discussing the acquisition and implementation of health promotion strategies. Risk 
perception is also described as perceived risk, perceived vulnerability, or perceived 
susceptibility in the health-protection behavior literature (Gerend, Aiken, West, & 
Erchull, 2004).  
 Surprisingly only 35% of women who were interviewed following an elective 
coronary artery angiography procedure recalled having been told they were at risk for 
CHD (King et al., 2002). This is surprising considering the majority of the women 
(83.6%) had  3 risk factors; another 12.2% had one or two risk factors, with less than 
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1% having no risk factors. The women who did not recall having been told they were at 
risk for CHD did not perceive their CVD risk prior to their elective procedure. 
 The relationship between knowledge of CVD and risk perception was 
investigated in a sample considered to be at high risk for CVD (Homko et al., 2006). 
The participants were recruited to participate in a telemedicine program designed to 
reduce their CVD risk. This sample was an interesting blend of rural (56%) and inner-
city (44%) men and women (44%). Overall, the women scored higher on CVD risk 
knowledge, had statistically lower actual CVD risk measured by the Framingham 10-
year risk index, but had significantly higher perceived risk compared to the men. Inner 
city participants were significantly less knowledgeable with lower perceived risk which 
indicates a need to increase both their knowledge of heart disease and awareness of 
their risk of CVD. 
 How perceived risk is formed has been studied. Women from a mammography 
screening program and a hormone replacement therapy study were investigated (Gerend 
et al., 2004). The model generated by this study revealed that epidemiological factors 
explained a small to moderate amount of the perceived susceptibility variance. 
Perceived susceptibility can be measured as direct comparative risk and absolute risk. 
Direct comparative risk is comprised of how a woman perceives herself as being similar 
to a woman who has experienced CHD and her awareness of her actual disease risk.  
Perceived susceptibility explained more than the calculated cardiac risk.  
As the women aged, their perceived risk decreased which was opposite to the 
age-perceived risk correlation in younger women. Gerend et al. (2004) examined this 
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surprising finding by examining possible mediators. Their analysis suggested that 
perceived prevalence, perceived similarity, and absent/exempt beliefs were the 
mediators between age and perceived risk. These findings about risk perception provide 
an important insight into health promotion programs. Although the Gerend et al. study 
did not measure affective mood such as depressive symptoms in their psychological 
factors items, examination of this variable may provide insight into one‘s risk 
perception. Might it be that someone who is depressed has a decreased perception of 
their cardiac risk?  
 Another important consideration in the complex analysis of health promotion 
behaviors is that of adherence to health promotion recommendations. Once we have 
made persons aware of their risk of CVD, the next step to improving health is outlining 
for them what they can do to reduce their risk. The next section presents a brief 
discussion of the relationship of depressive symptoms to adherence. 
Depressive Symptoms and Adherence 
 Depressive symptoms decrease one‘s ability to adhere to/comply with 
recommendations to alter unhealthy behaviors and other aspects of a medical treatment 
plan (Barefoot & Schroll, 1996; DiMatteo et al., 2000; Katon, 2003; Vinkers et al., 
2005). The authors of the often cited meta-analysis of the relevant literature for the link 
between depressive symptoms and nonadherence posited that nonadherence (also 
known as noncompliance) was a behavioral mediator that linked depression and 
complications of medical treatment (DiMatteo et al., 2000). They concluded that 
depressed patients were three times more likely to be noncompliant with treatment 
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plans.This finding contributes to the understanding of why there are less desirable 
medical outcomes in depressed and anxious patients. Nonadherence to a treatment plan, 
therefore, can contribute to increased morbidity and mortality regardless of the medical 
disorder. Nonadherence is amplified in CHD due to the higher rates of depression in 
this patient population (Katon, 2003). These findings support the advisability of 
screening for depression when one is proposing a health promotion plan to patients to 
reduce their CVD risk. What might the characteristics be of those who actually have 
adhered to a lifestyle intervention program? 
 The women who participated in a study of long-term participation in a lifestyle 
intervention program could be seen as exemplars of excellent adherence (Westerstahl et 
al., 2002). To examine if the awareness of CVD risk factors and CVD risk status 
influenced long-term participation in health promotion interventions, eight women who 
had participated in a community-based lifestyle intervention program were the subjects 
of a qualitative study (Westerstahl et al.). The investigators identified three core 
concepts which explained how the women dealt with their risk factors and sustained 
their high motivation for continuing long-term in the program: (1) there is no one but 
yourself to rely on, (2) resisting invasion, and (3) living with incompatibility. Resisting 
invasion represented feelings expressed about ―taking control over uncertainty‖ (p. 25), 
and remaining on target with the prescribed intervention despite distractions. Living 
with incompatibility represented expressions of how the women essentially translated 
the medical information they had been given. Part of this challenge was dealing with 
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the professionals‘ use of disease risk language. The women did not understand the 
meaning of risk factors.  
 The participants in a post-operative cardiac rehabilitation program were asked to 
describe their adherence to the cardiac rehabilitation program‘s specific health 
behaviors and general recommendations (Spernak, Moore, & Hamm, 2007). Lower 
satisfaction with physician interactions and what was described as the participants ―less 
constructive thinking‖ mediated the association found between greater depression and 
lower adherence. It would seem that these cardiac rehabilitation patients were dealing 
with a similar ―incompatibility‖ as were the highly motivated women in the long-term 
intervention study. 
 The challenge for healthcare providers, particularly those who manage health 
promotion programs, is assisting participants to achieve this high level of self-efficacy 
and self-awareness. This should begin with using language that promotes understanding 
inclusive of the issues of health literacy which remain an identified healthcare disparity 
(AHRQ, 2009). Being ―at risk‖ or even discussing ―risk modification‖ may not 
communicate the positive perspective that will motivate adherence. The competence-
orientation of the HPM which does not use fear or threat as the motivational basis for 
behavior change would seem to be supported by the themes identified in the 
Westerstahl et al. (2002) study. 
 Having considered the literature supporting the link between depressive 
symptoms along the continuum from depressive symptoms as independent risk factors 
for CVD to depressive symptoms increasing the risk for IHD and mortality, it is 
38 
 
relevant to examine how depressive symptoms relate to quality of life. Quality of life is 
the specified outcome for this proposed study and a basic precept of the Health 
Promotion Model (HPM). 
The Health Promotion Model 
 The HPM (Appendix F) incorporates the complexity of human behavior. It is, 
therefore, a logical framework for investigating the relationship of variables where 
successful health promotion and improved perceived QOL are desired outcomes. Many 
studies have used the HPM to describe the factors that constitute the complex 
interactive tapestry of individual characteristics and experiences with behavior-specific 
cognitions and affect (Young, Taylor, & McLaughlin-Renpenning, 2001). These 
interactions lead to the desired behavioral outcome of adopting health promoting 
behavior after committing to a plan of action that can be mediated by immediate 
competing demands and preferences. No studies have been identified thus far, however, 
that used the HPM to investigate the relationship of depressive symptoms to CVD or 
evaluation of CVD risk modification strategies. 
 The HPM is constructed to assess the interrelated variables that can promote and 
hinder the desired outcomes of health promoting behavior. The variables for the study 
addressed the components of the individual characteristics and experiences along with 
the components of the behavior specific cognitions and affect. The study addressed the 
personal factors through measurement of biological factors (measured by the CVD risk 
profile), psychological factors (limited to the measurement of depressive symptoms and 
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risk awareness), and socio-cultural factors (measured by the socioeconomic variables). 
The behavioral outcome elements were investigated in this study. 
 The HPM is also a good fit for an investigation where QOL is the outcome 
measure. The authors of the HPM posited an inextricable link between health and QOL. 
They described health promotion and health protection as corresponding processes that 
are fundamental to QOL through all developmental stages (Pender et al., 2006). While 
the HPM can assist us with tailoring risk modification strategy education and programs 
for women expressing an interest in improving their health by taking the first step in 
attending a CVD risk screening program, we need to examine the relationship between 
depressive symptoms and QOL as the desired outcome to health promotion. 
The Relationship Between Depressive Symptoms and Quality of Life 
 The phenomenon of quality of life is widely discussed, often measured, and 
avidly pursued with hopes that it shall be achieved and sustained. The impacts of 
disease, diagnosis, and treatment have been found to profoundly alter the person‘s 
perspectives of their QOL. Quality of life has been linked with health at least since the 
World Health Organization (WHO) 1947 definition of health ―as a state of physical, 
mental and social well-being and not merely the absence of disease‖ (King & Hinds, 
1998, p. xi) because well-being is often identified as a sub-concept of QOL. Quality of 
life was explicitly linked with health in 1978 when the WHO stated that individuals 
have a right to psychosocial care and an adequate QOL in addition to physiologic care 
(WHOQOL, 1995).  
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 For over twenty years, it has been accepted that CVD investigations also include 
the measurement of QOL to indicate the outcome for a proposed intervention (Wenger, 
Matteson, & Furburg, 1984). In both nursing and medical research, QOL continues to 
be an important CVD outcome indicator (Delunas & Potempa, 1999; King, Porter, 
Norsen, & Reis, 1992; Penckofer, Ferrans, Fink, Barrett & Holm, 2005; Ruo et al., 
2003; Spertus & Green-Conaway, 2004). Quality of life is also known to be 
compromised in people suffering from depressive symptoms (NIMH, 1999; Ruo et al., 
2003). 
 For decades there have been theoretical discussions of what is QOL, what 
should be included in its measurement, and perhaps most significantly, which 
perspective will guide these decisions. The term health-related quality of life (HRQOL) 
has been proffered to differentiate QOL investigations in healthcare as distinct from 
QOL investigations in other disciplines. Wilson and Cleary (1995) defined HRQOL as 
―the aspects of quality of life that relate specifically to a person‘s health‖ (p. 60). 
Wilson and Cleary developed a model of HRQOL that was later revised by Ferrans and 
colleagues (2005) (Appendix G). The model has been used extensively in research in 
assessing QOL outcomes in various populations: women who have had CABG surgery 
(Penckofer, Ferrans, Fink, Barrett, & Holm, 2005), adults with stable CAD (Ruo et al., 
2003), persons with heart failure (Heo, Moser, Riegel, Hall, & Christman, 2005), and 
AIDS (Sousa & Kwok, 2006). 
 One study using this model reported that emotions significantly impacted on 
QOL. Hofner et al. (2005) examined patients just before having a cardiac 
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catheterization and then again at one and three months post-catheterization. Physical 
functioning and anxiety were found to exert the greatest effect on global HRQOL. 
Global HRQOL was conceptualized as being comprised of emotional HRQOL, physical 
HRQOL, and social HRQOL. Depression, anxiety symptoms, and trait anxiety all were 
highly related to emotional HRQOL. Anxiety had a weak but positive correlation to 
symptom status which the investigators stated that with higher levels of anxiety the 
patients reported more severe symptoms. Studies of the effects that moods have on 
cardiovascular health and QOL have been reported. 
Depressive Symptoms and Quality of Life in Cardiovascular Disease Research Studies 
 Quality of life in women with CVD and depressed mood has been investigated. 
Although different measures of QOL were used, the relationship between depressive 
symptoms or depressed mood and QOL was consistent. Depressive symptoms and 
depressed mood were associated with decreased satisfaction with life. 
 Women who have had an MI have reported decreased satisfaction with life 
while women who have had CABG surgery reported an overall improved satisfaction 
with life. Kamm-Steigelman et al. (2006) found that 49% of post-MI middle-aged 
women were depressed and they reported a very low satisfaction with life measured by 
Diener‘s five-statement Satisfaction with Life Scale. Another study of women nearly 
one year post their first MI, also reported that depression reduced the overall QOL 
measured by the SF-36 (White & Groh, 2007). A study investigated the response of 
women to CABG recovery (Penckofer et al., 2005). Measured by the Quality of Life 
Index (QLI), the overall improvement in QOL was primarily due to improved health 
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and functional status. Interestingly, although not statistically significant, depressed 
mood improved while troublesome psychological effects persisted in many of the 
women. 
 The link between depressive symptoms and QOL was studied in the 1995-2000 
annual BRFSS surveys to describe the burden of mental distress in the United States 
(Kobau, Safran, Zack, Moriarty, & Chapman, 2004). Over the course of those surveys, 
over 166,500 respondents answered the question, ―During the past 30 days, for about 
how many days have you felt sad, blue, or depressed?‖ The number of sad, blue or 
depressed days (SBDD) was the measure of depressive symptoms. Overall, the survey 
respondents reported a SBDD of 3 (95% CI, 2.9-3.1). Consistent with prevalence data 
for depression and depressive symptoms, women reported more SBDD. An increased 
frequency of SBDD was seen with decreased HRQOL, which the investigators posit as 
indicating the burden of decreased life satisfaction imparted by this measure of 
depressive symptoms. Additional understanding of the burden of depressive symptoms 
through a negative impact on QOL is provided by another large study. 
 The BRFSS data from 2004 was used to examine gender differences in CHD 
and HRQOL (Ford et al. 2008). The presence of CHD was associated with significantly 
worse HRQOL particularly in women. Four HRQOL questions have been developed by 
the CDC and were found to have good construct validity with the SF-36. One of the 
four questions asked about the frequency during the prior 30 days of mentally unhealthy 
days related to stress, depression, and problems with emotions. People with CHD 
reported worse HRQOL, particularly women. While the question regarding mental 
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health does not single out depressive symptoms, this survey of 50,573 adults from 10 
states is particularly relevant from a public health perspective.  
 The socioeconomic burden of depressive symptoms as a function of impaired 
daily function was described in residents who participated in the NIMH 
Epidemiological Catchment Area Survey (ECA) (Judd, Paulus, Wells, & Rapaport, 
1996). Ten functional domains which included social irritability, household strain, 
social contacts, major financial loss and financial strain, talking to someone about 
personal problems, and days with restricted activity from physical illness were 
examined. Significantly more of the sample with depressive symptoms (11.3% of the 
sample) reported disability on seven of the 10 functional domains. The greatest 
disability, defined as having high levels of impaired function, was reported in the 
following domains: social irritability, household strain, and financial strain. Mental 
health was also rated as poor by the depressive symptoms group.  
 An intriguingly entitled study, The Heart and Soul Study, recruited participants 
with CHD to explicitly investigate how depressive symptoms and cardiac function each 
contributed to health status measures, including QOL (Ruo et al., 2003). The authors 
said the Seattle Angina Questionnaire was used to measure QOL because it was based 
on the Wilson and Cleary HRQOL model. A dose-response relationship between 
depressive symptoms, as measured by the Physician Health Questionnaire-9 (PHQ-9), 
and all health status measures was reported. An inverse relationship was found between 
depressive symptoms and QOL, symptom burden and physical limitation. Depressive 
symptoms were found to be independently associated with all the health status measures 
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after adjusting for cardiac function measures (e.g., resting left ventricular ejection 
fraction and wall motion score index at peak exercise), and patient characteristics (age, 
sex, medical history, medications and known CVD risk factors).  
 In a contrasting sample of healthy adult twins, a prospective cohort study 
investigated the relationship between depressive symptoms and life satisfaction 
(Koivumaa-Honkanen, Kapiro, Honkanen, Viinamaki, & Koskenvuo, 2004). The study 
was designed to assist the screening for depression. The investigators concluded that the 
4-item life satisfaction scale can identify people who have a high risk of having or 
developing depressive symptoms. The four life satisfaction items asked how the 
respondent would currently rate their life with regards to being interesting, happy, easy, 
and lonely. The investigators reported a strong linear correlation (r = 0.6) between the 
life satisfaction scale and the depressive symptoms scored by the BDI. Furthermore, the 
life satisfaction items explained 37.2% of the variance in BDI scores. Life satisfaction 
scores were also able to predict the risk of developing moderate to severe depressive 
symptoms. After adjusting for age, sex, marital status, social class, alcohol 
consumption, current smoking, and physical activity, a dose-response relationship was 
identified between increased dissatisfaction with life and the eevelopment of depressive 
symptoms.  
 Quality of life, measured by the SF-36 and the Assessment of Quality of Life, 
was examined in patients hospitalized with a cardiac diagnosis (unstable angina, MI, 
arrhythmia, heart failure, CABG, or PCI) (Cheok, Schrader, Banham, Marker, & 
Hordacre, 2003).  The depressive symptoms group had a lower QOL.  
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 Depressive symptoms are associated with diminished QOL in healthy subjects, 
subjects with confirmed CHD, and subjects hospitalized with a cardiac diagnosis. 
Depressive symptoms can increase the risk of socioeconomic burden mediated by 
diminished QOL. Diminished QOL can increase the risk of developing depressive 
symptoms. Given the increased prevalence of depressive symptoms in CVD, and the 
diminished QOL in CVD, it is important to examine variables beyond CVD that can 
affect QOL.  
Variables Affecting Quality of Life 
 Investigations of the relationship of depressive symptoms to CVD have 
identified that depressive symptoms have an inverse relationship with physical activity 
and the number of health-promoting behaviors. As the severity of depressive symptoms 
increased the level of physical activity decreased as well as the number of health-
promoting behaviors (Brown et al., 2005; Farmer et al., 1988; Raikkonen et al., 2002; 
Wassertheil-Smoller et al., 2004). Increased severity of depressive symptoms has also 
been associated with increased numbers of metabolic syndrome risk factors (Raikkonen 
et al., 2002). These and others studies have identified the CVD risk factors, which 
describe part of the health status of participants, that need to be included in adjusted 
models of the relationship between depressive symptoms and an outcome measure in a 
CVD population. 
 While geared for large epidemiological surveys, the CDC (2000) delineated 
variables of interest when investigating HRQOL. The CDC includes sociodemographic 
variables in investigations of HRQOL. Their current 4-item measurement of HRQOL 
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asks respondents about their general health, physical health (including illnesses and 
injury), mental health (including stress, depression and emotional problems), and ability 
to be involved in their usual activities (self-care, work and recreation) during the 
previous 30 days. The population variables that are used to describe the status of 
HRQOL in the nation are: sex, age, race, ethnicity, education, household income, 
employment status, and marital status. In addition to these sociodemographic variables, 
the following health variables are included: diabetes, hypertension, breast cancer, BMI, 
smoking status, alcohol use, and leisure-time physical activity. Respondents are also 
asked about their seatbelt use, how they would rate their health, and whether they have 
health insurance. 
 The results of prospective studies examining the relationship of depressive 
symptoms to CVD often reported gender and racial differences (Bonnet et al., 2004; 
Farmer et al., 1988; Wassertheil-Smoller et al., 2004). Gender and racial differences 
have also been reported in the BRFSS national surveys of the pattern of health risks, 
health-related behaviors, and modifiable CHD risk factors (Ashaye & Giles, 2003). The 
National Healthcare Disparities Report (AHRQ, 2005) reported that women had higher 
rates of arthritis, asthma, and depression. Higher rates of diabetes were reported by 
Black and Hispanic women. Limited activity and increased rates of depression, 
diabetes, hypertension, and obesity were reported by poor and near poor women. The 
most recent National Healthcare Disparities Report (AHRQ, 2009) focused on obesity 
as an underdiagnosed heart disease risk factor which is particularly problematic since 
34% of adults have a BMI equal to or greater than 30. Two recent reports indicate that 
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obesity has overtaken smoking in reducing quality-adjusted life-years (Jia & Lubetkin, 
2010; Stewart, Cutler, & Rosen, 2009). 
 The findings of these national epidemiological surveys support the necessity of 
analyzing and reporting healthcare studies according to race and ethnicity (Winker, 
2004). The identification of lower levels of nitric oxide, a pro-atherogenic mechanism, 
has been found lower in Black women (Ferlinz, 2005) serving as another potent reason 
to analyze racial differences in a study investigating cardiac risk status in women. 
While the mechanism linking race, ethnicity, and socioeconomic status (SES) to CVD 
has not been completely determined, access to health care and living environment have 
been described as contributing factors. Thus, it will be significant to include race, 
ethnicity, and SES indicators (family income, marital status, employment status, and 
geographical location) as variables affecting QOL in this proposed study. 
Summary 
 Evidence has been offered to support the relationship of depressive symptoms to 
cardiovascular disease risk factors, to increased risk of nonfatal and fatal ischemic heart 
disease, and to health promotion and quality of life. Depressive symptoms have been 
identified as an independent risk factor for CVD and increase the risk of decreased 
adherence to a healthy lifestyle. Quality of life is diminished by depressive symptoms in 
healthy subjects and in persons with CVD. What has not been investigated, however, is 
how depressive symptoms relate to CVD risk, health-promoting lifestyle and quality of 
life in women being screened for CVD risk. The literature has concentrated on the 
48 
 
impact of depressive symptoms and quality of life following a cardiac event such as an 
MI. 
 Therefore, this study will make a unique contribution in that the relationship 
between depressive symptoms and quality of life will be examined in women learning 
of their CVD risk. The study examined whether this relationship was influenced by the 
women‘s awareness of their heart disease risk, and/or their health-promoting lifestyle 
behaviors, and/or their estimated cardiac risk. Furthermore, the study examined whether 
there was a dose-response relationship between depressive symptoms and awareness of 
heart disease risk, health-promoting lifestyle behaviors, cardiac risk, and quality of life. 
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CHAPTER THREE 
METHODOLOGY 
 The purpose of this study was to investigate the relationship of depressive 
symptoms to the status of health-promoting lifestyle behaviors, the awareness of heart 
disease risk, and cardiac risk and how these relationships affect perceived QOL in 
women being screened for CVD risk. The following aims were examined:  
1) To determine the relationship between depressive symptoms, the cardiac risk score, 
the health-promoting lifestyle behaviors, an awareness of heart disease risk, and the 
perceived QOL in women being screened for CVD risk.  
2) To determine whether there is a dose-response relationship between depressive 
symptoms and: 
a) The cardiac risk score (Line a in Figure 1), 
b) the health-promoting lifestyle behaviors (Line b in Figure 1), and 
c) the perceived QOL (Line c in Figure 1).  
3) To determine whether the effect of depressive symptoms on the perceived QOL is 
direct or indirect (i.e., mediated by cardiac risk- d1 or health-promoting lifestyle 
behaviors-d2). (Figure 1). 
Design 
 A cross-sectional correlational descriptive study design was used. A 
correlational design is appropriate for the investigation of the relationship between 
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variables generated by the theoretical and research literature (Brink & Wood, 1998). 
Cross-sectional data collection is appropriate when the researcher is interested in the 
status of a set of variables at one point in time (Brink & Wood; Hulley et al., 2001). The 
following are considered strengths of cross-sectional studies: there is no waiting for the 
results, there is generally no participant attrition, they are a logical first step to 
conducting a cohort or experimental study, they are geared for the study of networks of 
causal links through identification of predictor variables, and they are relatively 
inexpensive to conduct (Hulley et al.). However, the researcher must still account for 
the possibility of missing data.   
An additional advantage of cross-sectional data collection is reduced participant 
burden due to the one-time versus longitudinal collection of data. The cross-sectional 
correlational descriptive design was appropriate to the aims of this study since no study 
thus far had investigated the relationship of depressive symptoms, CVD risk, health-
promoting lifestyle behaviors, and perceived QOL in women being screened for CVD 
risk. 
Setting 
The study was conducted in an outpatient service of a large urban medical 
center (700 beds) in the Great Lakes region from August 2008 to May 2009. This 
medical center serves a mostly rural 15-country area and is located in a racially and 
ethnically diverse small urban community. Participants were recruited at the medical 
center through an established cardiac screening program, Covenant Heart Advantage. 
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Participants in the Heart Advantage heart health risk assessment program were recruited 
three ways. 
The first method used direct mailings and spots in the local media (newspapers, 
radio, and television) to direct the public to a website which takes them directly to the 
Heart Advantage heart health risk assessment questions. At the completion of the risk 
assessment questions, the participant is asked to provide phone and mail contact 
information if they wish to have a personal review of their cardiac risk status. During 
the in-person 1:1 consultation conducted by a cardiovascular clinical nurse specialist, 
the woman‘s risk assessment is reviewed and then goals are set to mange her risk. 
The second method for recruiting women to participate in the Covenant Heart 
Advantage heart health risk assessment program also used direct mailing and spots in 
the local media to invite the public to attend large group heart health risk assessment 
programs which were scheduled twice a year. The public were invited to complete the 
online heart health risk assessment questions. If they elected not to complete the online 
survey, they were mailed a copy of the heart health risk assessment questions. The heart 
health risk assessment needed to be completed prior to attending the large group risk 
assessment event.  
The third method for recruiting participants in the Covenant Heart Advantage 
program was the introduction of the program during health fairs held in the area. 
Women who were interested in the program were again invited to either complete the 
online or paper version of the heart health risk assessment questions. The same process 
was followed as described above to invite interested women to attend either the next 
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large group screening event or a 1:1 counseling session when the risk assessment 
screening was completed. 
The heart health risk assessment program began in 2005. Of the over 10,000 
women enrolled in the Women‘s Heart Advantage at this medical center, over 2,000 
women have been screened from February 2005 through April 2008 (Debbie Best, 
MSN, RN, Coordinator of the Covenant Heart Advantage Program, Covenant 
HealthCare, Personal Communication, May 12, 2008). 
The in-person 1:1 counseling sessions took place in the outpatient 
cardiovascular services (CVS) area at the main campus of this healthcare organization. 
A separate office was available to the researcher to obtain consent and where the 
dissertation research study participants completed the dissertation research data 
collection booklet. The large group cardiac screening events took place in the same 
CVS area. This CVS area provided sufficient space for the participants to receive in 
private informed consent and to complete the data collection booklet. The outpatient 
CVS area is on the second floor of a building across the street from a parking lot. The 
entrance to the building is clearly marked and very well lit allowing for easy access. 
The elevator to the second floor is less than 50 feet from the ground floor entrance and 
exits on the second floor into the lobby of the CVS area. The lobby is adjacent to the 
registration area for the screening program. 
Sample 
A non-probability convenience sample of consecutive women who presented to 
the Covenant Heart Advantage screening was the sampling strategy. One hundred 
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twenty-five women completed the study.  Figure 2 depicts the total number of screening 
center clients reviewed for study inclusion and exclusion criteria. The no-shows were 
potentially eligible women who did not come in for their scheduled CVD risk screening 
appointment, thus were not approached to participate in the study. The study 
participation rate was 82.8% of those 151 women who were approached to participate. 
Of those who refused to participate, four stated they did not have the time, four refused 
to participate after reading the consent form, and the 18 who signed the consent form 
but who did not participate in the study were women attending one of the two large 
group sessions. It is not possible to know their reason for not participating in the study. 
Figure 2. Screening for Study Participants 
 
 
 
 
 
 
The inclusion criteria were women age 30 – 75 years, who were able to read, 
write, and speak English, and were able to participate in the informed consent process. 
The mean age for the study sample was 57.7 ( 9.6). The age-range was based on the 
age of women who had presented to the cardiac screening program from the program‘s 
inception through May 2007 (Table 3).  Since the inception of the online heart health 
risk assessment questions (February 2008), the number of women in the 30-40 year age 
Eligible   200 
 No shows    49 
Approached to participate 151 
 Not interested      8 
 Signed consent, but did 
not participate    18 
 Completed study 125 
Number Screened: 469 
Ineligible  269 
 Prior client  240 
 Exclusions     29 
o Heart condition   16 
o Age          7 
o Other                     6 
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range had increased (Personal Communication, Debbie Best, May 12, 2008). The 
database used at the medical center did not specify age ranges beyond 60. In addition, 
given the evidence for CVD onset in women, the age range of 30-74 would capture 
those most at risk. The 2007 AHA Heart Disease and Stroke Statistics (Rosamond et al., 
2007) reported the rate (7 per 100,000) and the age of onset for the first major cardiac 
event in women as being 45-54. In the study sample, the majority (n=40) of women 
who were aged 60 – 75 were between the ages of 60 and 69. 
Table 3. Age Range of Women Screened by Heart Advantage and the ASK Study 
Age Heart Advantage (n, %) ASK Study (n, %) 
< 20 7 (0.4%) n/a 
20 - 29 61 (3.2% n/a 
30 - 39 110 (5.8%)  3 (2.4%) 
40 - 49 329 (17.4%)  24 (19.2%) 
50 - 59 583 (30.9%) 42 (33.6%) 
60+ 798 (42.3%) 56 (44.8%) 
Total 1,888 (100.0%)  125 (100%) 
Note: n/a – not applicable. 
The study focused on women since there is a lack of awareness of CVD risk by 
women and by healthcare providers, and there is a higher prevalence of depressive 
symptoms in women. The exclusion criteria were the self-reported presence of pre-
existing heart disease, stroke, peripheral vascular disease, dementia, drug dependency, 
alcoholism, and diagnosed mental illness other than depression. Drug dependency and 
alcoholism are known to have an increased association with depression (Kessler et al., 
2003). Twenty-nine women were excluded: due to age (n = 7), or known cardiac 
condition (n = 22).  
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Power Analysis Calculations of Sample Size  
The targeted sample size for the study was estimated using power analysis in 
order to increase the probability of finding a statistically significant effect, which in this 
case is the probability of finding the associations between depressive symptoms, cardiac 
risk, health-promoting lifestyle behaviors, and perceived quality of life. The sample size 
was based on the recommended minimum number per variable used in regression 
analysis and it was also calculated based on the relationship between depressive 
symptoms and life satisfaction.    
With the aim of investigating whether depressive symptoms will have a direct 
effect on QOL or will have an indirect effect mediated by cardiac risk or health-
promoting lifestyle behaviors a series of simple linear regression analyses was 
performed. Based on the recommendation of 15 participants per predictor variable 
(depressive symptoms, health-promoting lifestyle behaviors, BMI, family history, 
education, employment, income, and marital status) in multiple regression analyses, the 
estimated sample size was 120 with eight predictor variables (Stevens, 1999).    
In examining the relationship between depressive symptoms and life 
satisfaction, a study by Koivumaa-Honkanen et al. (2004) was reviewed. In this study, 
9,679 participants were studied and life satisfaction measured by a 4-item life 
satisfaction scale explained 37.2% of the variance in depressive symptoms measured by 
the Beck Depression Inventory.  The online power analysis calculator G*Power 3 (Faul, 
Erdfelder, Land, & Buchner, 2007; G*Power 3, ND) was used to calculate the effect 
size based on the squared multiple correlation value of .372 producing an effect size of 
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0.59. Using the article by Rudy and Kerr (1991), this indicated a large effect size. With 
an effect size of .59, an alpha of 0.05, a power of 0.80 and eight predictors, G*Power 3 
calculated that 34 subjects would be the sample size. Using these 2 techniques for 
estimating power analysis, the range of recommended subjects was from 34 to 120.  
Given this, the higher sample size was used. 
Research Procedures 
This section includes the description of staff training, the recruitment and 
consent of the participants, and procedures. Following sections will address 
measurements, data analysis, the protection of human subjects, and study limitations. 
Research Assistant and Staff Training 
One research assistant was used to assist with data collection during the large 
group events. About half way through the data collection this research assistant also 
was present on 1:1 counseling session days when the researcher was not able to be 
present. The researcher instructed the research assistant on the screening process related 
to the inclusion and exclusion criteria and how to obtain the study consent. 
Furthermore, the research assistant, who was an experienced cardiology staff nurse, 
completed the training program for protection of human subjects and this information 
was included in all the IRB applications. 
 Those who volunteered to staff the large group screening events were informed 
regarding the study, and were asked to refer all questions regarding the study to the 
researcher. Those who volunteered to staff the large group screening events were 
provided information about the research on the afternoon of the event. The researcher 
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was present to answer any questions before the women began to arrive. The 
cardiovascular clinical nurse specialist who provided the in-person 1:1 consultations 
was the only person who gave the study information sheet to the women.  
Recruitment and Consent 
 All of the women who presented for the large group heart health risk assessment 
events had pre-registered for the program which means they had submitted the heart 
health risk assessment questions. Their registration confirmation assigned them an 
appointment for screening. The appointment helped with the flow of women during the 
large group screening events. During the screening events the following physical 
measurements were obtained: lipids, blood pressure, weight, percent body fat, and waist 
circumference. During the large group events, however, due to privacy issues, waist 
circumference was not obtained.  
Before the two large group events, the researcher pre-screened the responses to 
the heart risk assessment questions. It was possible to pre-screen for gender, age, and 
history of cardiac conditions. Of the total 219 female registrants, 144 were ineligible at 
pre-screening. At registration, only women who preliminarily met the study selection 
criteria were given a card that contained a brief description of the research study 
(Appendix I). Adjacent to the registration desk, the researcher had a table where women 
who were interested in participating in the study were screened for final inclusion and 
the consent process was completed. Between the two events, only two women refused 
to participate.  Thirty women (24%) from the study sample were recruited from two 
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large group events. They were instructed to go to the research study table in an adjacent 
hallway once their health screening was completed.  
The majority of the study participants (n = 95) were recruited when they 
attended a 1:1 consultation. Women who had a 1:1 consultation were given the brief 
study (Appendix I) explanation by the nurse who conducted the counseling session. 
Women who expressed interest in the study were escorted to the office where the 
researcher determined final eligibility for the study and completed the consent process. 
The 1:1 counseling sessions were held twice a week and were usually scheduled one to 
two months in advance. After six months of data collection, the research assistant was 
trained to obtain consents and present the data booklets to participants on days when the 
researcher was not able to be present. The research assistant was used on two occasions. 
 Eligible women were provided a copy of the informed consent document 
(Appendix J). They were instructed to ask any questions they may have. Once these 
questions were answered, the informed consent document was signed, and a duplicate 
signed copy was given to each participant. The study participants then completed the 
study questionnaire booklet. The completion of the study questionnaire booklet was 
done in the presence of the researcher or the research assistant. It took 15-20 minutes to 
complete the data booklets. Once completed, women were compensated with a $10.00 
gift card to a popular area store. Before leaving, all study participants were given a 
small brochure listing area psychological counseling services (Appendix K). The list of 
area psychological counseling services was obtained from the medical center‘s social 
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work service. The cardiac screening program likewise provided women with a referral 
for further evaluation of their CVD disease and information for risk modification. 
 
Measurements  
The list of study variables and corresponding measurements are delineated in 
Table 4. A description of each of these variables and how they were measured follows.  
Table 4. Study Variables and Measurements 
Variables Measurement 
Depression  Center for Epidemiological Studies 
Depression Scale (CES-D) 
Cardiovascular Disease Risk  Heart Health Questions & risk 
assessment physical measures (lipid 
profile, blood pressure, body mass index,  
percent body fat, waist circumference)  
 The ASK Study Questionnaire  
 Estimate of 10-Year Risk (Framingham 
Point Score)  
Quality of Life  Ferrans and Powers Quality of Life Index 
© Generic Version-III 
Health-Promoting Lifestyle 
Behaviors 
 
 Health-Promoting Lifestyle Profile – II 
(HPLP-II) 
Awareness of Heart Disease Risk 
 
 The ASK Study Questionnaire  
Demographics and Health History  
 
 Heart Health Questions 
 The ASK Study Questionnaire 
 
Center for Epidemiological Studies Depression Scale 
 The Center for Epidemiological Studies Depression scale (CES-D) was used to 
measure depressive symptoms severity as the predictor variable in the study model 
(Figure 1).The CES-D (Appendix L) was developed in 1977 to be a user-friendly self-
report scale to measure current levels of depressive symptoms in the general population 
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(Radloff, 1977). It has been reported to take five to ten minutes to complete the CES-D 
(Sharp & Lipsky, 2002). It was specifically designed to screen for depression in large 
epidemiological studies and is not associated with any specific theoretical framework 
(Pasacreta, 2004). The items included on the CES-D were culled from longer validated 
instruments, including the BDI, the Schedule for Affective Disorders and the depression 
subscale of the MMPI (Radloff), and this lends support for content validity.  
 The CES-D scale measures the frequency of the symptoms within the previous 
week. It is comprised of 20 items that are scored on a 0-3 scale:  rarely or none of the 
time (less than 1 day) is scored 0, some or little of the time (1-2 days) is scored 1, 
occasionally or a moderate amount of time (3-4 days) is scored 2, and most or all of the 
time (5-7 days) is scored 3. To determine the depression score items 4, 8, 12, and 16 
have to be reverse coded (0 = 3, 1=2, 2=1, and 3=0) before summing the score for all 20 
items. These four items were reverse coded before they were entered into the statistical 
database. A score of 16 or higher classifies respondents as having depressive symptoms 
that have been content validated with the DSM-IV. Radloff used principal components 
factor analysis to establish the subscales of depressed affect (items 3, 6, 9, 10, 14, 17, 
18), positive affect (items 4, 8, 12, 16), somatic and retarded activity (items 1, 2, 5, 7, 
11, 20), and interpersonal (13, 15, 19).   
 Radloff (1977) provided very thorough psychometrics for the CES-D. Based on 
five administrations of the CES-D, the reliability scores were coefficient alphas of 0.84 
to 0.90, split-halves of 0.76 to 0.85, and Spearman-Brown of 0.86 to 0.92. The 
coefficient alpha results far exceed the minimum for a new test and begin to approach 
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the clinical usage minimum of 0.90 (Bland & Altman, 1997). Inter-item correlations of 
> .30 were achieved in 24-55% across the samples with 34%-65% being in the range of 
.10-.30. Test-retest reliability was established in two, four, six, and eight week intervals 
yielding correlations of 0.51, 0.67, 0.59, and 0.59 respectively with a total test-retest 
correlation of 0.57. The CES-D was found to discriminate well between psychiatric 
inpatients and the general population samples. Criterion validity was established by 
correlating the CES-D with 12 other self-report scales. Construct validity was based on 
the clinical relevance of the items although a specific method for establishing the 
construct validity was not described. Construct validity was also established with the 
aforementioned factor analysis based on ―what is known about the theory and 
epidemiology of depressive symptoms‖ (Radloff, p. 385). 
 Additional construct validity was provided by a meta-analysis (Shafer, 2006) of 
studies that conducted factor analyses of the CES-D in a wide variety of populations. 
Shafer‘s meta-analysis confirmed the four factors which were consistent with previous 
reports including Radloff‘s (1977) original study. Seven items (# 1, 2, 5, 7, 11, 13, & 
20) loaded on the somatic factor; seven items (# 3, 6, 9, 10, 14, 17, & 18) loaded on the 
depressed affect factor; four items (# 4, 8, 12 & 16) loaded on the positive affect factor; 
and only two items (#15 & 19) loaded on the interpersonal problems factor (Shafer).  
 The internal reliability of the CES-D has been reported by Cronbach‘s alpha; the 
alpha scores have been reported in the range of 0.86 and 0.89 for elderly populations 
(Schein & Koenig, 1997) and 0.89 for a sample of women with breast cancer and an 
alpha of 0.87 for the comparison group of women without breast cancer (Hann, Winter, 
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& Jacobsen, 1999). Schein and Koenig reported that three previous studies had 
confirmed the original factor analysis for the subscales, with subscale reliabilities 
ranging from 0.57 to 0.85; they further reported the following alpha coefficients for 
their study: 0.86 for the full scale, 0.80 for depressed mood, 0.68 for psychomotor 
retardation, 0.65 for lack of well-being, and a low 0.40 for interpersonal difficulties. 
Only the alpha for depressed mood would be considered sufficient for clinical 
assessment. Cronbach‘s alpha for the study was .87. 
 In a study of stroke patients (Agrell & Dehlin, 1989), the CES-D Cronbach‘s 
alpha was found to be 0.64. Three items were found that did not correlate well with the 
sum of the scores: item 10 (―I felt fearful‖), item 15 (―People were unfriendly‖), and 
item 19 (―I felt that people disliked me‖). The same study established the CES-D‘s 
construct validity to a global rating of 0.73. Concurrent validity was established with 
other rating scales evaluated: 0.82 with the Geriatric Depression Scale, 0.81 with the 
Zung Self-Rating Depression Scale (SDS), 0.74 with the Hamilton Rating Scale, 0.83 
with the Comprehensive Psychopathological Rating Scale-Depression (CPRS-D) (all p 
< 0.001), and a low 0.32 (p < 0.02) for the Cornell Scale.  
 Strength of the CES-D is its emphasis on mood and affect rather than on the 
physical manifestations of depression. This is a CES-D advantage for assessment of 
depressive symptoms in the presence of co-morbid medical conditions (Hann et al., 
1999) which is a consideration for a study that includes CVD risk factor assessment and 
health-promoting lifestyle behaviors such as the proposed study.  
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 Additional clear strengths of the CES-D are that it was designed to be used in 
large epidemiological studies, that it has not been criticized for particular difficulty of 
use as a self-rating instrument, and its very low reading level. Using the Microsoft 
Word readability statistics option, the CES-D reading level was calculated to be grade 
2.3 (Table 5). When compared to the BDI and the SDS, the CES-D has been judged to 
be the most balanced and representative test, most likely because it was developed from 
other tests even though it does not equally address all the symptom areas (Shafer, 
2006).  One of the described weaknesses of the CES-D is that its items do not 
correspond to the current DSM-IV depression criteria; the same criticism applies to the 
SDS (Shafer, 2006). 
Table 5. CES-D Readability Statistics * 
Counts  
 Words 280 
 Characters 887 
 Paragraphs 106 
 Sentences 22 
Averages  
 Sentences per paragraph 1.0 
 Words per sentence 7.2 
 Characters per word 3.9 
Readability  
 Passive sentences 4% 
 Flesch Reading Ease 90.8 
 Flesch-Kincaid Grade level 2.3 
 
*  Used the Microsoft Word ―Tools – Options – Spelling & Grammar‖ to perform these 
statistics. 
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Cardiovascular Risk 
 Cardiovascular risk was calculated based on responses to the Covenant Heart 
Health Questions and physical measures performed during the heart health risk 
assessment sessions. The calculated cardiovascular risk was performed once the 
woman‘s data were entered into the health risk assessment software. The risk 
assessment was that of the Framingham Estimate of 10-Year Risk for Women which is 
described is this section. 
Covenant Heart Advantage Heart Health Risk Assessment  
Data from the Covenant Heart Advantage heart health risk assessment program 
that were used in this study included the Covenant Heart Health Questions (Appendix 
H) and physical measures that are part of the calculation of CVD risk. The data that 
were used from the heart health risk assessment program were summarized on a data 
collection sheet for each participant (Appendix M). 
The Covenant Heart Health Questions (Appendix H) were developed by 
HealthAware (nd), a well-established company known for the development of health 
risk assessment materials. HealthAware was selected by Covenant HealthCare as the 
vendor for the Covenant Heart Advantage heart health risk assessment program. All of 
the women participating in the Covenant Heart Advantage heart health risk assessment 
program completed the Heart Health questions before coming to the screening session.  
The Covenant Heart Health Questions is a 22 item survey that includes height 
and weight (which are used to calculate the BMI), personal history of traditional CVD 
risk factors (smoking, cholesterol, aerobic exercise frequency, diabetes, and blood 
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pressure). Additional data include family history of heart disease, diabetes, high blood 
pressure, and high cholesterol as occurring before the age of 55. Family was specified 
as parent or sibling. The respondents are also asked if they have been diagnosed by a 
doctor with a cardiovascular condition (e.g., heart attack, chest pain, heart failure), take 
medications (e.g., arthritis, aspirin on a regular basis, blood pressure, high cholesterol), 
or if they have had a cardiovascular procedure (e.g., cardiac catheterization, balloon 
angioplasty, bypass surgery, or stent). The zip code from the person‘s address was used 
to track the general area for the participants to differentiate rural, and urban 
participants. 
The physical measures that are part of the Covenant Heart Advantage heart 
health risk assessment program are blood pressure, lipid profile, weight, BMI, percent 
body fat, and waist circumference. Each woman had her blood pressure obtained using 
an electric digital noninvasive blood pressure device that was serviced periodically 
according to the organization‘s policies. Weights were measured using a scale that was 
periodically calibrated according to the organization‘s policies. The self-reported height 
and the measured weight were used to calculate the BMI. Waist circumference was 
measured in the standard fashion by trained staff. Due to the hectic pace and the lack of 
privacy during the large group events, it was not possible to obtain the waist 
circumference, thus this measurement is absent for 31 study participants.  
An Omron Model HBF-306 Fat Loss Monitor (Omron, nd) device was used to 
measure the percent body fat. The lipid profile – total cholesterol (TC), HDL-C, and 
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LDL-C was obtained via a finger-stick and processed with the Cholestech LDX. 
Trained personnel from the sponsoring organization performed these assessments. 
The Omron Model HBF-306 Fat Loss Monitor (Omron, nd) is a portable hand-
held battery operated device. It uses bioelectrical impedance to estimate the body fat 
percentage. This technology has been found to be comparable to standard 
anthropometric measurement methods (Lintsi, Kaarma, & Kull, 2004). It also calculates 
the BMI with the following equation: (weight in pounds x 703) / height in inches / 
height in inches. Covenant HealthCare staff trained in the use of this device obtained 
the percent body fat and BMI measures.  
The Cholestech LDX point-of-care system uses an enzymatic methodology and 
solid-phase technology to measure TC, HDL-C, LDL-C along with some other options 
not selected by the screening program (Cholestech Corporation, Hayward CA). 
Precision for the LDX ranges between 2% to 6%, with variation due to the cassette-
housed analyst reagent lot number. The finger-stick method correlates with venous 
plasma values (r  0.95) that meet the NCEP guidelines (Cholestech Corp.; Working 
Group, 1995). The quality controls for the devices are performed when the lot number 
for the cassettes changes. This approach to the device quality control is the standard 
authorized by the Laboratory Director at the cardiac screening program‘s sponsoring 
medical center (D. Best, Personal Communication, August 3, 2007). 
Description of Cardiac Risk 
Cardiac risk was described using two methods during the study. The first 
method was the Framingham Estimate of 10-Year Risk (Appendix N); this was 
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calculated by the HeartAware risk assessment program. The second method was the 
classification described in the AHA CVD prevention guidelines for women (Mosca, 
Banka et al., 2007); these guidelines described three levels of CVD risk in women as 
high risk, at risk, and optimal risk (Table 6). A combination of clinical criteria forms the 
basis for this classification schema. The Estimation of 10-Year Risk for Women uses 
the point scoring method originally developed for the Framingham Global Risk 
estimator. The Estimation of 10-Year Risk for Women (Framingham Point Scores) is 
utilized by the NCEP (NCEP, 2001).  
The data obtained as part of the Covenant Heart Advantage heart health risk 
assessment which includes the Framingham risk score (summarized on the data 
collection form, Appendix M) were used to classify the women according to the AHA 
classification as described in Table 6. Women with a 10-year Framingham global risk 
greater than 20% or women with diabetes comprised the high risk group in this study, 
since the other criteria in the high risk category were considered study exclusion 
criteria.  
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Table 6.  American Heart Association Classification of CVD Risk in Women 
High Risk At Risk Optimal Risk 
 Established CHD 
 Cerebrovascular 
Disease 
 Peripheral arterial 
disease 
 Abdominal aortic 
aneurysm 
 End-stage or chronic 
renal disease 
 Diabetes mellitus 
 10-Year Framingham 
global risk > 20% 
  1 major risk factors 
for CVD including: 
 Cigarette smoking 
 Poor diet 
 Physical inactivity 
 Obesity, especially 
central adiposity 
 Family history of 
premature CVD 
(CVD at < 55 
years of age in 
males relative and 
< 65 years of age 
in female relative) 
 Hypertension 
 Dyslipidemia 
 Evidence of 
subclinical vascular 
disease (e.g., 
coronary 
calcification) 
 Metabolic syndrome 
 Poor exercise 
capacity on treadmill 
test and/or abnormal 
heart rate recovery 
after stopping 
exercise 
 Framingham global 
risk <10%  
 A healthy lifestyle 
with no risk factors 
Mosca, Banka et al. (2007), p. 1482. 
Defining Obesity and Central Adiposity. Central adiposity is considered more 
atherogenic than total body fat (Everson-Rose, 2009). For a complete CVD risk 
assessment, it is considered most complete to measure for overweight, obesity and for 
central adiposity (AHA, 2009). The literature often differentiates between overweight 
and obesity, both of which are considered unhealthy for the specified individual‘s 
height highlighted by an AHA science advisory report addressing the overweight BMI 
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and mortality (Lewis et al., 2009). Overweight and obesity in adults are described by 
the BMI (CDC, 2009). A BMI (reported as kg/m
2
) less than 18.5 kg/m
2
 is considered 
underweight. A healthy weight is described by a BMI in the range of 18.5 to 24.9. A 
BMI between 25.0 and 29.9 defines overweight, and a BMI of 30 or more is considered 
obese. A BMI equal to or greater than 40 identifies extreme obesity. 
Central adiposity is a defining factor of the metabolic syndrome although the 
cut-points for waist circumference differ among leading groups (Alberti, et al., 2009). 
Waist circumference is one measure advocated for the determination of central 
adiposity. The most recent AHA metabolic syndrome criteria stated that the desired 
waist circumference for women to be less than 35 inches (Grundy et al., 2005). 
Investigators seeking to refine the identification of CVD risk factors also advocate for 
the measurement of percent of body fat to add to the definition of obesity. One study 
investigating the relationship between types of body fat and depressive symptoms 
(Everson-Rose et al., 2009)  identified that visceral adipose tissue was most highly 
associated with depressive symptoms rather than subcutaneous body fat. The 
measurement of these types of fat does not, however, currently lend itself to clinical 
practice. The current ideal percent of body fat for women is between 16 and 25% and 
measurements over 30% are classified as obese (CDC, 2009). 
Ferrans and Powers Quality of Life Index© Generic Version-III 
The Ferrans and Powers Quality of Life Index © (QLI) Generic Version-III 
(Appendix O) was used to measure the participant‘s perceived QOL (Ferrans & Powers, 
1985, 1992). The domains addressed in the QLI correspond very well with the variables 
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of the HPM. The QLI measures overall life satisfaction as well as 37 areas of life that 
have been identified as having an impact on QOL. The QLI produces five scores: 
quality of life overall and in four domains: health and functioning, family, social and 
economic, and psychological/spiritual. Directions for scoring are provided by the 
authors and reproduced in Appendix O. 
The QLI is available in several disorder specific validated versions, including a 
cardiac version. The Generic Version-III was selected because the sample for the study 
was women with no known cardiac disease. This selection decision was verified with 
Dr. Ferrans (Personal Communication, January 2008). Over 100 studies, with 41 in 
cardiovascular investigations, have been reported using the QLI along with established 
reliability and validity (Ferrans, 2004).  
 The QLI website reports that 48 studies have established the internal 
consistency reliability with Cronbach‘s alphas in the rage of .73 to .99 and that 19-24 
studies have established the reliability for the subscales with alphas ranging from .70 to 
.94 for the health and functioning subscale, .78 to .96 for the psychological/spiritual 
subscale, .71 to .92 for the social/economic subscale, and .63 to .92 fir the family 
subscale. Ferrans and Powers (1985) reported that an extensive literature review 
initially established content validity which was further established using the Content 
Validity Index (Oleson, 1990). Several studies established the construct validity of the 
QLI with other life satisfaction measures (Ferrans & Powers, 1985) and factor analysis 
which established the current subscales (Ferrans & Powers, 1992). The factor analysis 
was confirmed by a study of Norwegian women (Rannestad et al., 2000) and using the 
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contrasted groups approach with groups self-reported pain, depression and successful 
coping (Ferrans, 1990). The responsiveness of the QLI was established by 27 studies 
that reported changes in the QLI pre- and post-intervention or treatment 
(www.uic.edu/orgs/qli/reliability/reliabilitymain.htm). The QLI website states the 
readability to be at the fourth grade reading level. 
A recently reported study of the QOL in women after coronary artery bypass 
surgery used the QLI-Cardiac version to measure overall satisfaction with life and other 
variables which affect QOL (Penckofer et al., 2005). The investigators reported 
Cronbach‘s alpha preoperatively of .91 and postoperatively of .95 Overall, QLI 
improved postoperatively to 22.74 ± 4.64 from the preoperative average score of 21.37± 
4.34 (p = .004), producing a standardized effect size of 0.32. This investigation of 
women with known CAD is the closest study identified thus far to this study of women 
learning of their CVD risk.  
The Cronbach‘s alpha for the study for the QLI total score was .92.  The study 
alpha scores for the four QLI subscales were: .85 for health and functioning, .73 for 
social and economic, .88 for psychological/spiritual, and .73 for family. 
The domains addressed in the QLI correspond well to the HPM‘s individual 
characteristics and experiences of prior related behavior and the personal factors of 
biological, psychological and sociocultural etiology as well as the behavior-specific 
cognitions and affect of interpersonal influences (family, peers, providers); norms, 
support, models as well as situational influences, and the perceived benefits of action, 
perceived barriers to action, perceived self-efficacy, and the activity-related affect. ―The 
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goal of nursing in health promotion is to maintain or enhance the client‘s health status 
and well-being‖ (Pender et al. 2002, p. 260) is an extension of this author‘s theoretical 
definition of QOL. The HPM‘s definition of the concept health promotion is also 
explicitly linked to this author‘s QOL theoretical definition: ―Health promotion is 
behavior motivated by the desire to increase well-being and actualize human potential‖ 
(Pender et al. 2002, p. 7). Thus, the HPM is an excellent fit for a QOL study based on 
the model‘s health promotion concept and its theoretical propositions. 
Health-Promoting Lifestyle Profile-II 
The study variable, health-promoting lifestyle behaviors, was measured by the 
Health-Promoting Lifestyle Profile-II (HPLP-II) (Appendix P). The HPLP-II is a 
revision of an instrument designed to measure exercise benefits and barriers consistent 
with elements in the HPM (Walker, Sechrist, & Pender, 1987). The HPLP-II is a 52-
item instrument that measures the multi-dimensional pattern of self-initiated health-
promoting behaviors. These behaviors are intended to maintain or enhance the 
individual‘s health potential and wellness level (Acton & Malathum, 2000).  
The four-point response scale measures the frequency of the self-reported 
health-promoting behaviors as never, sometimes, often and routinely. The HPLP-II can 
be scored providing an overall health-promoting lifestyle score as well as six subscale 
scores. The six subscales are: (1) health responsibility, (2) physical activity, (3) 
nutrition, (4) spiritual growth, (5) interpersonal relations, and (6) stress management. 
No studies using the HPLP-II in a similar population have been identified.   
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The HPLP-II has strong psychometrics. Using young and middle-aged adults, 
the Cronbach‘s alpha for the whole instrument is .94 and for the six subscales are: 
health responsibility (.86), physical activity (.85), nutrition (.80), spiritual growth (.86), 
interpersonal relations (.87), and stress management (.79) (Susan Noble Walker, PhD, 
RN, personal communication, July 11, 2005). A study of 84 community-dwelling adults 
designed to investigate health-promoting behaviors‘ association with the satisfaction of 
basic needs (Acton & Malathum, 2000) reported similar Cronbach‘s alpha with .90 for 
the total scale and .88, .86, .83, .90, .85, and .85 respectively for the six subscales as 
delineated by Walker.  
The Cronbach‘s alpha for the study was .92 for the total mean score. The 
Cronbach‘s alpha for the six subscales were: .76 for health responsibility, .85 for 
physical activity, .79 for nutrition, .86 for spiritual growth, .81 for interpersonal 
relations, and .77 for stress management. These results on the whole are similar to those 
reported by Walker and then by Acton and Malathum (2000). 
A shortcoming of the HPLP-II is that the nutrition items do not reflect the 
current dietary recommendations. Dr. Walker would not permit revisions to the HPLP-
II (Dr. Susan Walker, Personal Communication, January, 2008). 
Awareness of Heart Disease Risk, Demographics and Health History: The ASK Study 
Questions 
 A compendium of additional questions to supplement the variables collected in 
the above described measures was developed by the study researcher (Appendix Q). To 
aid in the identification of this set of questions and to brand identify the research study, 
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these questions bear the title of The ASK Study. ASK is an acronym for Assessing 
Depressive Symptoms Improves the Knowledge of CVD Risk. The term ASK 
corresponds to the researcher‘s belief that women being screened for CVD risk should 
also be screened for the presence and severity of depressive symptoms and to be 
referred for counseling and possible treatment. 
 There are five groups of questions included in this measurement; 
sociodemographic, mental health, awareness of heart disease, comorbidity, and some 
single items. The items included also correspond to the Wilson and Cleary HRQOL 
domains. 
 Sociodemographic Questions. The sociodemographic questions address race, 
ethnicity, educational level, family income, employment status, and marital status. The 
race and ethnicity items follow the NIH Policy on Reporting Race and Ethnicity Data 
(NIH, 2001). The educational level and marital status items are worded according to the 
census survey.  
 Mental Health. Four items were included to assess depression history. Women 
were asked if there is a family history of depression, whether they have ever been 
diagnosed with depression, if they have ever been treated for depression, and whether 
they are taking any medication for depression. The WISE investigators stated that the 
combination of depressive symptoms scoring and the depression treatment history were 
strong predictors of increased CVD risk profile (Rutledge, Reis, Olson, Owens et al., 
2006),. 
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 Awareness of Heart Disease Questions. Since many women remain unaware 
that heart disease is their number one killer, it is important to ascertain whether the 
women coming to this cardiac risk screening program had awareness of their risk status 
before the screening program. If they were aware of their risk status, it would be helpful 
to determine the source of their awareness particularly considering that the Covenant 
Heart Advantage program sends each woman who is a member a quarterly newsletter 
which discusses some aspect of achieving or maintaining a heart healthy lifestyle. 
 Four items asked the participant about her awareness of her risk of CVD. The 
participant was asked if she knew about her risk for getting heart disease before 
attending the screening program and if she learned about her risk from her primary 
healthcare provider. Then she was asked if she was surprised to learn that all women 
should be evaluated for their risk of heart disease and how she might have learned about 
this need for CVD risk assessment. 
 Comorbidity Status. Medical conditions that exist along with a primary 
diagnosis or disorder are important to determine because they can effect treatment 
decisions and can influence the onset and progression of complications. Most 
significantly for this study, determination of participants‘ comorbidities is crucial to the 
statistical analysis.  
 One comorbidity index was found that described physical function rather than 
prediction of mortality as its outcome, the Functional Comorbidity Index (FCI) (Groll, 
To, Bombardier, & Wright, 2005). This self-administered index was incorporated into 
the ASK Study questions with the series of medical disorders listed on the second page 
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(Appendix Q). Permission to include the FCI has been obtained (Dr. Groll, Personal 
Communication, August 3, 2007). 
 The FCI was developed from an extensive review of the literature regarding 
functional status risk factors and a survey of existing comorbidity indices with physical 
function as the outcome (Groll et al., 2005). A series of focus groups of chronically ill 
participants and healthcare professionals reviewed the list of medical disorders. The 
results of the literature review and the focus groups were then organized according to 
standard diagnostic codes which then would lend the use of the index to the analysis of 
large administrative data sets. Using the SF-36 physical function subscale as the 
dependent variable, a series of regression analyses began to reduce the number of 
medical diagnoses that eventually became the FCI.  
 In an evaluation of three comorbidity indices, the FCI performed well as a 
multi-morbidity measure where HRQOL is considered the outcome of interest, as it is 
in this study (Fortin et al., 2005). These investigators also used the SF-36 to evaluate 
the performance of the selected comorbidity indices. An advantage they identified was 
the ease of scoring the FCI. The final FCI score is the sum of identified comorbidities. 
Groll et al. (2005) also reported on the advantage of non-weighted scoring as there was 
very little advantage from weighting the scores. 
 Single Items. The medication list has been added as another strategy to elicit 
relevant medical disorders history. Since the Covenant Heart Health Questions ask the 
respondents if they have had a cardiac catheterization, a balloon angioplasty, a stent, or 
bypass surgery (Appendix H), only whether they have had a stress test has been added 
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to validate that the women attending the cardiac screening program have no known 
CHD history. The snoring item was added as a proxy for sleep apnea. This is one item 
from a CVD risk factor analysis in a study investigating depressive illness patterns in a 
group of 77 participants with documented CAD to identify predictors of early onset of 
CHD (Ketterer et al., 2006) that had not been captured on the ASK Study items or the 
Women‘s Heart Advantage Heart Health Questions. These investigators found that 
snoring was among a set of predictors for early onset CHD. 
Ethical Considerations 
 The ethical conduct of this study was grounded in the traditional bioethical 
principles of autonomy, beneficence, justice, and nonmalfiesence (Beauchamp & 
Childress, 2001), which were further developed into seven ethical principles for 
research (Emanuel, Wendler, & Grady, 2000). The application of these ethical 
principles assured that the following were addressed in this research endeavor: (a) that 
the study have social or scientific value, (b) that the study have scientific validity, (c) 
that the subjects are fairly selected, (d) that the risk-benefit ratio is favorable, (e) that 
there is an independent review of the study protocol, (f) that the subjects are afforded 
informed consent, and (g) that potential and enrolled subjects be treated with respect. 
Additionally, the protection of human subjects participating in a correlational design 
includes the use of valid and reliable instruments, which are an essential element for the 
scientific validity of the study, so that the participants‘ time is not wasted (Brink & 
Wood, 1998). 
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 The next section summarizes the institutional review boards that were included 
in this process along with the description of the study to prospective participants, and a 
discussion of the study‘s potential risks. Additional ethical considerations presented are 
the referral sources for depression counseling, steps to insure the confidentiality of the 
participants, and the researcher‘s conflicts of interest. 
Institutional Review Board Review 
 Before beginning data collection, the proposed research protocol was submitted 
for institutional review board (IRB) approval through Loyola University Chicago Lake 
Shore Campus, to the IRB for Covenant HealthCare (the research setting) and to 
Saginaw Valley State University IRB (the researcher‘s faculty appointment). These IRB 
reviews helped to assure that the design was scientifically sound and that all necessary 
steps for the protection of human subjects and ethical conduct of the protocol from 
recruitment of subjects through the publication and dissemination of the findings were 
clearly delineated. The Covenant HealthCare and Saginaw Valley State University 
IRBs require that studies anticipating publication must have IRB approval. A letter of 
organization cooperation (Appendix R) was obtained from Covenant HealthCare giving 
permission to access the heart health risk assessment data and to recruit women 
participating in heart health risk assessment events.  
Study Explanation to Prospective Participants 
 Women who expressed an interest in participating in the study had the purpose, 
the procedures, the anticipated risks and potential benefits of the study explained to 
them before asking them to read and sign the consent form (Appendix J). The consent 
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form contains the following elements: a description of the study‘s purpose and 
procedures, a description of the risks and benefits, statements regarding compensation, 
confidentiality, and voluntary participation. The consent includes contact information 
for the researcher, the supervising faculty, and the IRB offices.  
During the consent process, prospective participants were informed that the 
study was not part of the cardiac screening and that refusal to participate in the study 
would in no way alter their ability to participate in the cardiac screening or alter any 
other aspect of their healthcare. The prospective participants were assured that all data 
would be collected and maintained in accordance with procedures protecting their 
confidentiality. Women were informed that the study questionnaire booklet as well as 
the information that was gathered during their cardiac screening would be used for the 
research study.  
Potential Risks 
 The only potential psychological risks were that of learning of their CVD risk of 
having a cardiac event within the next 10 years and responding to the CES-D, the 
depressive symptoms instrument. Given the nature of scoring the CES-D it was not 
possible to perform the scoring at the time of administration. Although it was 
anticipated that some women may have found the CVD risk status information new and 
unsettling, when asked at the completion of the data collection if the participant had any 
questions or concerns, no participants described any. Learning their CVD risk, 
however, is part of the Covenant Heart Advantage heart health risk assessment 
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program, thus would have occurred regardless of the research and was an intended 
beneficial outcome of the screening program.    
 As a precaution for near-term concerns being raised by participation in the 
study, all participants were given a list of referral resources for psychological 
counseling (Appendix K). The list was approved by a social worker at the organization 
where the research was conducted.  
 The only physical risks were related to the finger-stick aliquot of blood used for 
the non-fasting lipid profile that was part of the screening program. These data were 
used to calculate the Framingham Point Score and categorize the cardiac risk. The 
likelihood of significant pain, discomfort or physical damage from the finger-stick was 
extremely low. Furthermore, only trained staff performed the finger-stick and operated 
the analyzer, thus reducing the likelihood of having to repeat the finger-stick.    
The risks to the subjects were reasonable and were essential to determine each 
participant‘s cardiac risk factors. The cardiac screening program provided each woman 
with a copy of her results and strategies for reducing the risk factors. The advantage of 
the screening program was that the women learned their CVD risk factors and received 
instruction how to reduce their risk and received referrals to area cardiologists for 
further evaluation and treatment as necessary. The individual risk from the research 
study was minimal particularly with regards to the knowledge of the association of 
depressive symptoms to QOL, the health-promoting lifestyle pattern in depressive 
symptoms and also according to cardiac risk status. This knowledge will add to our 
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understanding of the experience of women with depressive symptoms at risk of CVD 
and of having a cardiac event within the next 10 years. 
Researcher Conflict of Interest 
 The only conflict of interest for the study was that it was a requirement for the 
completion of a PhD in nursing. The researcher was vested in the completion of the 
study. The ethical conduct of the study ultimately rested with the researcher, and her 
adherence to the code of professional ethical conduct. 
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CHAPTER FOUR 
RESULTS 
The purpose of the study was to investigate the relationship of depressive 
symptoms to the status of health-promoting lifestyle behaviors, the awareness of heart 
disease risk, and cardiac risk, and how these relationships affect perceived quality of 
life. The study aimed to not only identify these relationships, but to identify whether 
there was a dose-response relationship between depressive symptoms and the study 
variables of cardiac risk, health-promoting lifestyle behaviors, and quality of life in 
women presenting for CVD risk screening. The final study aim was to determine 
whether the effect of depressive symptoms on perceived quality of life was direct or 
indirect being mediated by either or both cardiac risk and health-promoting lifestyle 
behaviors.  
Description of the Sample  
One hundred twenty-five women completed the study. The study sample can be 
described as urban, non-Hispanic, white, and married, employed full-time, with a 
household income between $25,000-49,999 who had some college education but did 
not earn a degree. Anecdotally, most women who indicated that they were not seeking 
employment said they were retired. The sociodemographics of the study sample are 
summarized in Table 7.   
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Table 7.  Demographics of Study Sample 
Variable N (Percent) 
Age  Mean (Standard Deviation) 
 Median (Range) 
57.7 ( 9.6) 
58 (39 – 75) 
Ethnicity 
 Hispanic Origin 
 Not of Hispanic Origin 
Race 
 American Indian or Alaskan Native 
 Black or African-American 
 White 
 Missing 
Education 
 Less than 9
th
 Grade 
 9
th
 to 12
th
 Grade, no diploma 
 High school graduate (includes equivalency) 
 Some college, no degree 
 Associate degree 
 Bachelor‘s degree 
 Graduate or professional degree 
Total Family Income 
 Less than $15,000 
 $15,000 – 24,999 
 $25,000 – 49,999 
 More than $50,000 
 Missing 
Marital Status 
 Never married 
 Now Married 
 Separated 
 Divorced 
 Widowed 
Employment Status 
 Employed full-time 
 Employed part-time 
 Unemployed 
 Not seeking employment 
 
6 (4.8%)  
119 (95.2%) 
 
1 (0.8%) 
16 (12.8%) 
107 (85.6%) 
1 (0.8%) 
 
1 (0.8%) 
4 (3.2%) 
32 (25.6%) 
38 (30.4%) 
17 (13.6%) 
17 (13.6%) 
16 (12.8%) 
 
7 (5.6%) 
23 (18.4%) 
50 (40%) 
43 (34.4%) 
2 (1.6%) 
 
10 (8%) 
75 (60%) 
3 (2.4%) 
26 (20.8%) 
11 (8.8%) 
 
49 (39.2%) 
15 (12%) 
19 (15.2%) 
42 (33.6%) 
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Because the women voluntarily presented for CVD risk screening from the 
community, it was anticipated that the sample would closely resemble the racial and 
ethnic composition of the surrounding community. Although the medical center serves 
a 15-county area, the vast majority of patients (n = 104, 83.2%) participating in the 
study came from within 15 miles of the study setting, from just two of the area urban 
counties. Table 8 displays the geographic distribution of the sample generated from the 
zip codes and the June 2003 U.S. Office of Management and Budget designation of 
Michigan counties as rural or urban (Michigan League for Human Services, 2005). 
Table 8. Geographic Distribution 
Distance from Study 
Site (Range in Miles) 
Frequency County Classification 
(# Counties) 
0 – 4.9 62 (49.6%) Urban (1) 
5.0 – 9.9 8 (6.4%) Urban (2) 
10 – 14.9 35 (28%) Urban (2) 
15 – 19.9 3 (2.4%) Urban (1) 
20 – 24.9 8 (6.4%) Urban (1), Rural (3) 
25 – 29.9  1 (0.8%) Rural (1) 
41 – 111 8 (6.4%) All rural 
 
The three major counties served by the medical center are a blend of small 
urban, suburban, and rural communities. According to the year 2000 census, the 3-
county total population was 403,070 persons. The racial composition for the 3-counties 
was skewed: 75.3% was White, 18.6% was Black, nearly 7% was Hispanic or Latino, 
and nearly 1% each was Native American, or Asian. The racial composition for the city 
where the medical center is located was more racially balanced in the year 2000: 47% 
White and 43.3% Black. The Hispanic population was 11.7% (Census bureau note: 
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Some Hispanics may have reported more than one race, hence, the total percent is more 
than 100).  The racial composition for the sample was also skewed: White (85.6%), 
Black (12.8%), and non- Hispanic ethnicity (95.2%).  Related to the geographic 
distribution of the sample, the racial composition of the study sample more closely 
resembles the racial composition for the 3-county area which also corresponds to the 
geographic composition of the study sample 
Data Matching and Security 
 Data were abstracted from the Covenant Heart Advantage Heart Health 
Questions and from the online Health Aware database on to the archival data collection 
sheet (Appendix M) after participants completed the study questionnaire booklet. Data 
were then matched with the women‘s corresponding study questionnaire booklets.  
Stripped of all individual identifiers, all data from the archival data collection 
sheet and the questionnaire booklet were entered into a statistical software database 
(SPSS Windows Version 15.0, SPSS, Chicago, IL). All data were checked manually for 
errors and data entry errors were corrected. The database was stored in a password-
protected file and a protected backup system. Once the data were entered, only 
participant codes identified the raw data. All paper data and computer file backup data 
were secured in a locked cabinet in the researcher‘s office. 
Missing Data 
Before the women left the study area attempts to verify completion of the data 
were performed. This was not consistently done which may have contributed to missing 
data for some women. Data were considered missing if there was no response to an item 
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or the woman scored two responses to one item. Eleven participants had missing data 
(8.8% of sample) on the HPLP-II instrument. Two women missed responding to one 
item each on the CES-D. The patterns of missing data on the QLI were the job question, 
the children, spouse/lover/partner, sex life, and family‘s happiness items. The missing 
data were to be expected; if you don‘t have a job, then it is realistic to not answer the 
item. While the scoring on these missing items doesn‘t require the replacement of 
missing data, the missing data were replaced as described below. 
One of the metabolic syndrome variables, waist circumference, had a large 
amount of missing data. Thirty-one women (24.8%), all who attended one of the large 
group screening events, did not have waist circumference values most likely due to 
insufficient privacy for physical measurement. Two women did not have a body fat 
percentage value. Two women did not report income level, and one woman did not 
indicate her race. Two women did not indicate if they had had a stress test, snored, or 
had been diagnosed with sleep apnea. All other demographic and CVD risk factor 
variables were complete. 
The data were manually screened for missing or potentially erroneous data 
responses. The few data entry errors were corrected and frequencies were run again 
before continuing the data analysis. Missing data were imputed only for data missing on 
the CES-D, HPLP-II and QLI instruments. The PRELIS program (Jöreskog & Sörbom, 
1996) was used to estimate values for the missing data. As opposed to substituting 
mean item scores, PRELIS imputes values on the basis of like-responses. According to 
Little and Rubin (1987), this method is preferable to substitution with item mean values 
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that can obscure between group differences. Imputed data were estimated at less than 
1% of usable data.  
Data Analysis 
Data were analyzed for normality, outliers, and extreme scores that may exert 
undue influence. Normality was initially evaluated by examining histograms. Variables 
which appeared skewed were then analyzed for the presence of significant skewness. 
The following variables were found to be significantly negatively skewed: (1) whether 
the women knew their CVD risk before attending the screening program, (2) the percent 
body fat, (3) the presence of a positive family history, (4) family income, and (5) the 
total QLI score. The following variables were found to be significantly positively 
skewed: (1) marital status, (2) whether or not they had diabetes, (3) their calculated 
Framingham risk score, and (4) the total CES-D score.  
Although these variables were skewed, they are representative of what would be 
expected with the sample (for example, lower cardiac risk score, less depression, and 
fewer persons with diabetes since the sample was relatively healthy).  In addition, 
because data normality is not an assumption for Spearman rho correlation analysis or 
for predictors used in multiple linear regression analysis (Field, 2009), no data 
transformations were performed to correct skewness. The creation of dichotomized 
variables eliminated significant skewness. 
The next segments of data analysis will summarize the findings for the major 
study variables. This discussion will begin with the cardiac profile. Following the 
cardiac profile discussion will be the responses to the heart disease awareness items, the 
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health-promoting lifestyle behaviors, depressive symptoms, and conclude with the 
perceived quality of life. Following these data will be a series of group comparisons 
based on depressive symptoms status, the frequency of performing health-promoting 
lifestyle behaviors, and quality of life. The presentation of the results of the study aims 
follows the discussion of the study variables. 
Cardiac Risk Profile 
The cardiac profile section will address the traditional CVD risk factors 
according to the Framingham point score method. The next profile analysis will be that 
of the metabolic syndrome profile for the sample. The cardiac profile section concludes 
with the samples‘ results according to the AHA risk status classification for women. 
Estimate of Risk with Framingham Point Scores 
The estimate of 10-year risk for women (Framingham risk score, Appendix N) 
was used to describe the calculated cardiac risk. The vast majority of the sample 
(n=117, 93.6%) scored less than 10% for their calculated cardiac risk score. Table 9 
summarizes the CVD risk factors assessed in the sample according to the Framingham 
point scoring system. In order to score a 10% risk, a woman would have to have a total 
of over 19 points. Using the mean risk factor values for this sample, a 57 year old 
woman with a TC of 196 mg/dl, an HDL-C of 53 mg/dl, who does not smoke with a 
SBP of 128 mmHg who is on an antihypertensive medication would get 8 points for 
age, 2 points for TC, no points for HDL-C or smoking, and 3 points for SBP. Her total 
points would be 13 giving her a 2% 10-year Framingham risk score. Therefore, most of 
the points are due to age. Nearly half of the sample could add a maximum two 
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additional points for an HDL-C less than 50 mg/dl, 4-7 additional points for a TC 
greater than 200 mg/dl and 4-6 additional points for a treated SBP greater than 129.  
 It is noteworthy that the majority of women (n=90, 72%) had TC in the range of 
160-239 (although this was a non-fasting value) but only half of these women (n=47, 
37.6% of the sample) reported taking a cholesterol lowering medication. Considering 
the target for normal SBP is 120 mmHg, two-thirds (n=87, 69.6%) of the women 
exceeded that value and only half of them (n=45, 51.7% of the sample) reported taking 
an antihypertensive medication. 
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Table 9. Cardiovascular Disease Risk Factors per the Framingham Point Score 
System 
 
CVD Risk Factor N (Percent) 
Age   Mean (Standard Deviation) 
 Median (Range) 
57.7 (± 9.6) 
58 (39-75) 
 30-39 3 (2.4%) 
 40-49 24 (19.2%) 
 50-59 42 (33.6%) 
 60-69 40 (32%) 
 70-75 16 (12.8%) 
TC Mean (Standard Deviation) 
 Median (Range) 
 < 160 
 160-199 
 200-239 
 240-279 
 ≥ 280 
196 mg/dl (± 40.5) 
193 (118-327) 
21 (16.8%) 
45 (36%) 
44 (35.2%) 
12 (9.6%) 
3 (2.4%) 
HDL-C  Mean (Standard Deviation)
 Median (Range) 
 < 40 
 40-49 
 50-59 
 ≥ 60 
53 mg/dl (± 14.8) 
53 (17-97) 
23 (18.4%) 
29 (23.2%) 
32 (25.6%) 
41 (32.8%) 
Smoking  
 No 120 (96%) 
 Yes 5 (4%) 
SBP Mean (Standard Deviation) 
 Median (Range) 
128 mmHg (± 16) 
128 (88-170) 
 < 120 
 120-129 
 130-139 
 140-159 
 ≥ 160 
38 (30.4%) 
27 (21.6%) 
24 (19.2%) 
31 (24.8%) 
5 (4%) 
Framingham Risk Score  
 Mean (Standard Deviation) 
 
3.3% (± 3.9) 
 Median (Range) 1.0 (< 1% - 30%) 
Note: HDL-C = high density lipoprotein cholesterol; SBP = systolic blood pressure; TC 
= total cholesterol. 
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Other CVD risk factors beyond the Framingham point score system are worthy 
of consideration: diabetes, diastolic blood pressure, presence of a positive family 
history for CVD, and obesity measures - BMI, percent body fat, and waist 
circumference. Excluding family history, these risk factors define the metabolic 
syndrome.  A majority of women (n=96, 76.8%) reported a positive family history of 
CVD.  
Metabolic Syndrome 
The cardiac risk profiles were examined to determine the number of women 
with possible metabolic syndrome (Grundy, et al., 2005). Since triglycerides and fasting 
glucose were not obtained, metabolic syndrome was determined by having diabetes, 
increased waist circumference, decreased HDL-cholesterol, and/or hypertension (Table 
10).  Self-reported type 1 and type 2 diabetes were used as proxies for elevated blood 
sugar. Frequencies were calculated to determine the number of women who met the 
criteria of having three metabolic syndrome variables. Twelve women met the criteria 
for having the metabolic syndrome. An additional 26 women had two of the criteria 
which suggest that had there not been missing waist circumference data, the total 
women with metabolic syndrome might exceed 12. 
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Table 10. Metabolic Syndrome   
Variables Number Percent of Sample 
Diabetes   
Type I 2 1.6% 
Type II 11 8.8% 
Waist ≥ 35 inches a 54 57.4% 
HDL-C < 50 mg/dl or Drug 
treatment 
53 42.4% 
Elevated BP or Drug 
treatment 
60 
 
48% 
 
Note. BP = blood pressure; HDL-C = high-density lipoprotein-cholesterol. 
a = missing data for 31 women 
 
 
American Heart Association Risk Classification Assessment 
With the introduction of the AHA risk classification system for women (Table 
5; Mosca, Banka, et al., 2007) this streamlined approach may help to identify women 
―at risk‖ of developing heart disease and to do so in a more meaningful fashion. This is 
particularly relevant from the perspective of maximizing CVD risk modification. It is 
noteworthy that it takes a point score of greater than 19 points to reach the 10% 
threshold of having a 10-year risk of a cardiac event according to the Framingham point 
score method. Given the age range for the majority of women in this sample, most of 
the points were associated with their age. Therefore, it was important to extend the 
cardiac risk profile analysis of this sample to determine how they would be classified 
using the current AHA level of risk for women. How might the presence of CVD risk 
factors which constitute the AHA ―at risk‖ group alter the risk group assignment of the 
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study women? Table 11 lists the number of women who had each of the CVD risk 
factors that could make them eligible for being classified as ―at risk‖. 
Table 11. Sample Reclassification of American Heart Association Cardiac Risk 
 Profile for Women 
Risk Factors High Risk At Risk Optimum Risk 
 (N / Percent) 
Framingham Score 1 (0.8%) 7 (5.6%) 117 (93.6%) 
Diabetes 13 (10.4%) n/a n/a 
―At Risk‖ a 
 1 major risk factor for 
CVD including: 
b
 
   
Physical inactivity  89 (71.2%)  
Obesity, especially 
 central adiposity 
 72 (57.6%)  
Hypertension  60 (48%)  
Dyslipidemia   52 (41.6%)  
Poor diet  41 (32.8%)  
Metabolic syndrome  12 (9.6%)  
Cigarette smoking  5 (4%)  
Risk Class Total 
c
 14 (11.2%) 80 
d
 (64%) 31 (24.8%) 
Note. a= number of women who have one or more of the listed risk factors and or the 
metabolic syndrome; b = number (percent) of women who do have these risk factors; c 
= number of women reclassified after calculating the ―at risk‖ group; d = total ―at risk‖ 
adjusted for low physical activity women who were diabetics and those already 
identified as ―at risk‖ by Framingham score; n/a = not applicable. 
 
The first criterion in this schema is the Framingham risk score. The values in 
Table 10 are the calculated risk scores for the sample. The majority of the participants 
(n= 117, 93.6%) had calculated Framingham risk scores less than 10% which placed 
them in the ―optimum risk‖ classification. Based on a Framingham risk score less than 
20% but greater than 10%, seven women were classified in the ―at risk‖ category. With 
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a Framingham risk score of 30%, one woman in this sample would be classified in the 
―high risk‖ category.  
Diabetes is the next AHA criterion. An assessment of the CVD risk factors for 
the sample revealed that 13 women reported having diabetes. Twelve of these diabetic 
women had a Framingham risk score in the ―optimum risk‖ category, and one was 
classified in the ―at risk‖ category. Diabetes was the only CVD risk factor to shift 
women into the AHA ―high risk‖ category. The addition of these 13 diabetic women 
increased the number considered at ―high risk‖ to be 14.  
The next consideration was then how might the classifications shift further by 
the presence of at least one of the major CVD risk factors which place a woman in the 
―at risk‖ category? The values in the table in the ―at risk‖ column represent the total 
numbers of women with each of these risk factors in descending frequency. Since 
women often reported more than one risk factor, these totals exceed 100%. 
Physical inactivity was defined by a score of 1 (―never‖) or 2 (―sometimes‖) on 
the HPLP-II item number 10 questioning vigorous exercise for 20 or more minutes at 
least three times per week. The presence of this one risk factor - physical inactivity - 
increased the number of women to be considered ―at risk‖; the percent ―at risk‖ 
increased more than 11-fold from 5.6% to 64%. The shift of these previously classified 
―optimum risk‖ women reduced the number who would now be considered to be at 
―optimum risk‖ level to just one-quarter (n = 31) of the sample as compared to 94%.   
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Obesity was defined by a BMI > 30.  Table 12 lists the accepted estimates of 
obesity. Since all women did not have waist measurements, BMI was selected as the 
indicator for obesity.   
The metabolic syndrome definitions (Grundy et al., 2005) were used to classify 
women as having hypertension and dyslipidemia. Women were considered to have 
hypertension if they reported being treated for hypertension (n= 53, 42.4%) or had a 
measured systolic or diastolic blood pressure meeting the categorical cut points for the 
metabolic syndrome. Sixty women had a measured systolic blood pressure that was 
equal to or greater than 130 mmHg indicating those with possible hypertension.  Fifty-
two women with an HDL-C less than 50 mg/dl indicated those with dyslipidemia. A 
slightly lower number of women (n= 47, 37.6%) reported taking cholesterol lowering 
medication.  
For the purposes of this study, poor diet was defined by a score of 1 (―never‖) or 
2 (―sometimes‖) on the self-report nutrition subscale of the HPLP-II instrument. Items 
on the nutrition subscale question eating habits such as the number of servings of food 
that correspond to the food pyramid. Although the number of servings on the HPLP-II 
does not fully correspond to the current food pyramid guidelines, the developer of the 
HPLP-II would not grant revisions to the instrument.  
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Table 12. Estimation of Obesity 
Measure Mean (SD) Median (Range) 
Body Mass Index (BMI) 31.4 (± 6) 31.3 (18 - 48) 
Percent Body Fat 
a
 41.0 (± 5.8) 42 (26 - 50) 
Waist circumference 
b
 36 (± 6) 35.5 (23 - 54) 
 Number Percent of Sample 
BMI ≥ 30 70 56% 
Body Fat > 30% 
a
 115 93.5% 
Waist Circumference ≥ 35 inches 
b
 
54 57.4% 
Note. SD = standard deviation. a= missing data for 2 women; b= missing data for 31 
women 
 
The next criterion in the AHA classification schema is the presence of the 
metabolic syndrome. As discussed earlier, 12 women were determined to meet the 
metabolic syndrome criteria. Therefore, the number of women considered to be ―at 
risk‖ due to the presence of these risk factors is the number of women estimated to be 
physically inactive, the most frequently occurring risk factor once deleting those who 
were also diabetic. Thus, over half of the women (n = 73, 58.4%) were reclassified into 
the ―at risk‖ category based on their low physical activity risk factor after adjusting for 
those who were diabetic and already classified as at risk. The final criterion was the 
least frequently occurring risk factor for this sample - the self-report of cigarette 
smoking which was only reported by five women. 
The next sections address additional data that were collected for information 
that have relevance to cardiac risk. These data are concerning stress testing; the 
possibility of sleep disordered breathing, and selected medications. 
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Stress Testing, Snoring, and Sleep Apnea 
Three additional questions were asked which relate to cardiac risk (Table 13). A 
surprising number of women reported having had a stress test. When directly 
questioned, all of these women reported that the stress test was negative, so they didn‘t 
consider themselves as having diagnosed heart disease. The mean age for those who 
had a stress test was 58.7 (± 8.4), median was 58 (39-75). The stress tested subgroup is 
only 1-year older than the mean for the entire sample with identical median ages.  
Although more than half (59.2%) reported that they snored, fewer than 14% reported 
having been diagnosed with sleep apnea.    
Table 13.  Stress Testing, Snoring, and Sleep Apnea  
ASK Item Yes (N/Percent) No (N/Percent) 
Have you ever had a stress test? 
Do you snore? 
Have you ever been diagnosed with sleep 
apnea? 
Missing 
65 (52%) 
74 (59.2%) 
17 (13.6%) 
2 (1.6%) 
58 (46.4%) 
49 (39.2%) 
106 (84.8%) 
2 (1.6%) 
ASK = Assessing Depressive Symptoms Improves the Knowledge of CVD Risk.  
 
Medication History 
 The women were asked to report whether they were taking three types of 
medication relevant to basic risk modification management – aspirin, cholesterol 
lowering, and anti-hypertensive, and if they were taking hormone replacement therapy. 
Most women (n = 78, 62.4%) were not taking aspirin but were taking some form of 
medication to manage their cholesterol.  Most women were not taking medication to 
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manage their blood pressure (n = 72, 57.6%) and were not taking hormone replacement 
therapy (n = 104, 83.2%). 
 With this summary of the cardiac profile data for the sample, the presentation of 
results moves on to the summary of the major study variables. The first to be addressed 
will be awareness of heart disease, followed by the health-promoting lifestyle 
behaviors‘ data, the major study predictor of interest, depressive symptoms, and 
concludes with the outcome variable of interest, the perceived quality of life. 
Awareness of Heart Disease 
Overall, the women were aware of their risk of developing heart disease and 
believed that all women should be evaluated for cardiac risk (Table 14). Less than half 
reported learning about heart risk from their primary healthcare provider, and most 
reported learning about it from the Heart Advantage Program or other media (Table 13). 
Table 14. Awareness of Heart Disease 
ASK Item Yes (N/%) No (N/%) 
Did you know your chances/risk of getting heart 
disease before this screening? 
84 (67.2%) 41 (32.8%) 
Did you know that all women should be evaluated 
for their chances/risk of getting heart disease? 
96 (76.8%) 
 
29 (23.2%) 
 
Did you learn about your heart disease risk from 
your primary healthcare provider? 
54 (43.2%) 
 
71 (56.8%) 
 
Did you learn about heart disease in women from 
information you have received from being a member 
of the Women‘s Heart Advantage program or 
coverage on television, radio, or in the newspaper? 
106 (84.8%) 19 (15.2%) 
Note. ASK = Assessing Depressive Symptoms Improves the Knowledge of CVD Risk.
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Health-Promoting Lifestyle Behaviors 
The health-promoting lifestyle behaviors were measured by the HPLP-II. Table 
15 lists the frequency response for the HPLP-II total and subscale scores. Table 15 lists 
the mean scores for the total and for the subscales. The mean score for the total and for 
the six subscales are based upon a Likert scale of 1 (―never‖) to 4 (―routinely‖).  
Table 15. Health-Promoting Lifestyle Profile-II – Frequency Results 
Scale Never (1) 
(N/%) 
Sometimes 
(2) (N/%) 
Often (3) 
(N/%) 
Routinely 
(4) (N/%) 
Total Score 0 43 (34.4%) 79 (63.2%) 3 (2.4%) 
Subscales:     
Interpersonal 
Relations 
0 18 (14.4%) 75 (60%) 32 (25.6%) 
Spiritual Growth 0 27 (21.6%) 71 (56.8%) 27 (21.6%) 
Nutrition 3 (2.4%) 38 (30.4%) 73 (58.4%) 11 (8.8%) 
Health Responsibility 0 55 (44%) 60 (48%) 10 (8%) 
Stress Management 1 (0.8%) 69 (55.2%) 47 (37.6%) 8 (6.4%) 
Physical Activity 21 (16.8%) 62 (49.6%) 38 (30.4%) 4 (3.2%) 
 
A review of the mean scores for the women gives a sense of the overall status of 
the health-promoting lifestyle behaviors (Table 16). A mean total score of 2.63 
indicates that on average the sample performed health-promoting lifestyle behaviors in 
the sometimes-to-often range. The highest scoring subscales were interpersonal 
relations (mean = 3.07) and spiritual growth (mean = 3.03). These scores indicate that 
on average, the study sample women were ―often‖ performing these health-promoting 
lifestyle behaviors. The health responsibility (mean = 2.62) and nutrition (mean = 2.72) 
subscale scores indicate that on average, the study sample women were sometimes-to-
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often addressing health responsibility and nutrition activities. The lowest scoring 
subscale was physical activity (mean = 2.13) followed by stress management (mean = 
2.43). These results indicate that on average, that most women were only slightly more 
than sometimes performing physical activity behaviors or addressing management of 
their stress. The physical activity and nutrition subscales are worth examining on an 
individual item basis as they are particularly relevant to CVD risk status. 
Table 16.  Health-Promoting Lifestyle Profile-II (HPLP-II) and Subscale Scores 
 Mean Score  
(Standard Deviation) 
Median  
(Range) 
HPLP-II Total Score 2.63 (± .384) 2.67 (2 – 4) 
Subscales   
Interpersonal Relations 3.07 (± .498) 3.11 (2 – 4) 
Spiritual Growth 3.03 (± .547) 3.00 ( 2 – 4) 
Nutrition 2.72 (± .559) 2.78 (1 – 4) 
Health Responsibility 2.62 (± .520) 2.56 (2 – 4) 
Stress Management 2.43 (± .533) 2.38 (1 – 4) 
Physical Activity 2.13 (± .683) 2.00 (1 – 4) 
Note. Scores: 1 = never, 2 = sometimes, 3 = often, 4 = routinely.  
 
The individual item analysis of the physical activity subscale revealed that on 
average, the women in this sample only sometimes followed a planned exercise 
program, or exercised vigorously for 20 or more minutes three times a week. They only 
sometimes exercised moderately five or more times a week, performed any leisure time 
physical activity such as dancing, or exercised during usual daily activities such as 
taking the stairs, walking during lunch breaks.  Stretching exercises were only 
sometimes performed at least three times a week. Only sometimes did the women on 
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average check their pulse or reach their target heart rate when exercising, and only 
sometimes did the women park further away from their destination.  
An examination of the individual nutrition subscale items indicated that women 
only sometimes selected a low saturated fat and low cholesterol diet. They also reported 
only sometimes: limiting the use of sugar and consumption of sugar containing foods, 
eating the recommended portions of fruit, vegetables, and dairy products each day, 
limiting the portions of carbohydrates, meat, poultry, fish, dried beans, eggs or nuts 
each day, and eating eat breakfast each day, or reading the nutrient contents on labels.    
Health History and Depressive Symptoms 
 Health history information was obtained in addition to assessment of depressive 
symptoms. The health history data include the Functional Comorbidity Index (FCI), the 
medical history self-reported assessment, a selected medication survey, four mental 
health history items, and a one-item stress level question. The health history data will 
precede the results of the CES-D. 
Health History and Medications 
 An area of concern in the depression assessment literature is the potential 
confounding nature of co-morbid medical illnesses biasing the accuracy of self-report 
instruments to accurately detect depression and depressive symptoms. The FCI was 
used to obtain a self-report brief survey of coexisting diagnosed medical problems. The 
FCI total score, which is a simple sum of the number of checked items, includes the 
addition of the final item of whether the BMI was greater than or equal to 30. Items 
102 
 
checked by any participants plus the BMI, calculated as part of the CVD screening 
program, are listed in Table 17.  
No participants reported having angina, heart failure, myocardial infarction, 
neurological disease, stroke, and peripheral vascular disease; however, these were 
exclusionary study criteria. Nineteen participants (15.2%) reported no co-morbidities.  
The FCI total scores of 1 (n = 29, 23.2%), 2 (n = 30, 24%), 3 (n = 20, 16%), and 4 (n = 
15, 12%) accounted for 75.2% of the sample. The most frequent items in order were 
BMI > 30, presence of arthritis, upper gastrointestinal disorder, and depression.   
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Table 17. Functional Comorbidity Index (FCI) Sample Results 
FCI Item  
FCI Total Score 
Mean (Standard Deviation) 
Median (Range) 
 
2.2 (± 1.6) 
2.0 (0 – 7) 
Individual Items  (N, Percent) 
BMI 72 (57.6%) 
Arthritis 43 (34.4%) 
Upper GI Disease 30 (24%) 
Depression 29 (23.2%) 
DJD 18 (14.4%) 
Anxiety 16 (12.8%) 
Asthma 15 (12%) 
Osteoporosis 15 (12%) 
Visual Impairment 14 (11.2%) 
Diabetes 13 (10.4%) 
Respiratory Disorder 3 (2.4%) 
Hearing Impairment 2 (1.6%) 
Panic Disorder 2 (1.6%) 
TIA 2 (1.6%) 
Note.  BMI = body mass index; DJD= degenerative joint disease; GI = gastrointestinal;  
TIA = transient ischemic attack. 
 
Medication Data 
Nearly one-quarter of the sample (n = 30, 24%) reported taking medications for 
depression. While just over one-third of the sample reported a diagnosis of arthritis, 
only 18 (14.4%) women reported taking medication to manage their arthritis.  The other 
medications in the history were discussed in the cardiac profile section. 
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Mental Health History and Stress Level 
Data regarding depression history are presented in Table 18.  Almost half of the 
sample (47%) reported a family history of depression. Over one third (38%) reported 
being told at some point in their life they had depression. Although 40% reported that at 
some point in their life they were treated for depression, only 25% reported taking 
medication for depression.   
Table 18. Response to Mental Health Items 
ASK Item Yes (N/Percent) No (N/Percent) 
Is there a family history of depression? 
Have you ever been told you have depression? 
Have you ever been treated for depression? 
Are you taking any medication for depression? 
59 (47.2%) 
47 (37.6%) 
50 (40%) 
30 (24%) 
66 (52.8%) 
78 (62.4%) 
75 (60%) 
95 (76%) 
Note: ASK = Assessing Depressive Symptoms Improves the Knowledge of CVD Risk.
  
 Although women were asked to list all of their specific medications, nine 
women were unable to recall their anti-depression medications. Of those who could 
provide their current medication list, Prozac, Wellbrutin, Paxil and Zoloft were the most 
frequently taken anti-depressive medications (five, four, three and three women 
respectively).   
The Heart Aware questionnaire asked the women to rank their stress level. Most 
women (n= 81, 64.8%) reported their stress level as average. A quarter of the women (n 
= 31, 24.8%) ranked their stress level as high/chronic, and only 13 women (10.4%) 
ranked their stress level as low. A statistically significant inverse relationship was found 
between the reported stress level and the stress management subscale of the HPLP-II  
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(rS = -.28, p <.01). This inverse relationship indicates that as the reported stress level 
increased the frequency of performing stress management behaviors decreased.  
Depressive Symptoms 
Depressive symptoms were measured using the self-report CES-D twenty-item 
instrument.  Four items, numbers 4, 8, 12, and 16, are reverse-coded before tabulating 
the score. The CES-D scoring is the simple sum of the item scores and can range from 
0-60. There are no subscales. A score equal to or greater than 16 is used most frequently 
in the literature to indicate depressive symptoms. 
The mean score for the sample was 14 (SD ± 9). The median score was 12 with 
a range of 1 to 41. Table 19 displays the scores for the individual items. The values for 
the four asterisked items are the reverse coded values as recorded by the participants. 
Using the recommended CES-D guidelines (score > 16), one third of the women (n = 
42, 33.6%) reported significant depressive symptoms.  
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Table 19. Responses to the Center for Epidemiological Studies–Depression  
     (CES-D) 
 
 
 
During the past week: 
Rarely or 
none of the 
time (less 
than 1 day) 
Some or a 
little of the 
time (1-2 
days) 
Occasionally or 
a moderate 
amount of time 
(3-4 days) 
Most or all 
of the time 
(5-7 days) 
Item Response Score 0 1 2 3 
1. I was bothered by things 
that usually don‘t bother 
me. 
57 (45.6%) 45 (36%) 20 (16%) 3 (2.4%) 
2. I did not feel like eating; 
my appetite was poor. 
84 (67.2%) 23 (18.4%) 15 (12%) 3 (2.4%) 
3. I felt that I could not 
shake off the blues even 
with the help from my 
family or friends. 
86 (68.8%) 17 (13.6%) 18 (14.4%) 4 (3.2%) 
4. I felt that I was just as 
good as other people. * 
65 (52%) 21 (16.8%) 16 (12.8%)  23 (18.4%) 
5. I had trouble keeping my 
mind on what I was 
doing. 
37 (29.6%) 41 (32.8%) 38 (30.4%) 9 (7.2%) 
6. I felt depressed. 71 (56.8%) 32 (25.6%) 19 (15.2%) 3 (2.4%) 
7. I felt that everything I 
did was an effort. 
53 (42.4%) 40 (32%) 22 (17.6%) 10 (8%) 
8. I felt hopeful about the 
future. * 
61 (48.8%) 30 (24%) 22 (17.6%) 12 (9.6%) 
9. I thought my life had 
been a failure. 
103 (82.4%) 13 (10.4%) 9 (7.2%) 0 
10. I felt fearful. 83 (66.4%) 26 (20.8%) 12 (9.6%) 4 (3.2%) 
11. My sleep was restless. 27 (21.6%) 49 (39.2%) 30 (24%) 19 (15.2%) 
12. I was happy. * 11 (8.8%) 10 (8%) 30 (24%) 74 (59.2%) 
13. I talked less than usual. 62 (49.6%) 41 (32.8%) 17 (13.6%) 5 (4%) 
14. I felt lonely. 69 (55.2%) 34 (27.2%) 15 (12%) 7 (5.6%) 
15. People were unfriendly. 80 (64%) 32 (25.6%) 11 (8.8%) 2 (1.6%) 
16. I enjoyed life. * 11 (8.8%) 11 (8.8%) 25 (20%) 78 (62.4%) 
17. I had crying spells. 85 (68%) 29 (23.2%) 8 (6.4%) 3 (2.4%) 
18. I felt sad. 59 (47.2%) 49 (39.2%) 14 (11.2%) 3 (2.4%) 
19. I felt that people 
disliked me. 
96 (76.8%) 22 (17.6%) 4 (3.2%) 3 (2.4%) 
20. I could not get going. 66 (52.8%) 33 (26.4%) 22 (17.6%) 4 (3.2%) 
Note: * = items that are reverse coded for scoring. 
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 The relationship between the CES-D total score and the depression history items 
was analyzed (Table 20). Spearman rho (rS) was used to analyze these correlations due 
to the nominal level of measurement of the history items. The strongest correlation was 
between the CES-D score and taking medications to manage depression (rS = .33, p < 
.01).  Also significant were the relationships between being treated for depression as 
well as having co-morbid conditions. The relationship between the CES-D total score 
and a family history of depression was low (rS =.17) and approached statistical 
significance (p=.053).  
Table 20. Correlation Between Center for Epidemiological Studies Depression 
(CES-D) and Depression History Items 
 
Depression History Item Correlation with CES-D 
Functional Comorbidity Index .28** 
Takes Depression Medication .33** 
Has Been Treated for Depression  .28** 
Has Been Diagnosed with Depression .20** 
Family History of Depression .17 (p = .053) 
Note. **= p < .01 
Based on the number of women who were found to be depressed, these results 
were examined according to their cardiac risk status. Table 21 depicts the distribution 
of the women by depressive symptom score (depressed = CES-D score equal to/greater 
than 16) and the cardiac risk assessment using the traditional Framingham risk score 
and the AHA risk reclassification described earlier. Briefly, the number of women 
presenting with at least one CVD risk factor that would put them in the AHA ―at risk‖ 
group reduced the number of women who should be considered in the optimum risk 
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group. Based on only the Framingham risk score, the majority of the sample would be 
considered in the optimum risk group (n = 117, 93.6%). Once accounting for the 
presence of CVD risk factors, only a quarter of the women should be classified as at 
optimum risk. 
Table 21. Depressive Symptoms by Risk Classification: Framingham Score 
Compared to the American Heart Association (AHA) Risk Groups 
 
Risk Class Method High Risk At Risk Optimum Risk   
 (N / Percent) 
Framingham Score 
a
 1 (0.8%) 7 (5.6%) 117 (93.6%) 
Depressed 
b
 0 2 (4.8%) 40 (95.2%) 
Not Depressed 
c 
1 (1.2%) 5 (6%) 77 (92.8%) 
AHA Risk Classification 
d 
14 (11.2%)
e
 80 (64%) 31 (24.8%) 
Depressed 
b
 2 (4.8%) 30 (71.4%) 10 (23.8%) 
Not Depressed 
c
 12 (14.5%) 50 (60.2%) 21 (25.3%) 
Note. a = number of women per AHA class solely based on their Framingham risk 
score; b = Depressed equals CES-D score ≥ 16; c = Not depressed equals CES-D score 
< 16;  d = number of women reclassified after calculating the ―at risk‖ group based on 
risk factors identified in the study sample; e = women with diabetes added to high risk 
group.  
 
 Based on just the Framingham risk score, most of the 42 depressed women were 
in the optimum risk group (n = 40). Following the AHA reclassification, nearly three-
quarters of the depressed women were in the at risk group (n = 30).  
Perceived Quality of Life 
Perceived quality of life was measured by the Ferrans and Powers Quality of 
Life Index (QLI) – Generic Version-III. All QLI scores – the QLI total score and the 
subscale scores - can range from 0-30. A score of less than 19 indicates a poorer quality 
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of life (Dr. Ferrans, Personal Communication). The results are listed in Table 22. Most 
women reported an overall favorable quality of life reflected by the low number of 
women with a total score of less than 19. Health and functioning was reported as the 
lowest subscale. This scale asks about the satisfaction with and the importance of their 
health, health care, pain level, energy for everyday activities, independent self-care 
ability, control over their lives, chances of living as long as they would like, their sex 
life, ability to care for family responsibilities, their usefulness to others, what they do 
for fun, and their chances for a happy future.   
Table 22. Quality of Life Index (QLI) and Subscales’ Results 
 Score 
(Standard 
Deviation) 
Median 
(Range) 
Number 
Scoring Less 
Than 19 (%) 
QLI Total Score 22.4 (± 4) 22.7 (9-30) 16 (12.8%) 
Subscales    
Psychological/ Spiritual 23.2 (± 4.9) 24.4 (6-30) 19 (15.2%) 
Family 23 (± 5.3) 24 (6-30) 23 (18.4%) 
Social & Economic 22.7 (± 4.5) 23 (11-30) 21 (16.8%) 
Health & Functioning 21.5 (± 4.6) 21.8 (3-30) 25 (20%) 
 
Summary of the Descriptive Data Findings 
A group of women (n = 125) attended a CVD risk screening program and 
volunteered to participate in this study to investigate the relationship of depressive 
symptoms to the status of health-promoting lifestyle behaviors, the awareness of heart 
disease risk, cardiac risk, and how these relationships affect perceived QOL. The study 
sample (Table 6) was middle aged (mean age 57.7 years, ± 9.6), mostly urban, non-
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Hispanic, white, married, and employed full-time, with a household income between 
$25,000-49,999, who had some college education and most lived within five miles of 
the CVD screening center. The women mostly reported being aware of their individual 
cardiac risk and believed that all women should be evaluated for cardiac risk. Less than 
half of the women reported learning of their cardiac risk status from their primary care 
provider. They learned about cardiac risk from the media or from being members of the 
screening center‘s heart disease screening and education program (Table 13). 
The cardiac profile indicated that despite the majority (n = 117, 93.6%) having a 
Framingham risk score of less than 10%, the frequency of traditional CVD risk factors 
according to the AHA risk classification for women, indicated that the majority (n = 80, 
64%) should be reclassified as ―at risk‖ with only a quarter of the women (n = 31, 
24.8%) being classified in the ―optimum risk‖ class (Table 10). Nearly half of the 
women were found to be hypertensive (n = 60, 48%), dyslipidemic (n = 52, 41.6%), 
obese (n = 72, 57.6%), and almost three-quarters were generally physically inactive (n = 
89, 71.2%). The high percentage of infrequently performed regular physical activity 
was the CVD risk factor which increased the number of women who should be 
classified as ―at risk‖. Perhaps of more concern is that 12 diabetic women with low 
Framingham risk scores in the ―optimum risk‖ class should actually be classified in the 
―high risk‖ group according to the AHA classification system.  
Associated cardiac profile findings included that a majority of women (n = 74, 
59.2%) reported that they snored but only 13.6% (n = 17) reported being diagnosed 
with sleep apnea (Table 12). Most women were not taking aspirin (n = 78, 62.4%) but 
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nearly an equal number reported taking some form of cholesterol lowering medication. 
Sixty women had a measured SBP of equal to or greater than 130 mmHg but most 
women were not taking anti-hypertensive medication (n = 72, 57.6%). 
No more than a quarter of these generally cardiac risk aware women reported 
that they routinely performed health-promoting lifestyle behaviors (Table 14). 
Interpersonal relations‘ behaviors and spiritual growth behaviors were the most 
consistently performed. The group of physical activity behaviors were the least 
frequently performed. Based on the self-reported FCI health history, three-quarters of 
the women (75.2%) reported 4 or fewer co-morbidities with a mean FCI score of 2.2 (± 
1.6) and a median score of 2.0 (range = 0 – 7). By far the most frequent co-morbidity 
was obesity indicated by a BMI ≥ 30 (57.6%), with arthritis the next most frequent co-
morbidity reported by one-third of the women (Table 16).  
Nearly half of this generally healthy group of women reported a family history 
of depression, over one-third (n = 47, 37.6%) reported having been told they had 
depression and having been treated for depression (n = 50, 40%), and one-quarter were 
taking depression medication (Table 17). Based on a cut-score of ≥ 16, the CES-D total 
score indicated that one-third of the women (n = 42, 33.6%) of these generally healthy 
risk-assessment seeking women had depressive symptoms. The CES-D total score was 
found to be positively correlated with most of the depression history items and the FCI 
(Table 19). The majority of the depressed women were found to be classified in the 
AHA at risk group due to the low level of regular physical activity (Table 20).  
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With a total QLI score of ≤ 19 indicating a low perceived QOL, only 16 (12.8%) 
women reported they were dissatisfied with their QOL (mean = 22.4, ± 4; median = 
22.7, range = 9-30) (Table 22). The lowest scoring QLI sub-scale was health and 
functioning and the highest scoring sub-scale was psychological/spiritual.  
Data Analysis for Study Aims 
The purpose of the study was to investigate the relationship of depressive 
symptoms to cardiac risk, the status of health-promoting lifestyle behaviors, the 
awareness of heart disease risk, and how these relationships affect perceived quality of 
life. The next sections will present the results for the three study aims which explored 
these relationships. The first to be reported will be the bivariate correlations, followed 
by the assessment of a possible dose-response relationship between depressive 
symptoms and the major study variables, and will conclude with the determination of 
whether cardiac risk and/or the health-promoting lifestyle behaviors mediate the 
relationship between depressive symptoms and the perceived quality of life in this 
group of women being assessed for CVD risk. 
Aim 1- Description of the Relationships Among the Major Study Variables 
 The first study aim was to determine the relationship between depressive 
symptoms and: (1) cardiac risk, (2) health-promoting lifestyle behaviors, (3) an 
awareness of heart disease risk, and (4) perceived QOL in women being screened for 
CVD risk. Spearman correlation coefficient (rS) analysis was selected because it is a 
non-parametric statistic, therefore, it can be used when the data to be analyzed violate 
the assumptions of parametric data: normal distribution, homogeneity of variance, and 
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interval level data (Field, 2009, p. 180). The CES-D total score and the calculated 
Framingham risk score are interval level data. The HPLP-II and the QLI total score are 
ordinal level data. The awareness of heart disease risk and the AHA risk groups are 
nominal level data.  The first data to be presented are the relationships between 
depressive symptoms and the awareness of heart disease questions (Table 23). 
Following these data are the correlations between the CES-D and the other study 
variables (Table 24). 
Table 23. Correlation Between Center for Epidemiological Studies Depression 
 (CES-D) and Awareness of Cardiac Risk 
 
Awareness of Cardiac Risk Item Correlation with CES-D 
Were aware of chances of getting heart disease 
before this screening. 
.06 (p = .50) 
Learned about your heart disease risk from your 
primary healthcare provider. 
.06 (p = .53) 
Knew that all women should be evaluated for risk 
of getting heart disease. 
-.09 (p = .35) 
Learned about heart disease in women from 
Covenant Heart Advantage program or coverage 
on television, radio, or in the newspaper. 
.10 (p = .27) 
 
No statistically significant correlation was found between the depressive 
symptoms score and whether the women were aware of their own cardiac risk, or 
whether women should be evaluated for CVD risk. There was also no correlation 
between depressive symptoms and how women learned about their cardiac risk or about 
heart disease in women (Table 23).  
 The first study aim was to examine if there was a relationship between 
depressive symptoms and calculated cardiac risk (the Framingham risk score), health-
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promoting lifestyle behaviors, and the outcome of interest, perceived quality of life. 
These data are depicted in Table 24. With the Bonferroni correction for multiple 
comparisons (alpha .05 divided by the total of 15 correlations), the alpha .05 level is 
corrected to p = .003. Thus, the asterisked significant correlations remain significant. 
Based on the shift in the numbers of women considered at risk of heart disease, the 
AHA risk groups were added to this analysis. The single risk awareness item was also 
included in this analysis. Significant correlations found were between health-promoting 
lifestyle behaviors and AHA risk groups, the quality of life and depressive symptoms. 
The strongest correlation was found between the major predictor variable, depressive 
symptoms, and the outcome variable, quality of life measured by the QLI. Neither the 
Framingham risk score nor risk awareness were correlated with any of the other 
predictor variables or with quality of life. 
Table 24. Correlation of Major Study Variables 
 Framingham 
Risk Score 
AHA Risk 
Groups 
HPLP-II QLI CES-D 
Risk 
Awareness 
.04 -.03 -.07 -.12 .06 
Framingham 
Risk Score 
___ .16 .01 .11 -.09 
AHA Risk 
Groups 
 ___ -.26** -.06 -.07 
HPLP-II   ___ .46** -.37** 
QLI    ___ -.51** 
Note. AHA = American Heart Association; CES-D = Center for Epidemiological 
Studies Depressions; HPLP-II = Health- Promoting Lifestyle Profile-II; QLI = Quality 
of Life Index.  **= p < .01. 
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Summary of Aim 1 Findings 
 Depressive symptoms were not found to be associated with whether women 
were aware of their CVD risk or with how they learned of this risk. Risk awareness was 
also not associated with the calculated risk score, the AHA Risk Groups,  health 
promoting lifestyle behaviors, or quality of life. The frequency of performing health-
promoting lifestyle behaviors was found to be inversely correlated with AHA risk 
status, i.e. the less frequently health-promoting lifestyle behaviors were performed, the 
higher the AHA risk group status. 
 Depressive symptoms were inversely associated with health-promoting lifestyle 
behaviors, i.e., as depressive symptoms increased, the frequency of performing health-
promoting lifestyle behaviors decreased. An inverse relationship was also identified 
between depressive symptoms and quality of life so that quality of life was lower as 
depressive symptoms worsened.  
Aim 2- Examination of Dose-Response Relationship 
The second study aim was to determine whether there is a dose-response-
relationship between depressive symptoms and: (1) cardiac risk, (2) the health-
promoting lifestyle behaviors, and (3) the perceived quality of life. Logistic regression, 
specifically binary logistic regression, was selected as the method to examine for a 
possible dose-response relationship because the outcome for this statistical analysis are 
the odds (i.e., the predicted probability) of whether the presence or absence of a 
dichotomous outcome variable can be predicted. Binary logistic regression requires the 
outcome variable have only two categories. A categorical outcome violates a linear 
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regression assumption. Predictor variables may be continuous or categorical but are 
limited to two categories. For the purposes of these analyses, all the categorical 
variables were dichotomized. 
Due to the very low number of women with a Framingham risk score of greater 
than 10%, the AHA reclassified risk data were used in this analysis. The dichotomized 
AHA risk groups were the optimum risk category and the combined at risk and high 
risk women. The outcome of health-promoting lifestyle behaviors was dichotomized at 
a score of 2.5. This split was based on the 1(―never‖) to 4 (―routinely‖) scale for the 
mean HPLP-II score with 2.5 as the median score. The quality of life outcome was 
dichotomized at the recommended QLI score of 19.  
Covariates (i.e., the predictor variables) were selected from the literature as 
being relevant to the analysis of depressive symptoms and quality of life. The covariates 
were the categorical socioeconomic variables of education, employment, income, and 
marital status and the CVD risk factors of BMI entered as a continuous variable, and 
family history of CVD (present or absent) entered as a categorical variable. Other CVD 
risk factors were considered (age, TC, HDL-C, and SBP) but were then eliminated as 
covariates because they are the factors which constitute the Framingham risk score and, 
therefore, define cardiac risk. The socioeconomic variables were dichotomized as 
outlined in Table 25. The creation of the dichotomous variables was based on a logical 
grouping of the categories per variable.  
The dichotomized variables produced group sizes which all had sufficient data 
when subjected to crosstabulation analysis. Sufficient data are the first condition for 
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logistic regression. Sufficient data are defined by the expected frequencies in each cell 
in the crosstabulation‘s table  ―to make sure they are greater than 1 and no more than 
20% are less than 5‖ (Field, 2009, p. 274). Each predictor variable was entered into a 
crosstabulation with the outcome variable, quality of life delineated by the split of the 
QLI scores at 19, the HPLP-II mean score split at 2.5, and the two AHA cardiac risk 
groups. Sufficient data were identified in all crosstabulations. 
Table 25. Creation of Dichotomous Socioeconomic Variables 
Dichotomous Variables Created Original Variables 
Education 
Not College Graduate (n = 75) 
 
College Graduate  (n = 50) 
 
 Less than 9th Grade, High school 
graduate, Some college 
 Associate Degree, Bachelors Degree, 
Graduate or Professional Degree 
Employment 
Employed  (n = 64) 
Not Working  (n = 61) 
 
 Fulltime & Part-time 
 Unemployed & Not Seeking 
Employment 
Income 
Income < $25,000  (n = 30) 
Income > $25,000  (n = 93) 
 
 Less than $15,000, $15,000 – 24,999 
 $25,000—49,999, More than $50,000 
Marital Status 
Married  (n = 75) 
Not Married  (n = 50) 
 
 Married 
 Never Married, Separated, Divorced, 
Widowed 
 
Four logistic regression analyses were performed to determine whether there 
was a graded increased severity of the dependent variable depressive symptoms with 
the independent variables: (1) an increased likelihood of increased cardiac risk, (2) a 
decreased frequency of performing health-promoting lifestyle behaviors, and (3) a 
decreased perceived quality of life. Depressive symptoms were analyzed as a 
continuous variable in three models. A fourth model entered the CES-D score split at 16 
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to determine whether a dose-response relationship could be identified with cardiac risk 
when the initial model did not. The logistic regression data are presented in the 
following order: (1) review of the tests of logistic regression analysis conditions, 
assumptions, and outliers; and (2) the results of the logistic regression analyses 
particularly regarding the possibility for a dose-response relationship. 
Review of Logistic Regression Conditions, Assumptions, and Outliers 
 Following standard procedures, the conditions, assumptions and determination 
of any outlier cases that may have exerted undue influence were examined for all 
logistic regression models. Three necessary considerations were examined: (1) 
sufficient data for examination of all combinations of the variables, (2) complete 
separation, and (3) overdispersion. Three assumptions were examined: (1) a linear 
relationship between the continuous predictors and the logit of the outcome variable, (2) 
the independence of the errors, and (3) no perfect multicollinearity. A review of the 
casewise diagnostics of the residuals was used to determine the presence of any outlier 
cases. 
Summary.  The crosstabulations‘ analyses verified that there were sufficient data 
to support the logistic regression models. The examination of the classification tables 
verified that there were no problems with complete separation. Among the four models, 
concerns were raised for possible overdispersion in the QLI and AHA risk groups‘ 
models. Overdispersion ―tends to limit standard errors and results in narrower 
confidence intervals for test statistics of predictors in the logistic regression model‖ 
(Field, 2009, p. 276).  Narrower confidence intervals can lead to the conclusion that a 
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predictor is significant when indeed it is not (Field, 2009, p. 276). Examinations of the 
confidence intervals in these two models did not indicate they were unusually narrow, 
thus the predictors are significant. 
The review of the assumptions revealed that none of them were violated. The 
examination of the residuals revealed that there was no evidence for exertion of undue 
influence. The examination of the residuals, and leverage indicated there were cases 
that might not fit the model but these findings do not question the models‘ conclusions.  
Results of the Logistic Regression Analyses 
 Evidence for a dose-response relationship was found between depressive 
symptoms and quality of life and health-promoting lifestyle behaviors. As depressive 
symptoms increase, there is a graded worsening in quality of life and a graded decrease 
in the frequency of performing health-promoting lifestyle behaviors. As depressive 
symptoms increased the odds for a higher perceived quality of life were reduced (OR = 
.85, 95% CI .79, .92, p < .001) (Table 26). 
Table 26. Logistic Regression Results: Depressive Symptoms Predicting Quality of 
 Life 
 
  95% CI for Odds Ratio 
b (SE) Lower Odds Ratio Upper 
Constant 7.50 (2.09)    
CES-D -.16*** (0.04) .79 .85 .92 
Note: R
2
 = .35 (Hosmer & Lemeshow), .27 (Cox & Snell), .45 (Nagelkerke). Model χ2 
= 38.24 (7), p < .01; *** p < .001. CES-D = Center for Epidemiological Studies 
Depression, entered as a continuous variable; CI = confidence interval; quality of life 
entered as Quality of Life Index total score entered split at 19; SE = standard error. 
 
An increase in depressive symptoms was also associated with a reduced odds of 
performing health-promoting lifestyle behaviors (OR = .92, 95% CI .88, .97, p < .001) 
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(Table 27). Thus, as depressive symptoms worsen, there is a decreased performance of 
health-promoting lifestyle behaviors. 
Table 27. Logistic Regression Results: Depressive Symptoms Predicting Health-
 Promoting Lifestyle Behaviors 
 
  95% CI for Odds Ratio 
b (SE) Lower Odds Ratio Upper 
Constant 4.67 (1.36)    
CES-D -.08** (0.03) .88 .92 .97 
Note: R
2
 = .18 (Hosmer & Lemeshow), .22 (Cox & Snell), .29 (Nagelkerke). Model χ2 
= 29.822 (7), p < .001; ** p < .01. CES-D = Center for Epidemiological Studies 
Depression, entered as a continuous variable; CI = confidence interval; health-
promoting lifestyle behaviors entered as the mean HPLP-II score split at 2.5; SE = 
standard error. 
 
There was no evidence for a dose-response relationship between depressive 
symptoms and cardiac risk entered as the dichotomized AHA risk groups. The initial 
analysis entered depressive symptoms as a continuous variable with the CES-D total 
scores (Table 28).  
Table 28. Logistic Regression Results: Depressive Symptoms Not Predict AHA 
 Cardiac Risk 
 
  95% CI for Odds Ratio 
b (SE) Lower Odds Ratio Upper 
Constant -2.83 (1.44)    
CES-D -.02
a
 (0.03) .94 .99 1.04 
Note: R
2
 =.08 (Hosmer & Lemeshow), .09(Cox & Snell), .13 (Nagelkerke). Model χ2 = 
11.019 (7), p =.14; a = Not significant; AHA = American Heart Association; CES-D = 
Center for Epidemiological Studies Depression, entered as a continuous variable; CI = 
confidence interval; AHA cardiac risk entered as optimum risk and at/high risk; SE = 
standard error. 
  
When no dose-response relationship was found when depressive symptoms 
were entered as a continuous variable with the CES-D total scores, the AHA cardiac 
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risk model was run again with the CES-D total scores split at 16 (Table 29). This did 
not improve the model findings. 
Table 29. Logistic Regression Results: Depressive Symptoms Group Not Predict
 AHA Cardiac Risk 
 
  95% CI for Odds Ratio 
b (SE) Lower Odds Ratio Upper 
Constant -2.9 (1.43)    
DS Group -.11
a
 (0.48) .09 .89 1.05 
Note: R
2
 = .08 (Hosmer & Lemeshow), .08 (Cox & Snell), .12 (Nagelkerke). Model χ2 
= 10.74 (7), p = .15; a = Not significant. AHA = American Heart Association; CI = 
confidence interval; DS = depressive symptoms entered as CES-D cut-score of 16; 
AHA cardiac risk entered as optimum risk and at/high risk; SE = standard error. 
 
 Comparison of Quality of Life and Health-Promoting Lifestyle Behavior by 
Depressive Symptom Status. With these dose-response relationship findings, it is helpful 
to examine the scores for quality of life (measured by the QLI) and health-promoting 
lifestyle behaviors (measured by the HPLP-II) for depressed and not depressed women 
(Table 30). With the Bonferroni correction, the alpha 0.05 is corrected to p = .01 for the 
QLI and p = .007 for the HPLP-II comparisons. With these corrections, the depressed 
women have a significantly lower perceived quality of life overall and for all subscales. 
With the corrected significance level, the depressed women less frequently performed 
health-promoting lifestyle behaviors overall and specifically less frequently performed 
stress management, spiritual growth, and interpersonal relations behaviors. 
Summary of Aim 2 Findings 
 A dose-response relationship was found between depressive symptoms and the 
frequency of performing health-promoting lifestyle behaviors and quality of life but not 
with estimates of cardiac risk. Depressive symptoms were found to decrease the odds 
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for a good perceived quality of life and to decrease the odds for performing health-
promoting lifestyle behaviors. Depressed women had lower quality of life scores and 
less frequently performed health-promoting lifestyle behaviors.  
Table 30. Quality of Life and Health-Promoting Lifestyle Behaviors Compared by 
 Depression Status. 
 
 CES-D < 16 
(N = 83) 
CES-D ≥ 16 
(N = 42) 
p 
Quality of Life Index 
(QLI) 
   
Total Score 23.8 (± 2.9) 19.9 (± 4.6) .00 
Psychological/ Spiritual 25 (± 3) 20 (± 6.2) .00 
Family 24 (± 4.6) 21 (± 6) .01 
Social & Economic 24 (± 3.8) 21 (± 5) .00 
Health & Functioning 23 (± 3.8) 18.9 (± 5.3) .00 
Health-Promoting Lifestyle 
Profile-II (HPLP-II) 
   
Total Score 2.8 (± .36) 2.48 (± .36) .00 
Physical Activity 2.2 (± .67) 2.1 (± .71) .51 
Stress Management 2.6 (± .50) 2.2 (± .51) .00 
Health Responsibility 2.7 (± .51) 2.46 (± .50) .01 
Nutrition 2.8 (± .54) 2.6 (± .57) .03 
Spiritual Growth 3.2 (± .48) 2.7 (± .55) .00 
Interpersonal Relations 3.2 (± .47) 2.8 (± .47) .00 
Note: CES-D = Center for Epidemiological Studies Depression scale. All QLI scores 
range 0-30. QLI scores < 19 indicate a poorer quality of life. The scale for the HPLP-II 
is 1= never to 4 = routinely. All scores are reported a mean ± standard deviation. 
Independent t-tests were used to analyze depressive symptoms and quality of life; the 
Mann- Whitney test was used to analyze depressive symptoms and health-promoting 
lifestyle behaviors. 
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Aim 3 – Model of Mediators Between Depressive Symptoms and Quality of Life 
 The third study aim was to determine whether the effect of depressive symptoms 
on perceived quality of life is direct or indirect (i.e., mediated by cardiac risk – d1 or 
health-promoting lifestyle behaviors –d2), (Figure 1). To accomplish this, a series of 
multiple linear regression analyses (regression analyses) were performed. The questions 
were whether depressive symptoms directly influence perceived quality of life (line c in 
Figure 1) or whether the relationship of depressive symptoms to perceived quality of 
life was influenced by the association of depressive symptoms mediated by cardiac risk 
(lines a plus d1 in Figure 1) and/or health-promoting lifestyle behaviors (lines b plus d2 
in Figure 1). The data are presented in the following order: (1) summary of the tests of 
regression analysis assumptions, diagnostics, and outliers; (2) presentation of the 
regression analysis data; and (3) presentation of the mediator analysis. 
 The power analysis was repeated for the regression and mediation analyses. 
Based on the method suggested by Green (1991) using Cohen‘s (1988) calculations of 
sample size, a sample of n = 123 with seven predictor variables was able to achieve 
80% power to detect a large effect size (R
2
 ≥ .26). The n of 123 reflects two women 
who did not indicate their income. 
Summary of Regression Analysis Assumptions, Diagnostics, and Outliers 
Following standard procedures, the assumptions for regression analysis for each 
model were examined as were the regression and residuals diagnostics for each model. 
Seven assumptions were examined for each regression analysis: (1) the variable types, 
(2) no perfect multicollinearity, (3) presence of homoscedasticity, which indicates 
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constant variance across the range of all the predictor variables, (4) independent errors, 
(5) normally distributed errors, (6) independence of the outcome variable values, and 
(7) a linear relationship between the predictors and the outcome variable.   
There were no violations of the assumptions. Evidence was identified that there 
may be some suppression in the socioeconomic variables but this finding does not 
affect the significance of the predictability of the major predictor – depressive 
symptoms measured by the CES-D – to the possible mediator health-promoting lifestyle 
behaviors or the quality of life outcome variable. A review of the case diagnostics 
revealed that there was one potential outlier case. This case was examined and it was 
left in the analyses as there was no justification for its elimination. 
Presentation of the Regression Analysis Data 
The hierarchical/multiple block entry method was used to enable examination of 
the contribution of the sets of predictors since the final block produced the same data 
found when the simultaneous entry method is used. Simultaneous entry was the method 
recommended by Baron and Kenny (1986) to conduct the mediation analysis.  
The predictor variables were selected from the literature and are considered 
possible covariates when examining depressive symptoms. Block one entered the 
dichotomized categorical socioeconomic variables of: education, employment, income, 
and marital status and the CVD risk factors of BMI entered as a continuous variable and 
family history entered as a dichotomous categorical variable. In each model, the final 
block was depressive symptoms as the predictor of interest. In the final model, the 
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possible mediator, health-promoting lifestyle behaviors, was entered in the block before 
depressive symptoms.  
Correlations. Two sets of regression analysis Pearson‘s correlations (r) are 
presented. The first set examined the relationships between the predictor variables 
(Table 31), and the second set of correlations examined the relationships between the 
predictor variables and the outcome variables (Table 32).  
Table 31 presents the correlations between the socioeconomic and CVD risk 
factor predictor variables and the major predictor of interest, depressive symptoms. The 
majority of the predictor correlations were very small with Pearson r’s less than .15, 
none of which were significant. With the Bonferroni correction for multiple 
comparisons, the alpha 0.05 level is corrected to p = .001. Therefore, the actual 
significant correlations are income with education and marital status, BMI with health-
promoting lifestyle behaviors, and depressive symptoms with health-promoting lifestyle 
behaviors. 
Table 31. Covariate Predictor Variables’ Correlations  
 2 3 4 5 6 7 8 
1. Education .07 .24*** -.14 -.04 .02 .18* -.21** 
2. Employment ___ .18* -.08 -.05 -.02 -.15* -.09 
3. Income  ___ .35*** -.12 .10 .01 -.05 
4. Marital Status   ___ -.10 .03 -.03 .10 
5. BMI    ___ .02 -.31*** .17* 
6. Family History      ___ -.07 .05 
7. HP      ___ -.37*** 
8. DS       ___ 
Note. * = p < .05, ** = p < .01, *** = p < .001. BMI = body mass index, DS = 
depressive symptoms, HP = Health-promoting lifestyle behaviors. 
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Table 32 presents the correlations between the predictor variables and the 
outcome variables per model step in the mediation model determination. With the 
Bonferroni correction for multiple comparisons, the alpha 0.05 level is corrected to       
p = .002. Therefore, the examination of the regression analyses correlations between the 
predictor variables and each of the outcome variables for each of the four steps reveals 
that four of the 21 sets of correlations are significant correlations. Depressive symptoms 
were significantly and inversely correlated with two variables: (1) quality of life, as 
measured by the QLI (r = -.61) indicating that as the depressive symptoms worsen, 
quality of life tends to be lower, and (2) health promoting lifestyle behaviors (r = -.36) 
indicating that that as healthy lifestyle behaviors were less frequently performed, 
depressive symptoms worsened. Health-promoting lifestyle behaviors were positively 
correlated with quality of life (r = .45), indicating that as the frequency of health-
promoting lifestyle behaviors increase, so does the quality of life. Health-promoting 
lifestyle behaviors were found to have an inverse relationship with BMI (r = -.31), 
indicating that higher BMI‘s are related to a lower frequency of performing health-
promoting lifestyle behaviors.   
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Table 32.  Socioeconomic and Cardiovascular Disease (CVD) Risk Factor 
Predictor Variables with Depressive Symptoms and Outcome Variables 
per Mediation Model Analysis 
Outcome and Predictor Variables HPLP-II QLI CES-D 
QLI .45*** ___  
CES-D -.36*** -.61*** ____ 
Education .18* .12 -.21** 
Employment -.15* .09 -.09 
Income  .01 .12 -.05 
Marital Status -.03 -.04 .10 
Body Mass Index -.31*** -.26** .17* 
Family History -.07 -.08 .05 
Note. * = p < .05, ** = p < .01, *** = p < .001; CES-D = Center for Epidemiological 
Studies Depression total score; HPLP-II = health promoting lifestyle behavior –II mean 
score; QLI = Quality of Life Index total score. HPLP-II is both a predictor and an 
outcome variable depending on the mediation step. 
 
Contribution of the Predictors in the Final Regression Model. To be able to 
estimate the relative contribution of the predictor variables to the final model, a 
hierarchical/multiple block data entry method was employed (Table 33). The 
combination of the socioeconomic and CVD risk factor variables (Model 1) 
significantly explained 12% of the variance in this sample for quality of life as 
measured by the QLI. The addition of the health promoting lifestyle behaviors, as 
measured by the HPLP-II mean score (Model 2), added 12% to the variance (p < .001). 
The greatest addition to the variance in QLI was in the third model with the addition of 
depressive symptoms, as measured by the CES-D Total Score. The CES-D added a 
further 23% (p < .001) so that the final model explained 47% of the variance in quality 
of life.  
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Table 33. Model Summary Predicting Quality of Life 
Model R
2
 SE F (df) Sig. 
1 .12 3.87 2.57 (6) .02 
2 .24 3.61 5.22 (7) .00 
3 .47 3.04 12.41 (8) .00 
Note. df = degrees of freedom, SE = standard error, Sig. = significance. 
The predictors examined for the third model for quality of life are displayed in 
Table 34.  Not surprisingly following the summary of the hierarchical models‘ data, the 
CES-D was the strongest individual predictor (β = -.52, p < .001). In this final model, 
controlling the other predictors, the health-promoting lifestyle behaviors was the only 
other significant predictor (β = .21, p < .01).  
Table 34. Model 3 Predictors of Quality of Life 
 Unstandardized 
Coefficients 
Standardized 
Coefficient 
 
 
t 
 
 
Sig. b SE Beta 
(Constant) 20.17 3.55  5.69 .00 
Education -.26 .30 -.06 -.85 .40 
Employment -.54 .29 -.13 -1.86 .07 
Income  1.29 .74 .14 1.75 .08 
Marital Status -.24 .31 -.06 -77 .45 
Body Mass Index -.07 .05 -.11 -1.48 .14 
Family History -.44 .66 -.05 -.67 .50 
HPLP Mean Score 2.20 .83 .21 2.65 .01 
CES-D Score -.23 .03 -.52 -6.92 .00 
Note. Constant: Quality of Life total score; CES-D = Center for Epidemiological 
Studies Depression; SE = standard error; sig = significance.  
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Presentation of the Mediator Analysis 
 To examine the proposed mediation model (Figure 1), the analysis followed the 
analytical recommendations of Baron and Kenny (1986). To determine the effect of 
depressive symptoms on perceived quality of life as possibly being mediated by cardiac 
risk and/or health-promoting lifestyle behaviors, four conditions were examined 
through three multiple linear regression analyses for each of these possible mediators 
(Holmbeck, 1997). The results of these analyses are displayed in Table 35.  
Compared to Figure 1, the first step and the first condition in the analysis is line 
a; step and condition 2 examined the direct effect of depressive symptoms as the 
independent variable on quality of life as the dependent variable depicted by line c. Step 
3 examined the a plus d1 paths and also the b plus d2 paths. Conditions three and four 
are examined in step three. For all of these regression analyses, the following predictors 
were controlled: the dichotomous socioeconomic variables of education, employment, 
income, and marital status; and the CVD risk factors of BMI, and family history. 
 The first condition to be met is that the independent variable, depressive 
symptoms, needs to be significantly related to the proposed mediator. The first possible 
mediator to be examined was the AHA cardiac risk score. Depressive symptoms were 
not related to the risk score; therefore, the first condition was not met (Step 1A in Table 
35). This finding eliminated the risk score as a possible mediator between depressive 
symptoms and quality of life. 
 This first condition was met, however, when the independent variable, 
depressive symptoms, was regressed with the proposed mediator, health promoting 
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lifestyle behaviors (Step 1B in Table 35). The second condition was met because 
depressive symptoms was found to be significantly related to quality of life (b = -.26, p 
< .001 (Step 2 in Table 35). The third condition requires that the proposed mediator be 
significantly associated with the outcome variable, quality of life in this investigation. 
As a proposed mediator, the HPLP mean score was found to be associated with quality 
of life (b = 2.20, p < .01) (Step 3B in Table 35). Holmbeck (1997) described the fourth 
condition as a corollary of Baron and Kenny‘s (1986) three-step method. The fourth 
condition was supported by the finding that the independent variable, depressive 
symptoms, had a reduced impact on quality of life when controlling the proposed 
mediator, health promoting lifestyle behaviors. In the third step, the depressive 
symptoms unstandardized regression coefficient (b = -.23, p < .001) is reduced when 
compared to its coefficient (b = -.26, p < .001) when the HPLP is not in the regression 
equation in step 2. 
The effect of depressive symptoms on quality of life as being mediated by the 
health promoting lifestyle behaviors was found to be significant (Sobel test statistic = 
2.14, p = .03) (Baron & Kenny, 1986; Sobel, 1982). An interactive online calculator for 
the Sobel test was used to test that the health promoting lifestyle behaviors do carry the 
influence of the independent variable, depressive symptoms, to the dependent variable, 
quality of life (http://www.people.ku.edu~preacher/sobel.htm).  
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Table 35. Mediation Analysis of Quality of Life 
 
Step 1 A. Effect of Depressive Symptoms on AHA Risk Score;  
R
2 
= .06 (SE = .59 ); F (7, 122) 1.04
a
 
Variable b SE Beta t 
Depressive Symptoms -.01 .01 -.09 -.96
a
 
Step 1 B. Effect of Depressive Symptoms on Health Promoting Lifestyle Behaviors; 
R
2 
= .25 (SE = .34 ); F (7, 122) 5.48*** 
Variable b SE Beta t 
Depressive Symptoms -.01 .004 -.31 -3.63*** 
Step 2.  Effect of Depressive Symptoms on Quality of Life;  
R
2 
= .43 (SE = 3.12); F (7, 122)12.53*** 
Variable b SE Beta t 
Depressive Symptoms -.26 .03 -.59 -7.99*** 
Step 3 B. Effect of Depressive Symptoms and Health Promoting Lifestyle Behaviors 
on Quality of Life; R
2 
= .47 (SE = 3.04); F (8, 122) 12.41*** 
Variable b SE Beta t 
Health Promoting  
Lifestyle Behaviors 
2.20 .83 .21 2.65** 
Depressive Symptoms -.23 .03 -.52 -6.92*** 
Note. ** p < .01; *** p < .001.  a = Not significant. Covariates: Continuous variables - 
body mass index; dichotomous categorical variables - education, employment, family 
history, income, and marital status. AHA = American Heart Association.  
 
 
Revised Model 
 With the results of the mediation analysis, Figure 3 depicts the data-based 
model. The values depicted on the paths are the standardized coefficient (Beta) values 
which are also listed in Table 35 from Steps 1B and 3B so that the beta value for the 
depressive symptoms to quality of life path includes controlling for health-promoting 
lifestyle behaviors.  
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Figure 3. Revised Data-Based Mediation Model 
 
 
 
 
 
 
 
 
Summary of Aim 3 Findings 
Health-promoting lifestyle behaviors were found to be a significant mediator 
between depressive symptoms and the perceived quality of life. When depressive 
symptoms were not significantly associated with the cardiac risk score, the first 
condition for the examination of cardiac risk as a potential mediator was violated. 
Aims Summary 
Three aims and related hypotheses were investigated in this study. Data analysis 
yielded the following results. 
Aim 1. Relationship Among the Major Study Variables 
The hypothesis for this aim was mostly supported by the study findings. 
Depressive symptom status was not found to be associated with whether the women in 
this sample were aware of their CVD risk or with how they learned of this risk. 
Depressive symptoms status was inversely associated with health-promoting lifestyle 
 
DS 
 
HPLB 
QOL 
β = -.31 
β= -.52 
β = .21 
Note: DS = depressive symptoms; HPLB = health-promoting lifestyle 
behaviors; QOL = quality of life. 
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behaviors indicating that as the depressive symptoms increased the frequency of 
performing health-promoting lifestyle behaviors decreased. An inverse relationship was 
also found between depressive symptom status and quality of life. As the depressive 
symptoms increased the perceived quality of life decreased.  
Aim 2. Dose-Response Relationship Between Depressive Symptoms and the Major 
Study Variables 
The findings of the study mostly supported the associated hypothesis for this 
aim. Depressive symptoms were found to decrease the odds for a good perceived 
quality of life and to decrease the odds for performing health-promoting lifestyle 
behaviors. There was no evidence to support a dose-response relationship between 
depressive symptoms and either method for describing cardiac risk, i.e., the 
Framingham risk score and the reclassified AHA cardiac risk status. This is due to the 
lack of variance in the risk scores between the depressed and not depressed women. 
Aim 3. Determination of Mediators Between Depressive Symptoms and Quality of Life 
The hypothesis was that depressive symptoms would have either a direct or 
mediated effect on quality of life. The findings revealed that depressive symptoms does 
not have a direct effect on quality of life but rather is mediated by health promoting 
lifestyle behaviors. These results can be described as a partial mediation since the 
depressive symptoms‘ coefficient remained significant when the health promoting 
lifestyle behaviors were being controlled. Perfect mediation would exist if the 
independent variable, depressive symptoms, did not still have an effect on quality of life 
when health promoting lifestyle behaviors were being controlled (Baron & Kenny, 
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1986). The AHA reclassified risk status was found not to be a mediator in the 
relationship between depressive symptoms and quality of life. This occurred because 
depressive symptoms did not significantly predict the cardiac risk which violated the 
first condition in the mediation analysis (Baron & Kenny, 1986; Holmbeck, 1997), and 
thus no further analysis was warranted. 
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 CHAPTER FIVE 
DISCUSSION 
Overview 
This study identified that in a group of women being screened for their CVD 
risk, there was an inverse relationship between depressive symptoms and both health-
promoting lifestyle behaviors and quality of life. Furthermore, this was a dose-response 
relationship so that as depressive symptoms increased, the frequency of performing 
health-promoting lifestyle behaviors decreased and quality of life was perceived as 
poorer. It was also identified that health-promoting lifestyle behaviors mediated the 
relationship between depressive symptoms and quality of life. Regardless of method 
used, calculated cardiac risk was not related to depressive symptoms in this CVD risk 
aware group of women. No relationship was identified between risk awareness and 
depressive symptoms. 
The Health Promotion Model and the modified Wilson and Cleary health-related 
quality of life model guided the design of this cross-sectional study of depressive 
symptoms in women being screened for CVD risk. The HPM (Appendix F) addresses 
the complexity of human behavior to achieve the ultimate outcome of health promoting 
behavior. The current study addressed the personal factors through measurement of 
biological factors (measured by the CVD risk profile), psychological factors (limited to 
the measurement of depressive symptoms and risk awareness), and socio-cultural 
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factors (measured by the socioeconomic variables). The HPLP-II was designed to 
measure exercise benefits and barriers consistent with two of the behavior-specific       
elements in the HPM. Furthermore, the HPM is a good fit to a study of quality of life as 
its authors (Pender et al., 2006) posited there is an inextricable link between health and 
quality of life.  
For decades quality of life has been considered essential to CVD investigations 
(Wenger et al., 1984). Clarity to the concept of QOL for health related investigations 
was provided by the Wilson and Cleary HRQOL model (Spertus & Green-Conaway, 
2004; Wilson & Cleary, 1995) which was further clarified by Ferrans et al. (2005) 
(Appendix G). Several ―Characteristics of the Individual‖ were measured in this study. 
The measurement of the CVD risk factors and determination of the CVD risk profile 
addressed the ―Biological Function‖ of the women in this study. The CES-D measured 
one dimension of ―Symptoms‖. The HPLP-II addressed the ―Functional Status‖ of the 
women. The ―General Health Perceptions‖ were addressed by the risk awareness 
questions as well as the Health and Functioning QLI subscale. The ―Overall Quality of 
Life‖ was measured by the QLI. 
Discussion of the Sample 
 The mean age of the 125 women who were also free of CVD disease was 57.7 
(± 9.6) which is the median of the reported ages for the depressive symptoms studies 
cited in Appendices A – E. The sample was drawn from women presenting for CVD 
risk screening which is similar to the samples in the depressive symptoms studies of 
CVD risk factors summarized in Appendix B (Brown et al., 2005; Farmer et al., 1988; 
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Raikkonen et al, 2002; Wassertheil-Smoller et al., 2004). The women were 
predominantly white and non-Hispanic which reflects the vast majority of studies cited 
in Appendices A – E. The racial composition of the sample corresponds to the racial 
composition of the three counties primarily serviced by the screening center but under-
represents the Black and Hispanic women in the screening center city. Given the 
mission of the screening center to service their widest geographic area, the results of 
this study provide significant insights into the women participating in the screening 
center‘s health improvement efforts. 
Cardiovascular Risk Profile 
 The concern raised by the proportion of abnormal results for the individual CVD 
risk factors – lipid profile, SBP, and obesity - is that they indicate that the women were 
at a higher CVD risk than reflected by their Framingham risk score. The low mean 
Framingham risk score (3.3% ± 3.9) matches the 1999-2004 NHANES Framingham 
score for women for the 1988 to 1994 NHANES data (Towfighi, Zheng, & Ovbiagele, 
2009). The one very favorable CVD risk profile finding was that nearly all the women 
did not smoke. 
Most of the women (83.2%) had a TC at or over the Framingham risk score 
target of 160 mg/dl and 40% had an HDL-C less than the target of 50 mg/dl. It should 
be noted that the lipid testing was non-fasting which may have influenced the total 
cholesterol score. It is recommended that when a non-fasting TC equals or is higher 
than 200 mg/dl, or the HDL-C is less than 40 mg/dl, a fasting lipid profile should be 
obtained (Wong, Malik, & Kashyao, 2005). Nearly half of the women had a non-fasting 
138 
 
TC greater than 200 mg/dl while only 18.4% had an HDL-C less than 40 mg/dl (Table 
9). Fortunately, all women who participated in the screening program were given a 
voucher for a fasting lipid profile. The current NCEP (2004) guidelines target treatment 
based on low-density lipoprotein cholesterol (LDL-C) levels and secondarily target 
HDL-C for high risk persons. Although the LDL-C was not measured and the women 
were not questioned regarding their pre-treatment lipid profile, two-thirds of the women 
reported taking a cholesterol lowering medication. It was not a goal of this study to 
investigate treatment gaps yet it is interesting to note that despite treatment, less than 
half of the women were at desired TC levels. 
A SBP of less than 120 mmHg was set as normal by the most current report on 
the prevention, detection, evaluation, and treatment of high blood pressure (Chobanian 
et al., 2003).  Seventy percent of the women had a SBP greater than 120 mmHg and 
only half of these women reported taking an anti-hypertensive medication. So while 
some women were being treated for hypertension there appears to be a treatment gap 
for this CVD risk factor as well.  
Although only 12 women met the criteria for having the metabolic syndrome, 
their obesity measurements suggest that had a fasting glucose and triglycerides been 
measured, the actual number of women designated as having the metabolic syndrome 
might have been higher. Over half of the 94 women who had their waist circumference 
measured had a waist circumference equal to or greater than 35 inches. The mean waist 
circumference in this study matches the overall study mean for a recent investigation 
that recommended the addition of waist circumference to the Framingham-based 
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models to improve the CVD predictability (Sacco et al., 2009). Over half of the women 
had a BMI of equal to or greater than 30 and 12% had BMIs equal to or greater than 40. 
An alarming 93.5% of the women had a body fat measurement greater than 30%. This 
sample of women matches the trend exposed by the current NHANES data for women 
which revealed that the mean BMI was 34.1 (SE 1.4), a significant increase from the 
prior data (Towfighi et al., 2009). Given the large number of women in this study 
reflecting the increasing obesity trends in the population, it is of further concern that the 
number of metabolic syndrome risk factors has also been found to have a dose-response 
relationship with depressive symptoms. Women with higher depression scores were 
nearly a third more likely to develop more metabolic syndrome risk factors (Raikkonen 
et al., 2002).   
Given the low mean Framingham score and the CVD risk profile of the women, 
the CVD risk status was reexamined using the AHA cardiac risk profile for women 
(Mosca, Banka, et al., 2007) yielding a rather dramatic shift in how these women would 
be classified. Two CVD risk factors were responsible for the shift in their CVD risk 
status. Twelve optimum risk women with diabetes were now considered to be in the 
high risk group. Women who were physically inactive increased the number of at risk 
women from 5.6% to 64%, leaving only 24.8% of the women in the optimum risk 
group, a reduction of 68.8% in this classification. These findings add support to the 
discussion of the inadequacies of the traditional Framingham risk score to depict risk 
status in women particularly since it is directed narrowly at CHD and not the more 
global CVD risk (D‘Agostino et al., 2008; Sacco et al., 2009). 
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Revisions of the Traditional Framingham Risk Score 
 In an effort to increase the use of risk prediction methods in primary care and to 
also broaden it to a CVD risk assessment, D‘Agostino et al. (2008) added diabetes to 
their recalibration of the 1998 Framingham CHD risk score. The net effect with the 
addition of diabetes is that a lower number of points correspond to a higher CVD risk 
percent.  
Another study to improve global CVD risk assessment (Sacco et al., 2009) 
concluded in addition to waist circumference, alcohol consumption, and physical 
activity significantly added to the predictive ability of the 1998 Framingham risk 
profile. Support for the inclusion of physical activity to risk profiling is further provided 
by a study of the NHANES data from 1999 to 2004 (McGuire, Janssen, & Ross, 2009) 
which concluded that physical activity, independent of common cardiometabolic risk 
factors, predicted the likelihood of CVD (OR 1.52, 95% CI 1.16-1.98, p < .05). These 
studies support the reclassification based on physical inactivity performed for this 
study. 
Another important revision to traditional risk scoring is shifting away from 
linking the point allocation of individual risk factors to age. D‘Agostino et al. (2008) 
included in their recalibration that points are allocated at a younger age, and total 
cholesterol, smoking, and SBP are allocated points regardless of age. Support for 
altering the age-linked point allocation proposed by D‘Agostino et al. (2008) is 
provided by Marma and Lloyd-Jones (2009). These investigators emphasized that 
increasing age alone with all other risk factors held at normal levels significantly 
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predicted 10-year risk and that this risk was more accelerated after the age of 60. 
Marma and Lloyd-Jones added that ―a 10-year risk estimate of ≥ 20% is not predicted 
by the tool for a man with average risk factor values until 70 years of age and is never 
predicted (through 74 years of age, even with treated blood pressure) for a woman with 
average risk factor values‖ (p. 385-386). The heavy scoring for age seems to discount 
widely abnormal other risk factors.  
The gender perspective on risk scoring was highlighted by the publication of the 
Reynolds risk score that proposed to increase the accuracy of risk estimation for women 
(Ridker, Burning, Rifai, & Cook, 2007). The Reynolds risk score adds family history of 
premature MI, high sensitivity C-reactive protein, and hemoglobin A1C for diabetics to 
the variables measured by the Framingham CHD risk profile. The addition of two 
laboratory tests, however, may be seen as adding to the complexity and cost of the 
primary care setting‘s screening which was the case for the center where this study was 
conducted, hence this information was not available due to cost (D. Best, Personal 
Communication). 
From a risk reduction perspective, a low Framingham score might diminish a 
woman‘s concern for her overall CVD risk status. Recent discussions in the literature 
have addressed two concerns related to the use of risk assessment tools: low risk scores 
delay the initiation of risk factor treatment (Vasan & Kannel, 2009) and the use of risk 
scores must be augmented as we attempt to motivate women to modify their risk burden 
(D‘Agostino et al., 2008; Marma & Lloyd-Jones, 2009). Given the association between 
depressive symptoms and health-promoting lifestyle behaviors and quality of life, this 
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study adds to the literature that risk identification must go beyond describing risk solely 
based on the traditional Framingham risk score but to also do so in a fashion congruent 
with primary care and particularly risk screening programs. In addition to the more 
traditional CVD risk factors, this study identified other CVD risk vulnerabilities in an 
apparently healthy group of women. 
Over half of the women reported that they snored yet only a fraction of the 
women reported they had been diagnosed with sleep apnea (Table 12). This suggests 
that sleep-disordered breathing screening assessments should be added to the screening 
center‘s CVD assessments and follow-up information should be provided to women 
who snore. While all people who snore may not have sleep-disordered breathing, the 
CVD risks associated with sleep-disordered breathing should not be ignored since they 
include a higher risk for fatal cardiovascular events (Takama & Kurabayashi, 2009). In 
a study of 135 people with CVD, those diagnosed with obstructive sleep apnea (n = 43, 
31.8%) had a significantly lower survival rate (OR 2.45, 95% CI, 1.26-5.08, p < .01) 
compared to those without obstructive sleep apnea (Takama & Kurabayashi). Snoring 
was added to this study based on an investigation of early CHD predictors that 
identified snoring among the early predictors (Ketterer et al., 2006).  
While the assessment for sleep-disordered breathing is an opportunity for 
improvement, the frequency of exercise stress testing may be a reflection of the 
emphasis on cardiovascular health in women that has been promoted by the screening 
center and a large cardiovascular practice in the area. While there are no absolute 
indications for an exercise stress testing in asymptomatic persons, the most recent AHA 
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scientific statement regarding this (Lauer, Froelicher, Williams, & Kligfield, 2005) did 
cite a study that supported a Framingham score of > 2% as a criterion.  Each woman 
who indicated a stress test was asked about the results. All the women said the results 
were normal, thus they felt they did not have heart disease. There seems to be a 
disconnect between the number of women who had a stress test and how they learned of 
the CVD risk status. 
Awareness of CVD Risk 
 Although there is room for much improvement, compared to the national data 
(Christian et al., 2007) a larger percentage of these women were aware of the risk for 
heart disease in women. A lingering concern, however, is that over half of the women 
said that they did not learn about their heart disease risk from their primary care 
provider but from the media or from being a member of the screening center‘s 
Women‘s Heart Advantage program. This would suggest that many primary care 
providers in the area of the screening center may have low awareness of heart disease 
risk in women or believe that women are already knowledgeable about this topic 
(Mosca et al., 2005).  
While primary care provider practices seem to be lagging behind, the efforts to 
increase the awareness of women in the community served by the screening center that 
began four years prior to the beginning of this study had been effective. Those efforts 
were further extended to all participants in the screening program when they were 
provided individual realistic risk modification targets and strategies to reach these 
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targets along with the continuing supportive publications and events sponsored by the 
screening center.  
Discussion of Lifestyle Behaviors, Depressive Symptoms, and Quality of Life 
 The three major study measurements were the Health-Promoting Lifestyles 
Profile-II developed to address the multi-dimensional pattern of self-initiated health 
promoting behaviors consistent with the HPM, the Center for Epidemiological Studies 
Depression scale, and the Quality of Life Index. The results of these measurements 
provide additional insight into the women. 
Health-Promoting Lifestyle Behaviors 
 The measurement of the health-promoting lifestyle behaviors indicates there is 
much room for improvement in the frequency of self-initiated health promotion 
behaviors and, therefore, the CVD risk modification recommendations and support 
provided the women attending this program is encouraging. Overall, these women were 
physically inactive and performed physical activity below the recommended levels to 
reduce CVD risk (Table 14). Recent investigations have added to the evidence for the 
relationship between physical activity and CVD risk. Physical inactivity has been 
identified to independently predict CVD risk (McGuire et al., 2009) and has been 
recommended to be added to the traditional CVD risk assessment (Sacco et al., 2009). 
Thus, the finding that low physical activity increased the CVD risk assessment 
classification in this group of women coming for CVD risk assessment support the data 
on physical activity and CVD risk particularly in women. 
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In addition to being generally physically inactive, these women had room to 
improve the frequency of performing healthy nutrition behaviors as only a small 
fraction routinely performed these behaviors. The number of women who generally did 
not follow a heart healthy diet and were physically inactive is consistent with the large 
number of women who were obese reflected by their BMI, percent body fat, and waist 
circumference and their abnormal lipid profiles. All women attending the program are 
provided guidance to improve their nutrition. 
Another area for improvement was identified by a small fraction of women who 
routinely performed stress management behaviors. Somewhat surprising, only a quarter 
of the women reported their stress level was high or chronic. An inverse relationship 
was found between the women‘s self-reported stress level and the performance of stress 
management behaviors (r S = -28, p < .01). The addition of stress management 
behaviors could be added to the risk reduction strategies provided women attending the 
CVD risk screening program.  
Only a small fraction of women reported routinely performing the health 
responsibility behaviors. Being a member of the center‘s Heart Advantage program and 
attending a CVD screening program would indicate an interest in health promotion. 
This may help explain the relatively high number of women who were already aware of 
the risks of heart disease in women although they may have just been learning how they 
could improve their own risk status through participation in the Heart Advantage 
program. Anecdotally, many women, when agreeing to participate in the study, said 
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they were finally having time to do positive things for themselves like finding out more 
about how to live healthier lives. 
The most positive health-promoting lifestyle behaviors for the women were that 
the majority reported that they often performed the spiritual growth and interpersonal 
relations behaviors. Anecdotally, often women said they learned of the CVD risk 
screening program from a friend or family member who often accompanied them to the 
large group screening events. The Heart Advantage program provided them the 
knowledge to make healthier lifestyle changes. With these insights into their health-
promoting lifestyle behaviors, the next question is about their mood. 
Depressive Symptoms 
 The literature addressing the self-reported measurement of depressive symptoms 
discusses the confounding issue of the presence of co-morbid medical conditions 
particularly somatic complaints common in CVD (Simon & von Koroff, 2006).  While 
the CES-D emphasizes mood and affect more than the physical dimensions of 
depression (Hann et al., 1999), it was nevertheless important to identify the co-morbid 
health status with an instrument designed to measure functional status and one that has 
worked well with studies of HRQOL. The FCI met those criteria.  
Based on the scores of the FCI, these women were healthy with a mean score of 
2.2 (± 1.6). An elevated BMI was the most frequent item (57.6%) with one-third of the 
women reporting they had arthritis and a quarter saying they had upper GI disease. Less 
than 15% indicated any other medical conditions. Women with a history of CVD were 
excluded from the study. Thus, the presence of confounding medical conditions was not 
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a concern for the self-reported depressive symptoms assessment. Furthermore, it was 
not the intent of this study to make a clinical diagnosis of depression. 
 Identifying that one-third of these apparently healthy women had significant 
depressive symptoms is alarming. This prevalence of depression is more than six times 
the rate of major depression identified in a national study (Hasin et al., 2005) and is 
twice the incidence reported in studies investigating the relationship of depression to 
incident CVD in women (Wassertheil-Smoller et al., 2004). What may be placing these 
women at higher risk for depression?  
Examining the individual CES-D items and the pattern of responses per the 
CES-D factors, only three individual items were reported by more than a quarter of the 
participants as occurring at least 3 days in the past week and all three items were from 
what Radloff (1977) named the somatic and retarded activity group. These items were: 
―I felt that everything I did was an effort‖ (25.6% checked as occurring 3 or more days 
in the past week), ―I had trouble keeping my mind on what I was doing‖ (37.6% 
checked as occurring 3 or more days in the past week), and ―My sleep was restless‖ 
(39.2% checked as occurring 3 or more days in the past week). Recall that almost 60% 
of the women indicated that they snored which may indicate a physical reason for their 
restless sleep. 
The mental health history items in this study (Table 17) identified that nearly 
half of the women reported a family history of depression. Nearly equal numbers of the 
women reported ever being told they had depression or were ever treated for 
depression. The number of women reporting having been treated for depression is 
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nearly identical to that found in the WISE study (Rutledge, Reis, Olson, Kelsey et al., 
2006). A quarter of the women were currently being treated for depression. These 
mental health history items and the FCI score were all modestly correlated with the 
CES-D scores (Table 19) although the family history of depression was just 
approaching statistical significance (rS = .17, p = .053).  
Some antidepressants have been found to increase the risk for CVD. The women 
in this study reported taking a variety of anti-depressants with a selective serotonin 
reuptake inhibitor (SSRI) the most often reported. The results of a study of the effects 
of antidepressant use on CVD (Smoller et al., 2009), the largest study of its kind, are 
particularly relevant. Smoller et al. (2009) reported that of the 136, 293 women at 
baseline who were not taking an antidepressant, only 4% were taking an antidepressant 
at follow-up while more than double this amount (9.2%) were depressed at the follow-
up visit.  
These data lend support to the reports that depression is under-diagnosed and 
under-treated (Huffman et al., 2006; NIMH, 2001; Ziegelstein et al., 2005). Half of the 
women in the WHI study (Smoller et al.,) who were taking an antidepressant were 
taking a SSRI. The SSRI drug class was found not to be associated with CHD. 
Unfortunately, women taking SSRIs had an increased risk of stroke (HR = 1.45, 95% 
CI 1.08-1.97) and all-cause mortality (HR = 1.32, 95% CI 1.10-1.59). These authors 
caution that women taking an antidepressant should have their CVD risk factors 
vigilantly controlled (Smoller et al.)  
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Relationship Between Cardiac Risk, Lifestyle Behaviors and Depressive Symptoms 
 The depressed women tended to be younger, obese, have a lower TC and lower 
HDL-C, and were at higher AHA risk for CVD. Although there was no statistically 
significant difference between the depressed and not depressed women compared by the 
Framingham risk score or the AHA risk classification, nearly three-quarters of the 
depressed women were calculated to be in the AHA at risk group (depressed women: 
71.4%, not-depressed women: 60.2%) (Table 21).  
Among the socioeconomic factors, only education approached statistical 
significance (p = .06) which revealed that women who were not depressed tended to be 
better educated. Among the individual CVD risk factors, the only statistically 
significant differences between the depressed and not depressed women were age 
(depressed women: 55.4 ± 10 years, not-depressed women: 59 ± 9 years, p = .05), and 
total cholesterol (depressed women: 183 ± 37.4 mg/dl, not-depressed women: 203 ± 
40.5 mg/dl, p = .01) with HDL-C approaching statistical significance (depressed 
women: 50 ± 13.9 mg/dl, not-depressed women: 55 ± 15 mg/dl,  p = .06). Waist 
circumference was the only statistically different metabolic syndrome factor with the 
depressed women having the larger waist circumference (depressed women: 38 ± 6 
inches, not-depressed women: 35 ± 6 inches, p = .02). This might be due to the fact that 
most of the women were obese (depressed women: BMI 32.8 ± 6.7, not-depressed 
women: BMI 30.7 ± 5.6, p = .07), and only thirteen women self-reported having 
diabetes. Given the prevalence of obesity in this group, it would have been interesting 
to have the results of even a random blood glucose measurement to screen for diabetes.  
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Depressed women significantly less frequently performed health-promoting 
lifestyle behaviors (Table 30). The physical activity subscale scores were essentially 
identical for both groups thus it is not surprising this was the one subscale that was not 
statistically different between the depressed and not depressed women. Clearly, all the 
women had room for improvement in their physical activity behaviors.  
Women in the higher AHA risk groups were less physically active, and less 
frequently followed good nutritional and health responsibility behaviors. This pattern of 
behaviors is consistent with their metabolic syndrome status.  
 The large percentage of low physical activity in this sample that had depressive 
symptom scores equal to or greater than 16 supports the finding of an inverse 
relationship between physical activity and depressive symptoms. Thus, women who 
were less active had more depressive symptoms. This has previously been reported in 
four studies (Brown et al., 2005; Farmer et al., 1988; Knox et al., 2006; Wassertheil-
Smoller et al., 2004). Farmer et al. (1988) found this relationship more pronounced in 
women while Knox et al. (2006) did not find a gender difference. The other two studies 
only enrolled women. The unique aspect of this study was the measurement of a 
comprehensive span of health-promoting lifestyle behaviors which revealed that these 
risk-aware women were at a higher AHA cardiac risk status than revealed by their 
Framingham risk score. The other contribution of this study was the investigation of the 
relationship of depressive symptoms and health-promoting lifestyle behaviors to 
perceived quality of life. 
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Quality of Life 
 These women who were essentially healthy albeit with significant cardiac risk 
factors, generally perceived their quality of life as acceptable. Quality of Life Index 
total scores above 19 are considered to indicate a better perceived QOL (Dr. Ferrans, 
Personal Communication). While the mean total score was in the acceptable range (22.4 
± 4), it was only three and a half points above the cut-score of 19 that indicates a poor 
quality of life (Table 21). Furthermore, all the subscale scores were close to the poorer 
quality of life cut score. The subscale scores ranged from 21.5 (± 4.6) for health and 
functioning to 23.2 (± 4.9) for the psychological/spiritual subscale. There was a narrow 
difference of only 1.7 points for the subscale scores for the whole sample. Consistent 
with the health-promoting lifestyle behaviors‘ scores, the health and functioning QLI 
subscale was the lowest scoring subscale.  
Women who tended to less frequently perform health-promoting lifestyle 
behaviors (HPLP mean score of ≤ 2.5) had a statistically lower quality of life than 
women who more frequently performed health-promoting lifestyle behaviors (QLI 
mean score of 20.4, ± 4.4 compared to 24, ± 3, p < .01).  The statistical differences for 
the QLI subscale scores persisted for all but the family subscale which approached 
statistical significance where women who less frequently performed health-promoting 
lifestyle behaviors tended to have a lower family subscale score (21.6, ± 4.7 compared 
to 24, ± 4, p = .06). Women who had the lowest frequency of performing health-
promoting lifestyle behaviors had the lowest subscale score for the health and 
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functioning subscale at 19 (± 5.3). No studies were identified that investigated health-
performing lifestyle behaviors and quality of life in women prior to a cardiac event. 
Depressed women tended to have a poorer quality of life overall and particularly 
on the health and functioning subscale which was just below the QLI cut-score of 19 at 
18.9 (± 5.3). There was a statistical difference of 3.9 points on the total QLI score 
between the groups: depressed women‘s mean score was 19.9 (± 4.6) versus a mean of 
23.8 (± 2.9) for not-depressed women (p < .01). The statistical difference continued for 
each of the subscales as well with the depressed women consistently scoring lower than 
the not-depressed women. No studies were identified that investigated quality of life 
and depressive symptoms in women prior to a cardiac event. Depression has been found 
to be associated with a poorer quality of life in women who have had an MI (Kamm-
Steigelman et al., 2006) which may extend as long a one-year post MI (White & Groh, 
2007). However, women who have had a CABG reported an improved quality of life 
primarily attributed to an improved health and functional status (Penckofer et al., 2005).   
Discussion of Major Findings 
 There were three study aims and three related hypotheses. Overall, the 
hypotheses were supported by the findings.  
Aim 1. Relationship Among the Variables 
 The first study aim was to determine the relationship between depressive 
symptoms, the cardiac risk score, the health-promoting lifestyle behaviors, an 
awareness of heart disease risk, and the perceived QOL in women being screened for 
CVD risk. The related hypotheses had a mixed outcome. The findings revealed inverse 
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and moderate to strong relationships between depressive symptoms and health-
promoting lifestyle behaviors (rS = -.37, p < .001) and perceived quality of life (rS = 
 -.51, p < .001) (Table 24).  No relationship was found between depressive symptoms 
and cardiac risk described by the Framingham risk score or the AHA risk groups (Table 
24). 
Since three-quarters of the depressed women were in the at risk and high risk 
groups (Table 21), the absence of a relationship between depressive symptoms and risk 
status might be explained by the fact that two-thirds of the women were not depressed. 
Although low physical activity increased the number of women considered to be in the 
at risk AHA group, the majority of low physically active women had depressive 
symptom scores below the depression cut-score of 16. No relationship was found 
between depressive symptoms and risk awareness (rS = .06, p =.50; Table 23). These 
were, however, a predominantly risk aware group of women.   
The literature investigating depressive symptoms in incident CVD did not report 
Framingham risk scores. They investigated individual risk factors. Consistent with the 
findings in this study, certain CVD risk factors were the dominant elements. Low 
physical activity has been linked to depressive symptoms in four investigations of 
incident CVD (Brown et al., 2005; Farmer et al., 1988; Knox et al., 2006; Wassertheil-
Smoller et al., 2004). The NHANES data (Farmer et al., 1988) also reported a higher 
BMI in the less physically active women. An investigation of perimenopausal women 
identified those with higher depression scores were nearly a third more likely to 
develop more metabolic syndrome risk factors (Raikkonen et al., 2002).  The Seasons 
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Study (Rosal et al., 2001) investigated the co-occurrence of unhealthy behaviors – 
smoking, high-fat diet, sedentariness, and high-risk drinking - and psychosocial 
variables. The higher the depression score, the higher were the number of risk 
behaviors. Other investigators identified that the higher the depression score the less 
likely was adherence to heart healthy behavior guidelines regardless of gender (Bonnet 
et al., 2004). 
 Although not identified as part of the original hypothesis, two additional 
interesting relationships were examined (Table 24). A strong positive relationship was 
found between quality of life and health-promoting lifestyle behaviors (r S = .46, p < 
.001). Women who more frequently performed health-promoting lifestyle behaviors 
also reported an overall favorable perceived quality of life. An inverse relationship was 
identified between AHA risk groups and health-promoting lifestyle behaviors rS = -.26, 
p < .001). Women who least frequently performed health-promoting lifestyle behaviors 
tended to have a higher risk status. 
Aim 2. Dose-Response Relationship 
 With these patterns of relationships, the findings for the second hypothesis for a 
dose-response relationship between depressive symptoms and health-promoting 
lifestyle behaviors and perceived quality of life were not surprising. Also not surprising 
was the absence of a dose-response relationship between depressive symptoms and 
cardiac risk regardless of risk determination method. Based on the depressive symptoms 
and CVD literature, the same sets of covariates were used in these logistic regression 
analyses: the socioeconomic variables of education, employment, income and marital 
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status, and two CVD risk factors that are not part of the Framingham risk calculations: 
BMI and family history of CVD. Body mass index was included as an indicator of 
obesity which is considered a modifiable CVD risk factor. Family history was included 
as it is a traditional non-modifiable CVD risk factor. Since the Framingham risk score 
was one of the variables being investigated, the individual CVD risk factors which 
comprise it (age, HDL-C, TC, SBP, and smoking) were eliminated as covariates. 
As depressive symptoms increased, there was a graded decrease in perceived 
quality of life (Table 26) and a graded decrease in the frequency of performing health-
promoting lifestyle behaviors (Table 27). To try to elicit a dose-response relationship 
between depressive symptoms and cardiac risk, the depressive symptoms score was 
entered first as a continuous variable (Table 28) and then dichotomized at the CES-D 
cut-score of 16 (Table 29). Neither approach detected a significant relationship. As 
discussed above, two-thirds of the women were not depressed (CES-D < 16) and these 
women out-numbered the depressed women regardless of AHA risk status: there were 
only 32 depressed women between the at risk and high risk groups compared to 62 not-
depressed women in these same AHA risk groups (Table 21). Furthermore, no 
statistical relationship was detected between depressive symptoms and AHA risk status 
(rs = -.07, p = not significant). No studies were identified that reported the relationship 
between depressive symptoms and either the Framingham risk score or the AHA risk 
groups. 
 Investigations of quality of life and cardiac disease have been numerous but 
have addressed changes in quality of life in persons with heart disease (Ford et al., 
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2008; Ruo et al., 2003), persons who have had a diagnostic cardiac procedure (Cheok et 
al., 2003; Hofner et al., 2005), or following a cardiac event such as an MI (Kamm-
Steigelman et al, 2006), a treatment for heart disease such as a CABG (Cheok et al., 
2003; Penckofer et al., 2005) or a heart disease complication, such as heart failure (Heo 
et al., 2005). No studies have been identified that investigated the association between 
depressive symptoms and quality of life in women prior to a cardiac event. Only one 
study of depressive symptoms and an aspect of quality of life in healthy participants 
was identified. Koivumaa-Honkanen et al. (2004) found in their investigation of twins a 
strong linear relationship between the life satisfaction scale and depressive symptoms.  
This investigation reported that the life satisfaction scores were able to predict moderate 
to severe depressive symptoms and to explain 37.2% of the variance in depressive 
symptoms scores. One BFRSS survey reported on depressive symptoms and quality of 
life in healthy participants using a one-item assessment for depressive symptoms, the 
number of sad, blue or depressed days and a 4-item assessment of quality of life (Kobau 
et al., 2004).  The more frequently the respondents experienced sad, blue or depressed 
days the worse was their HRQOL.  
The bulk of the literature investigating depressive symptoms in incident CVD 
identified a dose-response relationship between depressive symptoms and the risk for 
CVD (Appendices B and E), IHD (Appendix C), and IHD mortality and sometimes 
with all-cause mortality (Appendix D). While the literature reported dose-response 
relationships between depressive symptoms and physical activity, the number of 
metabolic syndrome elements, the frequency of performing health promoting behaviors 
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and specific CVD risk factors such as blood pressure (Artinian et al., 2006), none of the 
literature reported the calculated CHD or CVD risk scores. Despite less of the 
population having lower Framingham scores (Lloyd-Jones et al., 2009), somewhat 
paradoxically the majority of reports indicate that low Framingham scores still 
predominate (Marma & Lloyd-Jones, 2009; Sacco et al., 2009). While there are dose-
response relationships between some CVD risk factors and depressive symptoms, it is 
not clear why this dose-response relationship does not apply to the actual risk score and 
depressive symptoms. Some recent publications argue that the components of the 
traditional Framingham risk scores, even when expanded from the CHD to the CVD 
models, do not sufficiently discriminate cardiac disease risk status.  
Aim 3. Model of Mediators Between Depressive Symptoms and Quality of Life 
 The final study aim was to determine whether the effect of depressive symptoms 
on perceived quality of life was direct or indirect (i.e., mediated by cardiac risk –d1, or 
health-promoting lifestyle behaviors – d2 in Figure 1). Following the absence of a 
relationship between depressive symptoms and cardiac risk, cardiac risk was eliminated 
as a potential mediator (Table 34). In the series of linear regression analyses in the 
mediation analysis, the same sets of covariates were used in each model; the 
socioeconomic variables were education, employment, income, and marital status, and 
the CVD risk factors were BMI and family history of premature CVD. 
 Health-promoting lifestyle behaviors were found to mediate the relationship 
between depressive symptoms and perceived quality of life (Table 34). The mediation 
is described as a partial mediation because even with the inclusion of health-promoting 
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lifestyle behaviors, depressive symptoms remained a significant predictor of quality of 
life in a reduced amount (Baron & Kenny, 1986; Holmbeck, 1997). In the final 
regression analysis model with both the mediator and the predictor entered, depressive 
symptoms was the stronger predictor (β = -.52, p < .001) contrasted to health-promoting 
lifestyle behaviors (β = .21, p < .01). The revised study model depicts the path values 
(Figure 3). The analysis of the explanation of the variance in quality of life (Table 32) 
identified that the covariates explained 12% of the variance; the addition of the health-
promoting lifestyle behaviors explained 24% of the variance; and the introduction of the 
depressive symptoms increased the explanation of the variance to 47%.  So while 
controlling for socioeconomic variables and CVD factors, and then for health-
promoting lifestyle behaviors, depressive symptoms explain most of the variance in 
perceived quality of life. 
Study Limitations 
 The limitations of any study are based on threats to internal and external 
validity. Three threats to internal validity were identified in this study: participant 
selection bias, missing data on the study questionnaires, and possible instrumentation 
errors. 
Participant selection bias occurred because the sample was a nonrandom 
convenience sample of women who voluntarily presented to a free heart disease 
screening program. This sampling strategy is also a threat to external validity, thus 
reducing the generalizability of the results. Further, the sample was not powered to 
analyze the findings according to the race and ethnicity, thus reducing the 
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generalizability of the findings. Half the sample came from within 5 miles of the 
screening center in a community where race was fairly evenly divided between White 
(47%) and Black (43.3%) in the year 2000. However, the study sample was 
disproportionately White and only 4.8% Hispanic women (where the census reported 
11.7% Hispanic in 2000).  While there was not purposive sampling to achieve a racial 
and ethnic balanced sample as has been suggested by the AHA ―Minority Health 
Summit 2003‖ (Benjamin et al., 2005), the number of Black and Hispanic women 
presenting to the free screening program may be related to the fact that there was no 
racial or ethnic targeted advertising for this program. Increasing the racial and ethnic 
participation rate in clinical research remains a challenge. 
 This is problematic in light of the results of the Well-Integrated Screening and 
Evaluation for Women Across the Nation (WISEWOMAN) study (Finkelstein, 
Khavjou, Mobley, Haney, & Will, 2004). The WISEWOMAN study findings 
concluded that racial/ethnic risk factor disparities were statistically significant and that 
the greatest risk of CVD was found in black women; these findings were only partially 
explained by community characteristics.  
 There was minimal missing data on the CES-D, the QLI, and the HPLP-II with 
the largest percentage of missing data being waist circumference. Thirty-one women 
did not have a waste circumference measurement when they attended a large group 
screening event. This was due to the lack of privacy at the large group screening events 
(D. Best, Personal Communication). The other missing data might have been decreased 
had the screening of completed questionnaire booklets been consistently done. During 
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the busy large group events and on the busiest individual screening days, the review of 
individual‘s responses was not consistently performed. The pattern of missing data was 
random and thus should not have impacted the study findings.   
 There did not appear to be instrumentation errors with either the body-fat 
measurement device or the lipid measurement device. The instrument used to test for 
the cholesterol profile, the Cholestech LDX, is powered by electricity, and requires 
quality controls are performed on the testing cassettes. Controls are run according to 
accepted laboratory standards when a new lot number of testing cassettes is used 
(Debbie Best, personal communication, August 2, 2007). The researcher verified that 
the quality controls were performed as specified. There were no electrical or operational 
failures during the study period. The screening center staff who performed the 
cholesterol and body-fat checks during the large group events were all competency-
verified to do the testing as was the nurse specialist who conducted the individual 
screenings. 
 There are potential threats to external validity in addition to the sample as 
described above. There may have been interactions between the setting and the testing 
and the voluntary participation of the women in a heart screening program. The women 
who decided to present for the program may not be representative of women who are 
not interested in finding out about their heart health status and/or are so significantly 
depressed that they would not consider participation is such a health-oriented program. 
There was also the potential that the setting in an outpatient clinic of a hospital may 
have influenced the women who presented. Women may have come to the screening 
161 
 
center because they or their families are used to receiving their inpatient hospital care at 
the facility. Thus women used to going to one of the other area hospitals may not have 
attended the CVD screening program which could also reduce the representative nature 
of the sample.  
 A final external validity threat relates to the study exclusion criteria. The results 
of this study may not apply to women with: (a) a known cardiac history, defined as 
having had a cardiac event, (b) a psychiatric diagnosis other than depression, (c) 
dementia, or (d) known substance abuse as these are the exclusion criteria for the 
proposed study. 
 The inability to establish causal relationships is a leading limitation of the 
correlational design. The study, however, did illuminate the relationship of depressive 
symptoms, cardiac risk, and health-promoting lifestyle behaviors to perceived quality of 
life and in so doing added to the knowledge of the health status of women being 
screened for CVD risk. 
Summary of Major Findings 
 Depressive symptoms have a strong inverse relationship with health-promoting 
lifestyle behaviors and quality of life. There is a strong positive relationship between 
health-promoting lifestyle behaviors and quality of life. Depressed women less 
frequently perform health-promoting lifestyle behaviors. Women who less frequently 
perform health-promoting lifestyle behaviors report a lower quality of life. An inverse 
dose-response relationship was found between depressive symptoms and health-
promoting lifestyle behaviors and quality of life. The link between depressive 
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symptoms and quality of life is partially mediated by health-promoting lifestyle 
behaviors.  
While no association was found between Framingham risk score or AHA risk 
status and depressive symptoms, many more depressed women were in the AHA at and 
high risk groups compared to the few women in the optimum risk group. Low 
frequency of performing physical activity behaviors increased the number of women 
who would be classified in the AHA at risk group compared to those classified as at risk 
based on their Framingham risk score 
Implications for Nursing Knowledge and Practice 
Nurses are at the forefront in many settings where screening programs are made 
available to the public. Considering the relationship between depressive symptoms and 
adherence to medical treatment plans, screening for depressive symptoms should be 
encouraged with baseline CVD risk assessment and not delayed until a cardiac event 
has occurred. Considering the link between treatment delay for cardiac symptoms in 
women found to be depressed (Bunde & Martin, 2006), nurses who provide cardiac 
health screening should be aware of the links between depressive symptoms and CVD 
particularly in women. Nurses who work in emergency departments and clinical 
decision units who care for patients coming with complaints of chest pain, need to be 
aware that over half of the people admitted for acute coronary syndrome were 
depressed prior to their hospitalization and 94% of these depressed people reported that 
they were depressed more than 30 days prior to their hospitalization (Glassman et al., 
2006) regardless of gender. 
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In addition to adding depression screening to CVD risk assessment, CVD risk 
screening programs should add questions regarding the use of anti-depressants and 
screen for snoring and sleep-disordered breathing. Clients who present with snoring 
should be told to bring this to the attention of their primary care provider as a CVD risk 
factor warranting additional assessment. Cardiovascular disease risk modification 
programs should consider the use of a health-promotion lifestyle assessment to expand 
the understanding of self-care behaviors. Based on the data from this assessment, these 
CVD risk modification programs could minimally provide stress management 
interventions in addition to the information provided to modify nutrition, physical 
activity, and knowledge of all modifiable CVD risk factors. 
Implications for Future Research 
The release of the AHA advisory to include screening for depression and 
referral for treatment when depression is identified (Lichtman et al., 2008) has 
increased the attention to depression and depressive symptoms. This advisory, however, 
was for persons with CHD and did not address persons who are being screened for 
CVD risk. Over the last six years there has been a modest up-tick in the number of 
research studies addressing depression conducted by nurses and physicians. The studies, 
however, remain predominantly focused on people who have had a cardiac event or live 
with chronic heart failure. Therefore, this remains the first study thus far identified that 
has investigated the relationship of depressive symptoms to cardiac risk, health-
promoting lifestyle behaviors and quality of life in women being screened for CVD 
risk. 
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Given the nature of the association between depressive symptoms and CVD 
risk, it would be realistic to design longitudinal CVD risk modification programs that 
consistently measure for depressive symptoms. Based on the health-promoting lifestyle 
behavior scale responses, it would be logical to begin with a physical activity and stress 
management intervention. There is a potentially easily accessible sample at the 
screening center facility. The organizational wellness program sponsors events which 
might be amenable to adding short depressive symptoms screening items such as the 
PHQ-2 to their tracked data. The addition of depressive symptom screening questions 
could also be added to the ongoing Heart Advantage program and track participants 
who return for follow-up assessments where the baseline data is repeated. It would be 
interesting to identify any reduction in depressive symptoms in those who have 
improved their heart healthy lifestyles inclusive of improved nutrition and exercise 
frequency. These investigations will expand the understanding of the relationship of 
depressive symptoms to adherence to treatment programs. All delay to treatment 
investigations should include the assessment of depressive symptoms. 
When designing intervention studies, the demographics of the community 
served by an existing CVD risk screening program should be taken into consideration. 
Research programs need to be racially balanced since the majority of programs continue 
to be skewed toward White participants. Strategies to recruit more non-White 
participants needs to be a priority, particularly in communities that are not 
predominantly White. Recruitment of non-white participants will likely require targeted 
community outreach activities such as recruiting from other community agencies such 
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as the public health department and faith-based health initiatives. Other nursing 
research strategies include academic nurse researchers establishing research 
partnerships with existing healthcare organization‘s health-promotion activities and 
employee wellness programs.  
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APPENDIX A 
RESEARCH STUDIES: DEPRESSIVE SYMPTOMS AND PRECLINICAL 
ATHEROSCLEROSIS
  
Depressive Symptoms and Preclinical Atherosclerosis 
Author 
(Year) 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Agatisa 
(2005) 
n/a Study: SWAN 
N = 210 
Age* = 51.0 
Female = 100% 
White = 72.4% 
AA = 27.6% 
SCID-IV & 
CES-D 
 Elevated DS more common with any coronary calcification 
(14.6%) than with no calcification (6.5%), p = .06. 
 Women with history of recurrent depression: 
o OR (95% CI) = 2.46 (1.06-5.67; p = .04) - coronary calcium 
scores > 0 < 10 
o OR = 2.71 (1.08-6.81; p = .03) - coronary calcium score > 
10 
o OR = 3.39 (1.34-8.63; p = .01) - aortic calcium score > 100 
Elovainio et 
al. (2005) 
9 years Study: CV Risk 
in Young Finns 
N = 1,126 
Age* = 31.4 
Female = 64% 
BDI Only high DS scores were related to carotid intima media 
thickness & only in men. 
 
AA = African American; Age* = mean age for sample; BDI = Beck Depression Inventory; CES-D = Center for Epidemiological 
Studies-Depression Scale; CI = confidence interval; CV = cardiovascular; DS = depressive symptoms; n/a = not applicable; OR = 
odds ratio; SCID-IV = Structured Clinical Interview for Depression, DSM-IV criteria; SWAN = Study of Women‘s Health Across 
the Nation. 
1
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APPENDIX B 
RESEARCH STUDIES: DEPRESSIVE SYMPTOMS AND CARDIOVASCULAR 
DISEASE RISK
  
Depressive Symptoms and Cardiovascular Disease Risk  
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Farmer 
et al. 
(1988) 
Mean 8 
years 
Study: NHANES 
N = 1,497 
Age* = NR 
Female = 54.5% 
White = 92% 
Black = 8% 
CES-D  OR (95% CI) = 2.2 (1.2-4.2) for DS for white men with little or 
no recreational physical activity 
 OR = 16.5 (2.1-128) for DS for  black men with little or no 
recreational physical activity 
 OR = 2.1 (1.1-4.0) for DS for white women with little or no 
physical activity apart from recreation 
 OR = 19.2 (2.3-160) for DS for black women with little or no 
physical activity apart from recreation 
 OR = 1.9 (1.1-3.2) for DS for  men and OR = 1.3 (0.5-3.1) for 
DS for women for physical activity at follow-up with CES-D < 
16 
 OR = 12.9 (1.7-98.9) for DS for men and OR = 2.0 (0.8-14.5) 
for DS for women for physical activity at follow-up with CES-
D  16. 
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Appendix B (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Raikkonen et 
al. 
(2002) 
7.4 years Study: Healthy 
Women‘s Study 
N = 425 
Age* = 50.4 
Female = 100% 
White = 90.6% 
BDI  No metabolic syndrome-risk factors: BDI mean score 
4.3 ( 4.6) 
 1 metabolic syndrome-risk factor: BDI mean score 4.5 
( 4.9) 
 2 metabolic syndrome-risk factors: BDI mean score 
6.5 ( 6.3) 
 3 – 5 metabolic syndrome-risk factors: BDI mean 
score 7.1 ( 7.2), p < 0.002 
 HR = 1.29 (95% CI, 1.03-1.62) for the higher baseline 
BDI risk of developing the metabolic syndrome. 
Wassertheil-
Smoller et al. 
(2004) 
Mean 4.1 
years 
Study: WHI-OS 
N = 93,676 
Age: 60-69 = 44% 
Female = 100% 
White = 83.3% 
AA = 8.2% 
CES-D (6 
items) 
 OR = 0.78 (0.74-0.82) for DS  and some exercise  
 OR = 0.67 (0.62-0.71) for DS and 2-4 episodes of 
exercise  
 OR = 0.56 (0.53-0.59) for DS and > 4 episodes of 
exercise.    
 
 
Continued on next page 
1
7
0
 
  
Appendix B (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Brown et al. 
(2005) 
15 years Study: ALSWH 
N = 9,207 
Age* = 45-50 
Female = 100% 
Race = NR 
CESD-10 & 
SF-36 
Mental 
Health 
Subscale 
CESD-10  10 (95% CI for all OR were less than 1.0): 
 OR = 0.6 DS & high habitual physical activity 
 OR = 0.78 DS & moderate habitual physical activity 
 OR = 0.8 DS with low habitual physical activity  
Knox et al.  
(2006) 
15 years Study: CARDIA 
N = 5,115 
Age* = 33-45 
Female = 54.5% 
White = 48.5% 
AA = 51.5% 
CES-D  AA women experienced most episodes of depression  
 Significant association between depression and 
diabetes in African Americans only 
 History of depression was positively associated with 
smoking and BMI and inversely associated with 
physical activity 
 History of depression was positively associated with 
HDL and negatively associated with LDL only in 
Caucasians with same LDL pattern regardless of 
gender and HDL only significant in men. 
§ = studies in ascending chronological order; AA = African-American; Age* = mean age for sample; ALSWH  = Australian 
Longitudinal Study on Women‘s Health; BDI = Beck Depression Inventory; CES-D = Center for Epidemiological Studies-
Depression Scale; CESD-10 = 10 item version of CES-D; CI = confidence interval; DS = depressive symptoms; HR = hazard ratio; 
NHANES = National Health and Nutrition Examination Survey; NR = reported; OR = odds ratio; SF = short form; WHI-OS = 
Women‘s Health Initiative Observational Study. 1
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APPENDIX C 
RESEARCH STUDIES: DEPRESSIVE SYMPTOMS AND NONFATAL ISCHEMIC 
HEART DISEASE
  
Depressive Symptoms and Nonfatal Ischemic Heart Disease 
 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Hallstrom et 
al. (1986) 
12 years N = 795 
Age* = NR 
Female = 100% 
Race = NR 
HRS  RR = 1.2 for myocardial infarction with one factor 
 RR = 3.6 for myocardial infarction with 2 factors 
 RR = 5.4 for myocardial infarction with 3 factors p  
0.05; no confidence intervals reported. 
 
Anda et al. 
(1993) 
Mean = 
12.4 years 
Study: NHEFS 
N = 2,832 
Age* = 57.5 
Female = 52.4% 
White = 87.8% 
Black = 12.2% 
 
GWB- 
depression 
subscale 
 RR = 1.6 (1.1 – 2.4) for nonfatal IHD 
 RR = 1.05 (1.02-1.08) for nonfatal IHD - when 
depression subscale was entered into the model as a 
continuous variable. 
 
Barefoot & 
Schroll 
(1996) 
27 years N = 730 
Age* = 50 
Female = 44% 
Race = NR 
MMPI  RR = 1.71 (1.19-2.44; p = .005) for depression scores 
predicting incidence of acute MI. 
 
 
Continued on next page. 
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Appendix C . (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Pratt et al. 
(1996) 
13 years Study = 
Baltimore ECA 
Follow-up 
N = 1551 
Age* = < 65 at 
entry 
Female = 62% 
Black = 34.5% 
 
DIS  OR = 2.06 (95% CI, 1.15-3.72) for MI with a history of 
dysphoria (2 weeks of sadness) 
 OR = 4.14 (95% CI, 1.48-11.62) for MI with a history 
of major depressive disorder 
Wassertheil-
Smoller et al. 
(1996) 
5 years Study: SHEP 
N = 4,367 
Age* = 72 
Female = 53% 
White = 86.1% 
Black = 13.9% 
CES-D;  
Short Care 
Depressive 
Symptoms 
Scale 
 RR = 1.18 (.08-1.30; p  0.001) for stroke or MI 
(adjusted for gender and other CVD risk factors)  
 RR = 1.25 (p  0.001) for MI for women  
 RR = 1.29 (1.13-1.48, p < 0.001) of stroke for women 
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Appendix C. (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Ford et al. 
(1998) 
37 years 
(median) 
Study = 
Precursors 
N = 1190 
Age* = 66 
Female = 0% 
White = 98% 
DSM-III 
based self-
report tool; 
diagnosis 
confirmed 
by 5 blinded 
physicians. 
 RR = 2.12 (95% CI, 1.24-3.63 for CHD associated with 
depression 
 RR = 2.12 (95% CI, 1.11-4.06) for MI associated with 
depression 
 RR = 2.1 (95% CI, 1.1-4.0) for MI 10 years after first 
depressive episode. 
 
Sesso et al. 
(1998) 
7 years Study: 
Normative 
Aging Study 
N = 1,305 
Age* = 61.8 
Female = 0% 
Race = NR 
MMPI-2 D 
& DEP, 
SCL-90, 
CES-D 
All depressive symptom scores measured by MMPI-2 D Score: 
 RR for scores in the mid and highest DS tertiles: 
o RR = 2.15 (0.72-7.44); 2.40 (0.74-7.85), trend p value 
0.19 - for nonfatal MI 
 RR for scores in the mid and highest DS tertiles: 
o RR = 1.51 (0.69-3.30); 2.30 (1.00-5.28), trend p value 
0.039 for angina 
RR = 1.46 (0.82-2.53); 2.07 (1.13-3.81), trend p value 
0.016 for total CHD & angina.      
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Appendix C. (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Ariyo et al. 
(2000) 
6 years Cardiovascular 
Health Study 
N = 4,493 
Age* = 73 
Female = 61% 
White = 84% 
CESD-10  CHD risk increased with increased DS scores 
 HR = 1.15 (1.04-1.27, p < 0.006) for CHD 
 HR = 1.20 (1.05-1.38) for angina without concurrent 
MI. 
Ferkeitch et 
al. 
(2000) 
Mean 8.3 
years 
(Range 
0.02-11.1 
years) 
Study: NHANES 
N = 7,893 
Age = 53.7 
(female), 55.9 
(male) 
Female = 63% 
White = 88.1% 
Black/other = 
11.9% 
CES-D  The RR = 1.25 (read from a figure) for women for a 
nonfatal CHD event when CES-D of 10,  
 RR = 1.6 when the CES-D reached 20  
 RR > 2.0 when the CES-D exceeded 25 
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Appendix C. (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Rosengren et 
al. (2004) 
NA – Case-
control 
design. 
Study = 
INTERHEART 
N = 11,119 
Age* = 58.2  
12 (Cases) 
Female = 24.2% 
(Cases) 
Ethnicity = 52 
countries 
One depression 
screening 
question. 
Severity graded 
by seven yes-no 
questions. 
 Depression was associated with MI regardless of 
ethnicity.  
 Depression was found in 24% of the participants. 
 Stated did not find a dose-response relationship 
between risk of MI and increased number of items 
on the depression scale.  
 MI risk was increased with depression regardless of 
depression score. 
Astin et al. 
(2005) 
6-8 months N = 140 
Age* = 62  
10.7 
Female = 25% 
European 
ethnicity = 98% 
CDS  Mean depression scores were lower at 6 - 8 weeks 
and at 6 months post-procedure compared to pre-
procedure, but were higher at 8 months post-
percutaneous angioplasty. 
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Appendix C. (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Rasul et al. 
(2005) 
5-10 years N = 6,575 
Age* = 55 
Female = 55% 
Race = NR 
(Scotland) 
GHQ  RR = 1.78 (95% CI, 1.15-2.75) for CHD events at 5 years 
in men 
 RR = 1.60 (95% CI, 0.74-3.44) for CHD events at 5 years 
in women 
 
Thurston & 
Kubzansky 
(2007) 
 
 
 
 
 
 
 
 
Mean 15 
years 
 
Study = 
NHANES 
N = 6,025 
Age* = 50 
Female = 54.4% 
White = 87% 
Black = 12% 
Other = 1% 
 
 
 
GWB  Increased risk of incident CHD with increased number of 
psychosocial risks, especially in women.  
 Women: 1 risk factor HR 1.45 (95% CI, 1.12-1.87) to ≥ 4 
risk factors HR 2.18 (95% CI, 1.53-3.12). 
 Women only: graded increase between BMI and almost all 
other psychosocial risks. 
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Appendix C. (continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Gilmore 
(2009) 
12 years N = 4,948 
Age* = 55 
Female = 57.6% 
Race = NR 
(Canada) 
CICI-SF  Higher incidence of depression in women (16.8% versus 
10.9%, p < .001) 
 Incident heart disease event in depressed women. HR = 1.8, 
95% CI=1.3, 2.7) but NS in men. 
§ = studies in ascending chronological order; Age* = mean age for sample; CDS = Cardiac Depression Scale; CES-D = 
Center for Epidemiological Studies-Depression Scale; CESD-10 = 10 item version of CES-D; CHD = coronary heart disease; 
CI = confidence interval; CIDI-SF = Composite International Diagnostic Interview; DSM-III = Diagnostic & Statistical 
Manual third edition; CVD = cardiovascular disease; DIS = Depression Interview Schedule; DS = depressive symptoms; 
ECA = Epidemiological Catchment Area; GHQ = General Health Questionnaire; GWB = General Well Being Schedule; 
HAD = Hospital Anxiety and Depression scale; HR = Hazard Ratio; HRS = Hamilton Rating Scale; IHD = ischemic heart 
disease; MI = myocardial infarction; MMPI = Minnesota Multiphasic Inventory; MMPI-2 D = depression scale of second 
version of MMPI; MMPI-2 DEP = depressive thoughts scale of MMPI-2 ;  n/a = not applicable, NHANES = National Health 
and Nutrition Examination Survey; NHEFS = National Health Examination Follow-up Study; NR = not reported; NS = not 
significant; OR = Odds Ratio; RR = relative risk; SCL-90 = Symptom Checklist 90; SHEP = Systolic Hypertension in the 
Elderly Program. 
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APPENDIX D 
RESEARCH STUDIES:  DEPRESSIVE SYMPTOMS AND FATAL ISCHEMIC 
HEART DISEASE AND ALL-CAUSE MORTALITY
  
Depressive Symptoms and Fatal Ischemic Heart Disease and All-Cause Mortality 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Anda et al. 
(1993) 
Mean = 
12.4 
years 
Study: NHEFS 
N = 2,832 
Age* = 57.5 
Female = 52.4% 
White = 87.8% 
Black = 12.2% 
GWB- 
depression 
subscale 
 RR (95% CI) = 1.5 (1.0 – 12.3) for fatal IHD  
 RR = 1.04 (1.01-1.07) for each unit increase in CES-D score 
for fatal IHD, when depression subscale was entered into the 
model as a continuous variable. 
 
Barefoot & 
Schroll 
(1996) 
27 
years 
N = 730 
Age* = 50 
Female = 44% 
Race = NR 
MMPI  RR = 1.59 (1.26-2.00; p < .001) for depression scores 
predicting total mortality. 
Wassertheil-
Smoller et 
al. 
(1996) 
5 years Study: SHEP 
N = 4,367 
Age* = 72 
Female = 53% 
White = 86.1% 
Black = 13.9% 
CES-D;  
Short Care 
Depressive 
Symptoms 
Scale 
 RR = 1.25 (1.15-1.36, p < 0.001) for death (adjusted for 
stroke and MI)  
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Appendix D.  (Continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Ariyo et al. 
(2000) 
6 years Cardiovascular 
Health Study 
N = 4,493 
Age** = 73 
Female = 61% 
White = 84% 
CESD-10  All-cause mortality increased with increased DS scores 
 HR (95% CI) = 1.16 (1.04-1.28, p < 0.006) for mortality 
 
 
 
 
Ferkeitch 
et al. 
(2000) 
Mean 8.3 
years 
(Range 
0.02-11.1 
years) 
Study: NHANES 
N = 7,893 
Age = 53.7 
(female), 55.9 
(male) 
Female = 63% 
White = 88.1% 
Black/other 
=11.9% 
CES-D  Results in women: 
o RR = 0.74 (0.40-1.61) for fatal IHD 
o RR = 1.21 (0.90-1.61) for all-cause mortality 
 RR = 1.6 when the CES-D reached 20  
 RR > 2.0 when the CES-D exceeded 25 
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Appendix D.  (Continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Pennix et 
al. 
(2001) 
4 years Study: Longitudinal 
Aging Study 
Amsterdam 
N = 2,847 
Age* = 70.5 
Female = 52% 
Race = NR 
 CES-D 
 DIS when 
CES-D > 
16. 
 Cardiac mortality for participants without cardiac disease 
o RR = 1.6 (1.0-2.8) for minor depression 
o RR = 3.8 (1.4-10.6) for major depression 
 Cardiac mortality for participants with cardiac disease 
o RR = 5.1 (3.1-8.6) for minor depression 
o RR = 10.5 (4.1-26.7) for major depression 
Gump et 
al. (2004) 
18.43 
years 
(median) 
Study = MRFIT 
N = 11,216 
Age* = 46.5 
Men = 100% 
White = 89.8% 
CES-D  HR = 1.03 (95% CI, 1.01-1.06; p = 0.011) for all- cause 
mortality for each higher CES-D quintile 
 HR = 1.20 (95% CI, 1.07-1.34, p = 0.002) for stroke 
mortality for each higher CES-D quintile 
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Appendix D.  (Continued) 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Wulsin et 
al. (2005) 
> 6 years Study: Framingham 
Heart Study 
N = 3,634 
Age* = 52 
Female = 55% 
Race = 
predominantly 
Caucasian 
CES-D  HR (95% CI) = 1.46 (0.95-2.23) and 1.33 (0.86-2.04) for 
second tertile in the age-adjusted and the multivariable-
adjusted models respectively 
 HR=2.07 (1.34-3.18) and 1.88 (1.22-2.91) for the third 
tertile in the age-adjusted and multivariate-adjusted models 
 HR=1.44 (1.16-1.78) and 1.37 (1.10-1.71) across tertiles for 
the age-adjusted and for the multivariate-adjusted models 
respectively. 
 HR=1.66 (0.98-2.82; p= 0.06) for CES-D scores of 4-8 
 HR=1.72 (0.97-3.02; p= 0.06) for CES-D scores of > 9 
 HR=1.30 (0.99-1.71; p= 0.55) trend across CES-D scores. 
§ = studies in ascending chronological order; Age* = mean age for sample; CES-D = Center for Epidemiological Studies 
Depression Scale; CESD-10 = 10-item version of CES-D; CHD = coronary heart disease; CI = confidence interval; DIS = 
Depression Interview Schedule; DS = depressive symptoms; GWB = General Well-Being Schedule; HR = hazard ratio; IHD = 
ischemic heart disease; MI = myocardial infarction; MMPI = Minnesota Multiphasic Inventory; n/a = not applicable; MRFIT = 
multiple risk factor intervention trial;  NHANES = National Health and Nutrition Examination Survey; NHEFS = National Health 
Examination Follow-up Study; NR = not reported; RR = relative risk; SHEP = Systolic Hypertension in the Elderly Program. 
1
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APPENDIX E 
RESEARCH STUDIES: DEPRESSIVE SYMPTOMS AND HEALTH PROMOTION
  
Depressive Symptoms and Health Promotion 
Author 
(Year) § 
Follow-up 
Duration 
Sample 
Characteristics 
Depression 
Instrument 
Findings 
Rosal et 
al. 
(2001) 
1 year Study: Seasons 
N = 496 
Age* = 48 
Female = 49% 
White = 95% 
BDI  No RBs were found with BDI mean score 4.2 ( 3.5) 
 1 RB was found with BDI mean score of 5.6 (  4.9) 
  2 RBs were found with BDI mean scores from 6.8 ( 5.8) to 7.6 
( 6.0), p < 0.0001. 
 OR = 1.06 (95% CI, 1.02-1.09) for prediction of the number of 
RBs for depression 
Bonnet 
et al. 
(2005) 
NA: 
Cross-
sectional 
design. 
N = 1612 
Age* = 50.8  
12.8 (females); 
49.2  10.6 
(males) 
Female = 38.8% 
Ethnicity = FR 
HAD  OR = 2.14 (95% CI, 1.16-3.94; p = 0.01) for mildly depressed 
women to have unhealthy behaviors 
 OR = 5.95 (95% CI, 1.83-19.29; p = 0.003) for markedly 
depressed women to have unhealthy behaviors.  
 OR = 2.23 (95% CI, 1.27-3.90; p = 0.005) for mildly depressed 
men to have unhealthy behaviors 
 OR = 5.18 (95% CI, 2.09-12.84, p = 0.0004) for markedly 
depressed men to have unhealthy behaviors. 
§ = studies in ascending chronological order; Age*= sample mean age; BDI= Beck Depression Inventory; DRR= dose-response 
relationship; FR= France; HAD= Hospital Anxiety and Depression Scale; OR= odds ratio; RB= risk behaviors; Seasons = Seasonal 
Variation of Blood Cholesterol Level.
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APPENDIX F 
HEALTH PROMOTION MODEL
188 
 
 
 
 
* From Pender, N. J., Murdaugh, C. L., & Parsons, M. A. (2006). Health promotion in 
nursing practice. (5
th
 ed.). Upper Saddle River, NJ: Pearson Prentice Hall.  Copyright 
2006. All Rights Reserved. Page 50. 
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APPENDIX G 
WILSON AND CLEARY HEALTH-RELATED QUALITY OF LIFE MODEL 
  
 
 
 
 
 
 
Characteristics of the Individual 
 
Characteristics of the Environment 
 
 
Biological 
Function 
 
Symptoms 
 
Functional 
Status 
General 
Health 
Perceptions 
Overall 
Quality 
of Life 
Figure 2. Revised Wilson and Cleary model for health-related quality of life. Ferrans et al., (2005) page 338. 
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APPENDIX H 
COVENANT HEART ADVANTAGE HEART HEALTH ASSESSMENT 
QUESTIONS 
192 
 
Covenant Heart Health Risk Assessment Questions 
Title: Mr. _____  Mrs. _____  Dr. _____ 
First name: _______________________________ MI: ______ 
Last name: __________________________________________ 
Address _____________________________________________ 
City/State/Zip _________________________________________ 
Birth date: _____/ _____/ _____ 
Email: _______________________________________________ 
Daytime phone: ( _______ ) ______________________________ 
Do you have a primary care doctor? ________ Yes ________ No 
I would like to receive by email the following topics: 
 [_] Heart Health [_] Fitness [_] Nutrition [_] Smoking Cessation 
We’re glad you are taking an active interest in your heart health. This assessment is 
quick, simple, and FREE. Answer these simple questions to find out if you’re at risk. 
 
1. Are you:  [_] Male  [_] Female (Females, see questions 1a and 1b) 
 1a. Are you postmenopausal?     [_] Yes  [_] No 
 1b. Are you on estrogen replacement therapy?  [_] Yes  [_] No 
2. What is your age? ____________________ 
3. What is your zip code? ________________ 
4. What is your ethnic origin? (optional) 
[_] Caucasian [_] African-American [_] Hispanic, Asian/Pacific Islander 
[_] American Indian/ Alaska Native  [_] Other 
5. What is your height? _____ feet  _____ inches 
6. What is your weight? _____ pounds 
7. Do you use tobacco products or smoke cigarettes?  [_] Yes   
 [_] No (skip to question 13)  [_] No, but I have smoked before (skip to question 
10) 
8. How long have you been smoking? 
 [_] Less than 1 year   [_] 1 to 9 years     [_] 10-19 years     [_] 20 years or more 
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9. How many cigarettes do you smoke per day? 
 [_] Less than 1 pack     [_] 1 pack     [_] 2 packs     [_] More than 2 packs 
 [_] I smoke cigars or chew tobacco 
10. How long ago did you quit using tobacco or stop smoking? 
 [_] Less than 1 year   [_] 1 to 9 years     [_] 10-19 years     [_] 20 years or more 
11. How long had you been using tobacco or smoking? 
 [_] Less than 1 year   [_] 1 to 9 years     [_] 10-19 years     [_] 20 years or more 
12. How many times per week do you ―aerobically exercise‖ (increase your heart rate)? 
[_] None [_] 1-2 times [_] 3-4 times [_] 5 or more times 
13. How much stress do you ―feel‖ you have in your life? 
[_] Low [_] Average/normal [_] High/chronic 
14. What is your blood pressure? Systolic  Diastolic 
     [_] < 120  [_] < 80 
     [_] 120-129  [_] 80-84 
     [_] 130-139  [_] 85-89 
     [_] 140-159  [_] 90-99 
     [_] 160-199  [_] 100-114 
     [_] > 199  [_] > 114 
     [_] Unsure  [_] Unsure 
14a. When was the last time you had your blood pressure checked? 
 [_] Less than 1 year ago [_] More than 1 year ago [_] Never or unsure 
15. What is your cholesterol? 
  Total  HDL  LDL 
  [_] < 160 [_] > 59 [_] < 100 
  [_] 160-199 [_] 50-59 [_] 100-129 
  [_] 200-239 [_] 45-49 [_] 130-159 
  [_] 240-279 [_] 35-44 [_] 160-189 
  [_] > 279 [_] < 35 [_] > 189 
  [_] Unsure [_] Unsure [_] Unsure 
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15a. When was the last time you had your cholesterol checked? 
 [_] Less than 1 year ago [_] More than 1 year ago [_] Never or unsure 
16. Are you taking any of the following medications? 
 [_] Arthritis [_] Blood pressure [_] Cholesterol 
 [_] Aspirin on a regular basis 
 [_] None  
17. Has your immediate family (parent and/or sibling) had any of the following 
conditions before age 55? 
 [_] Cardiovascular disease [_] Stroke [_] High blood pressure 
 [_] Diabetes [_] High cholesterol 
 [_] None [_] Unsure 
18. Are you diabetic?  [_] No     [_] Yes, Type 1 diabetes (juvenile) 
 [_] Yes, type 2 diabetes (adult-onset) 
 [_] Pre-diabetes [_] Unsure 
19. Have you been diagnosed by a doctor as having any of the following conditions? 
 [_] Abdominal aortic aneurysm 
 [_] Angina (chest pain)  [_] Acute MI (heart attack) 
 [_] Atrial Fibrillation  [_] Cardiac arrest (sudden loss of heart function) 
 [_] Claudication (leg pain) [_] CHF (congestive heart failure) 
 [_] Renal Artery Stenosis [_] Stroke 
 [_] None of the above 
20. Have you ever had any of the following cardiovascular procedures? 
 [_] Cardiac catheterization [_] Balloon angioplasty 
 [_] Bypass surgery  [_] Stent 
 [_] Other    [_] None of the above 
21. Have you experienced pain in either leg during the past year? 
 [_] Yes (if yes, see question 21a.)     [_] No 
21a. When did you experience the pain in your leg? 
      [_] Only when exercising [_] Both during exercise and at rest    [_] Only at rest 
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22. Have you experienced any of the following in the past year (check all that apply)? 
 [_] A shade or curtain down over one eye 
 [_] Brief episode of weakness of an arm or leg 
 [_] Darkening of the vision in one eye 
 [_] Momentary loss of vision 
 [_] Slurring or difficulty with speech 
 [_] Dizziness 
 [_] None of the above 
23. Do you have a cardiologist? 
[_] Yes [_] No  [_] Unknown 
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APPENDIX I 
STUDY INFORMATION SHEET 
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Study Information Sheet 
 
Study Title:  Depressive Symptoms in Women Being Screened for Cardiovascular 
Disease Risk 
Researcher: Suzanne M. Savoy, MN, RN, ACNS-BC; Nursing Doctoral Student, 
Loyola University of Chicago; Assistant Professor of Nursing, Saginaw Valley State 
University. 
 
The purpose of this study is to see if there is a link between depressive symptoms, heart 
disease awareness, a healthy lifestyle, and measured heart disease risk to quality of life. 
 
If you agree to be in the study,  
 You will be asked to complete a booklet of questions. The questions ask about heart 
disease awareness, health history, healthy behaviors, life satisfaction, how you have 
felt or behaved during the last week, and general information. It takes about 15-20 
minutes to complete the booklet of questions. 
 You give permission to the researcher to use the responses you gave the heart health 
risk assessment questions and to use the risk assessment summary information you 
were given as part of the Covenant Heart Advantage program. This information tells 
us about your chances/risks of getting heart disease. This information will be 
matched to your booklet of questions. All identifying information will be removed 
and replaced by a code. 
 
This study is separate from the heart health risk assessment activities of the Covenant 
Heart Advantage program. 
 
When you complete the research study booklet of questions, you will be given a $10.00 
gift card. 
 
If you are interested in being in this study, please come to the research study 
office/information table. 
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APPENDIX J 
CONSENT FORM 
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CONSENT TO PARTICIPATE IN RESEARCH 
 
Project Title: Depressive Symptoms in Women Being Screened for Cardiovascular 
Disease Risk 
Researcher: Suzanne M. Savoy, MN, RN, ACNS-BC 
Faculty Sponsor: Sue M. Penckofer, Ph.D., RN 
 
Introduction:  
You are being asked to take part in a research study by Suzanne Savoy (Assistant 
Professor of Nursing, Saginaw Valley State University) for a dissertation supervised by 
Sue Penckofer, Ph.D., RN, Professor of Nursing, School of Nursing at Loyola 
University of Chicago. 
You are a woman who wants to learn about your chances/risks of heart disease. About 
150 women coming to the Covenant Heart Advantage program will be asked to be in 
this study. Women who have been told by their healthcare provider that they have heart 
disease, stroke, peripheral vascular disease, dementia, drug dependency, alcoholism, 
and diagnosed mental illness other than depression will not be asked to take part. 
Please read this form and ask any questions you have before taking part in the study. 
 
Purpose:  
The purpose of this study is to see if there is a link between depressive symptoms, heart 
disease awareness, a healthy lifestyle, and measured heart disease risk to quality of life. 
 
Procedure: 
If you agree to be in the study,  
 You will be asked to complete a booklet of questions. The questions ask about heart 
disease awareness, health history, healthy behaviors, life satisfaction, how you have 
felt or behaved during the last week, and general information. It takes about 15-20 
minutes to complete the booklet of questions. 
 You give permission to the researcher to use the responses you gave to the heart 
health risk assessment questions and to use the risk assessment summary 
information you were given as part of the Covenant Heart Advantage program. This 
information tells us about your chances/risks of getting heart disease. This 
information will be matched to your booklet of questions. All identifying 
information will be removed and replaced by a code. 
 
Risks/Benefits: 
There are no known risks of being in this study beyond those experienced in everyday 
life. You will be given a list of local counseling services. You can contact them if you 
have questions about your emotions. You should talk to your healthcare provider if you 
need help with managing your emotions. 
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As in all research, there may be unknown risks to you. If an accidental injury occurs, 
the right emergency measures will be taken. You will not be paid except as stated in 
this consent form. 
 
There are no direct benefits to you from being in this study. Your part in this study may 
help health professionals learn about how depressive symptoms in women are linked to 
their health promoting lifestyle behaviors according to their level of heart disease risk 
and satisfaction with life.  
 
Compensation: To thank you for your time, when you finish the research study booklet 
of questions, you will be given a $10.00 gift card.  
 
Confidentiality: 
No information collected for this study will identify you. Your heart health information 
will be given to the researcher. This information will be matched with your booklet of 
questions. All your personal identifying information will then be removed and a code 
will be assigned. All paper records will be stored in a locked cabinet in the researcher‘s 
office. The paper records will be destroyed when the study is completed. Coded data 
from the paper records will be entered into a password-secured computer file that only 
the researcher can enter.  
 
The results of this study will be presented to my faculty sponsor and my dissertation 
committee. The study results will be submitted for publication to advance nursing 
knowledge. You will not be identified by name or by any other identifying information 
in any publication or report about this study. 
 
Voluntary Participation: 
Being in this study is voluntary. This study is not part of the Covenant Heart Advantage 
program. If you do not want to be in this study, you can say no. If you decide to be in 
this study, you do not have to answer any question and you can stop at any time without 
penalty. If you decide to stop being in this study, you can still be part of the Covenant 
Heart Advantage program. 
 
Contacts and Questions: 
If you have questions about this study, call Suzanne Savoy at 989-964-7026 or call the 
faculty sponsor, Sue Penckofer, PhD, RN at 708-216-9303. 
 
If you have questions about your rights as a research participant, you may contact the 
Compliance Manager in Loyola‘s Office of Research Services at 773-508-2689, Dr. 
Dennis Boysen, Chairman of the Covenant HealthCare Institutional Review Board at 
989-583-6098, or Dr. Frank Dane, the Chair of the SVSU HSIRB at 989-964-2046; 
fadane@svsu.edu. 
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Statement of Consent: 
Your signature below says that you have read and understood the information above, 
that you have had a chance to ask questions, and that you agree to be part of this 
research study. You will be given a signed copy of this form to keep for your records. 
 
This consent document has been approved for use for one year by the Human Subjects 
Institutional Review Board (HSIRB) as indicated by the stamped date and signature of 
the board chair in the upper right corner. Subjects should not sign this document if the 
corner does not show a stamped date and signature. 
 
_________________________________________ ___________________________ 
Participant Signature     Date 
 
_________________________________________ ___________________________ 
Researcher Signature     Date 
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Information and Tri-City Psychological Counseling Referral Sources 
            
Thank you for participating in a study designed to find out about your chances/risk of heart 
disease. You were asked to answer a set of questions about depressive symptoms which may 
have raised some concerns about whether you have depressive symptoms.  
 
Depressive symptoms are a subclinical subset of depression. If you have any questions or 
concerns about whether you are experiencing depression or depressive symptoms, please talk to 
your primary healthcare provider or please consult any of the following list of psychological 
counseling services. 
 All phone numbers 989 area code unless other listed. 
Bay City 
 Bay Arenac Behavioral Health     895-2300 
 201 Mulholland St. 
 
 Bay Psychological Associates, PC     686-1990 
 Suite 300, 3941 Traxler Ct 
 1420 Center Ave.        686-1990 
 Accepts most insurance. 
 Offers psychotherapy & psychiatric services. 
 
 Catholic Family Services      892-2504 
 915 Columbus Ave. 
 Accepts most insurance. 
 Has sliding fee scale. 
 Offers psychotherapy 
 
 Delta Psychological & Neuro Behavioral Services   895-0788  
 200 S. Wenona 
 Accepts most insurance. 
 Offers psychotherapy & psychological testing.  
 
 List Psychological Services PLC     
 126 Washington       460-1000 
 3741 E. Wilder       684-7977 
 Accepts most insurance. 
 Offers psychotherapy & psychiatric services. 
 
Lutheran Child and Family Services     686-7650 
6019 West Side Saginaw Rd. 
 Accepts some insurance. 
 Has sliding fee scale.   
 Offers Psychotherapy.  
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Bay City (continued) 
Michigan Psychiatric and Behavioral Assoc. (MPBA)  922-4900 
690 S. Trumbull 
 Accepts most insurance. 
 Offers psychotherapy, psychiatric services & case management.  
 
MPA Group Mental Health Services     667-9661 
1217 S. Euclid Ave. 
 Accepts most insurance. 
 Offers psychotherapy & psychiatric services.  
  
Shindling, Shindling, & Haller     667-5654 
2355 ½ Delta Rd 
 Offers psychotherapy.  
 Eating Disorders therapist: Pamela Kohn, LMSW  
 
Midland 
 Family and Children‘s Services of Midland    631-5390 
 1714 Eastman Road 
 Accepts most insurance. 
 Offers psychotherapy and other services.  
 
 Midland County Community Mental Health Services Crisis Line  631-4450 
 Midland County Mental Health 
 200 McDonald St. 
 Accepts some insurance, Medicaid and Indigent.  
  
 Psychiatric Associates of Midland PC    636-7120 
 2726 N. Saginaw Rd. 
   
 S.W. Zimostrad & Associates      839-6565 
 728 W. Wackerly St., Ste. 101 
 Accepts most insurance. 
 Offers psychotherapy & psychiatric services.  
 
Saginaw 
 Affiliated Behavioral Consultants     791-1151 
 3195 Christy Way 
 
Catholic Family Services      753-8446  
710 N. Michigan 
 Accepts most insurances, has sliding fee scale.   
 Offers psychotherapy.  
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Saginaw (continued) 
Child & Family Services of Saginaw County   790-7500  
2806 Davenport Ave. 
 Accepts most insurance. 
 Offers crisis and sexual assault counseling, psychotherapy  
 & psychiatric services.  
 
 HealthSource Outpatient Behavioral Services   790-7742 
 3340 Hospital Road    
 Accepts most insurance, some HMO Medicaid.   
 Psychotherapy & psychiatric services. 
 
 List Psychological Services PLC     790-3130 
 5024 N. Center 
 Accepts most insurance. 
 Psychotherapy & psychiatric services.  
 
 Saginaw County Community Mental Health Authority      800-258-8678 
 500 Hancock 
CMH Crisis Services- 24 hour Crisis Services   792-9732  
 Saginaw County Mental Health Access Line    797-3559  
 Phone access for Saginaw County Medicaid  
 recipients/ uninsured.  
 
 Saginaw Psychological Services, Inc.    799-2100 
 2100 Hemmeter 
 Accepts most insurance (not Blue Cross).   
 Psychotherapy & psychiatric services 
 
 St. Marys Cathedral       752-8119  
 615 Hoyt Ave. 
 Out-patient mental healthcare for those  
 underinsured or uninsured.  
 
 Synergy Medical Education Alliance – Counseling   583-7910 
 1000 Houghton 
 
 Westlund Guidance Clinic      793-4790  
 3253 Congress 
 Accepts most insurance. 
 Psychotherapy & psychiatric services.   
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Centers for Epidemiological Studies Depression (CES-D) 
Below is a list of some ways you may have felt or behaved. Please indicate how often 
you have felt this way during the last week by checking the appropriate space. 
 
 
 
During the past week: 
Rarely or 
none of the 
time (less 
than 1 day) 
Some or a 
little of the 
time (1-2 
days) 
Occasionally 
or a moderate 
amount of 
time (3-4 
days) 
Most or all 
of the time 
(5-7 days) 
1. I was bothered by things that 
usually don‘t bother me. 
0 1 2 3 
2. I did not feel like eating; my 
appetite was poor. 
0 1 2 3 
3. I felt that I could not shake 
off the blues even with the 
help from my family or 
friends. 
0 1 2 3 
4. I felt that I was just as good 
as other people. 
0 1 2 3 
5. I had trouble keeping my 
mind on what I was doing. 
0 1 2 3 
6. I felt depressed. 0 1 2 3 
7. I felt that everything I did 
was an effort. 
0 1 2 3 
8. I felt hopeful about the 
future. 
0 1 2 3 
9. I thought my life had been a 
failure. 
0 1 2 3 
10. I felt fearful. 0 1 2 3 
11. My sleep was restless. 0 1 2 3 
12. I was happy. 0 1 2 3 
13. I talked less than usual. 0 1 2 3 
14. I felt lonely. 0 1 2 3 
15. People were unfriendly. 0 1 2 3 
16. I enjoyed life. 0 1 2 3 
17. I had crying spells. 0 1 2 3 
18. I felt sad. 0 1 2 3 
19. I felt that people disliked 
me. 
0 1 2 3 
20. I could not get going. 0 1 2 3 
Scoring: Score is the sum of the 20 item weights. Possible range is from 0-60. If more 
than four questions are missing answers, do not score the CES-D. A score of 16 or more 
is considered depressed. 
Radloff, L. S., (1977). The CES-D scale: A self-report depression scale for research in 
 the general population. Applied Psychological Measurement, 1, 385-401. 
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Archival Data Collection Sheet 
 
 
 
 
Data to be abstracted from Covenant Heart Advantage Heart Health Risk Assessment. 
 
 
Last Name ______________________ First Name _____________________________    
 
Age __________  
 
Zip Code ______________ 
 
Date of Screening ________________________ 
 
Height  (Ht) (inches) ________________ Weight (Wt) (pounds) ________________   
 
BMI _________________ 
 
% Body Fat ______________ Waist Circumference (inches) ____________________ 
 
Lipid Profile: TC    _______   HDL  ________ 
 
Framingham Risk Score __________________ 
 
Stress Level:  Low  [_]    Average  [_]    High/Chronic  [_] 
 
CV Risk Factors: 
 Smoke  [_]    BP: _____ / _____     Diabetes:   Type 1  [_]    Type 2  [_]     
 
 Verify:  No cardiac conditions: [_] No PVD  [_] 
 
 Family Hx: Diabetes  [_] HC  [_] HBP  [_] CVD  [_] 
  
Cardiovascular Procedures: Cath  [_]    Plasty  [_]    Stent  [_]    CABG  [_] 
 
Medications:  Aspirin  [_]    Arthritis  [_]    Cholesterol  [_]    HBP  [_]    HRT  [_] 
 
 
Note: BMI = body mass index; BP = blood pressure; Cath = cardiac catheterization; 
CABG = coronary artery bypass graft surgery; CVD = cardiovascular disease; HBP = 
high blood pressure; HC = high cholesterol; HTN = hypertension; HRT = hormone 
replacement therapy; Plasty = coronary artery balloon angioplasty, PVD = peripheral 
vascular disease. 
Research Study Participant Code 
__________________________ 
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Estimate of 10-Year Risk for Women (Framingham Point Scores) 
 
 
 
Age          Points               
 
Total 
Cholesterol 
Points 
Age  
20-39 
Age  
40-49 
Age  
50-59 
Age 
60-69 
Age 
70-79 
20-34 -7 < 160 0 0 0 0 0 
35-39 -3 160-199 4 3 2 1 1 
40-44 0 200-239 8 6 4 2 1 
45-49 3 240-279 11 8 5 3 2 
50-54 6  280 13 10 7 4 2 
55-59 8  
60-64 10  Points 
65-69 
70-74 
12 
14 
Age  
20-39 
Age  
40-49 
Age  
50-59 
Age 
60-69 
Age 
70-79 
75-79 16 Nonsmoker 0 0 0 0 0 
 Smoker 9 7 4 2 1 
 
Systolic BP 
(mmHg) 
If 
Untreated 
  
  
If 
Treated 
< 120 0 0 
120-129 1 3 
130-139 2 4 
140-159 3 5 
 160 4 6 
HDL 
(mg/dL) 
 
Points 
 Point 
Total 
10-Year 
Risk % 
 
 -1 < 9 <1 
50-59 0 9 1 
40-49 1 10 1 
< 40 2 11 1 
 
 
 
 
 
 
 
 
12 1 
13 2 
14 2 
15 3 
16 4 
17 5 
18 6 
19 8 
20 11 
21 14 
22 17 
23 22 
24 27 
 25  30
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Ferrans and Powers 
QUALITY OF LIFE INDEX© GENERIC VERSION - III 
 
PART 1. For each of the following, please choose the answer that best describes how 
satisfied you are with that area of your life. Please mark your answer by circling the 
number. There are no right or wrong answers.  
 
 
 
 
 
 
 
 
 
 
HOW SATISFIED ARE YOU WITH:  V
er
y
 D
is
sa
ti
sf
ie
d
 
M
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y
 D
is
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S
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 D
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y
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ed
 
V
er
y
 S
at
is
fi
ed
 
1. Your health? 1 2 3 4 5 6 
2. Your health care? 1 2 3 4 5 6 
3. The amount of pain that you have? 1 2 3 4 5 6 
4. The amount of energy you have for everyday 
activities? 
1 2 3 4 5 6 
5. Your ability to take care of yourself without help? 1 2 3 4 5 6 
6. The amount of control you have over your life? 1 2 3 4 5 6 
7. Your chances of living as long as you would like? 1 2 3 4 5 6 
8. Your family‘s health? 1 2 3 4 5 6 
9. Your children? 1 2 3 4 5 6 
10. Your family‘s happiness? 1 2 3 4 5 6 
11. Your sex life? 1 2 3 4 5 6 
12. Your spouse, lover, or partner? 1 2 3 4 5 6 
13. Your friends? 1 2 3 4 5 6 
14. The emotional support you get from your family? 1 2 3 4 5 6 
15. The emotional support you get from people other than 
your family? 
1 2 3 4 5 6 
(Please Go To Next Page) 
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers 
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HOW SATISFIED ARE YOU WITH:  V
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16. Your ability to take care of family responsibilities? 1 2 3 4 5 6 
17. How useful you are to others? 1 2 3 4 5 6 
18. The amount of worries in your life? 1 2 3 4 5 6 
19. Your neighborhood? 1 2 3 4 5 6 
20. Your home, apartment, or place where you live? 1 2 3 4 5 6 
21. Your job (if employed)? 1 2 3 4 5 6 
22. Not having a job (if unemployed, retired, or disabled)? 1 2 3 4 5 6 
23. Your education? 1 2 3 4 5 6 
24. How well you can take care of your financial needs? 1 2 3 4 5 6 
25. The things you do for fun? 1 2 3 4 5 6 
26. Your chances for a happy future? 1 2 3 4 5 6 
27. Your peace of mind? 1 2 3 4 5 6 
28. Your faith in God? 1 2 3 4 5 6 
29. Your achievement of personal goals? 1 2 3 4 5 6 
30. Your happiness in general? 1 2 3 4 5 6 
31. Your life in general? 1 2 3 4 5 6 
32. Your personal appearance? 1 2 3 4 5 6 
33. Yourself in general? 1 2 3 4 5 6 
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PART 2. For each of the following, please choose the answer that best describes how 
important that area of your life is to you. Please mark all your answers by circling the 
number. There are no right or wrong answers. 
 
 
 
 
 
 
 
 
 
 
HOW IMPORTANT TO YOU IS:  V
er
y
 U
n
im
p
o
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an
t 
M
o
d
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el
y
 U
n
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p
o
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S
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g
h
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y
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n
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o
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S
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g
h
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M
o
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y
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m
p
o
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V
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y
 I
m
p
o
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an
t 
1. Your health? 1 2 3 4 5 6 
2. Your health care? 1 2 3 4 5 6 
3. Having no pain? 1 2 3 4 5 6 
4. Having enough energy for everyday activities? 1 2 3 4 5 6 
5. Taking care of yourself without help? 1 2 3 4 5 6 
6. Having control over your life? 1 2 3 4 5 6 
7. Living as long as you would like? 1 2 3 4 5 6 
8. Your family‘s health? 1 2 3 4 5 6 
9. Your children? 1 2 3 4 5 6 
10. Your family‘s happiness? 1 2 3 4 5 6 
11. Your sex life? 1 2 3 4 5 6 
12. Your spouse, lover, or partner? 1 2 3 4 5 6 
13. Your friends? 1 2 3 4 5 6 
14. The emotional support you get from your family? 1 2 3 4 5 6 
15. The emotional support you get from people other 
than your family? 
1 2 3 4 5 6 
 
(Please Go To Next Page) 
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers 
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HOW IMPORTANT TO YOU IS:  V
er
y
 U
n
im
p
o
rt
an
t 
M
o
d
er
at
el
y
 U
n
im
p
o
rt
an
t 
S
li
g
h
tl
y
 U
n
im
p
o
rt
an
t 
S
li
g
h
tl
y
 I
m
p
o
rt
an
t 
M
o
d
er
at
el
y
 I
m
p
o
rt
an
t 
V
er
y
 I
m
p
o
rt
an
t 
16. Taking care of family responsibilities? 1 2 3 4 5 6 
17. Being useful to others? 1 2 3 4 5 6 
18. Having no worries? 1 2 3 4 5 6 
19. Your neighborhood? 1 2 3 4 5 6 
20. Your home, apartment, or place where you live? 1 2 3 4 5 6 
21. Your job (if employed)? 1 2 3 4 5 6 
22. Having a job (if unemployed, retired, or disabled)? 1 2 3 4 5 6 
23. Your education? 1 2 3 4 5 6 
24. Being able to take care of your financial needs? 1 2 3 4 5 6 
25. Doing things for fun? 1 2 3 4 5 6 
26. Having a happy future? 1 2 3 4 5 6 
27. Peace of mind? 1 2 3 4 5 6 
28. Your faith in God? 1 2 3 4 5 6 
29. Achieving your personal goals? 1 2 3 4 5 6 
30. Your happiness in general? 1 2 3 4 5 6 
31. Being satisfied with life? 1 2 3 4 5 6 
32. Your personal appearance? 1 2 3 4 5 6 
33. Are you to yourself? 1 2 3 4 5 6 
 
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers 
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Items for Subscales for the 
Quality of Life Index (QLI) – Generic Version - III  
 
Five scores are calculated for the Ferrans and Powers Quality of Life Index: (1) Total Quality of Life 
Score, (2) Health and functioning subscale score, (3) Social and economic subscale score (4) 
Psychological/spiritual subscale score, and (5) Family subscale score.  Items listed below are from both 
Part 1 (Satisfaction) and Part 2 (Importance).  For exams, A1. Health refers to question #1 in Part 1 and 
question #1 in Part 2. 
 
Total Quality of Life Score 
All of the items are used to calculate the total score, which reflects overall quality of life. 
 
Health and Functioning Subscale 
1. Health 
2. Health care 
3. Pain 
4. Energy (fatigue) 
5. Ability to take care of yourself without help 
6. Control over life 
7. Chances for living as long as you would like 
11. Sex life 
16. Ability to take care of family responsibilities 
17. Usefulness to others 
18. Worries 
25. Things for fun 
26. Chances for a happy future 
 
Social and Economic Subscale 
13. Friends 
15. Emotional support from people other than your family 
19. Neighborhood 
20. Home 
21/22. Job/not having a job 
23. Education 
24. Financial needs 
 
Psychological/Spiritual Subscale 
27. Peace of mind 
28. Faith in God 
29. Achievement of personal goals 
30. Happiness in general 
31. Life satisfaction in general 
32. Personal appearance 
33. Self 
 
Family Subscale 
8. Family health 
9. Children 
10. Family happiness 
12. Spouse, lover, or partner 
14. Emotional support from family 
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Description of Scoring for the 
Ferrans and Powers Quality of Life Index (QLI) 
NOTE: This is a description of the steps for calculating the five scores of the Quality of Life Index: total 
scale, health and functioning subscale, social and economic subscale, psychological/spiritual subscale, 
and family subscale.  To calculate the scores, we recommend using the computer syntax for SPSS-PC, 
which is included in this web site. 
STEPS DESCRIPTION 
OVERALL QLI SCORE (overall quality of life) 
1. Recode satisfaction 
scores 
To center the scale on zero, subtract 3.5 from satisfaction response 
for each item.  (This will produce responses of -2.5, -1.5, -.5, +.5, 
+1.5, +2.5.) 
2. Weight satisfaction 
responses with the 
paired importance 
responses. 
Multiply the recoded satisfaction response by the raw importance 
response for each pair of satisfaction and importance items. 
3. Obtain preliminary 
sum for the overall 
(total) score. 
Add together the weighted responses obtained in step 2 for all of 
the items. 
4. Obtain final overall 
(total) QLI score. 
To prevent bias due to missing data, divide each sum obtained in 
step 3 by the number of items answered by that individual.  (At this 
point the possible range for scores is -15 to +15.)  Next, to 
eliminate negative numbers for the final score, add 15 to every 
score.  This will produce the final overall (total) QLI score.  
(Possible range for the final scores = 0 to 30.) 
SUBSCALE SCORES 
The same steps are used to calculate subscale scores as total scores.  The only difference is that the 
calculations are performed using subsets of items, rather than on all of the items. 
1. Recode satisfaction scores 
 
To center the scale on zero, subtract 3.5 from the satisfaction 
response for each item.  (This will produce responses of -2.5, -1.5, -
.5, +.5, +1.5, +2.5.)  This is exactly the same step as #1 above. 
2. Weight satisfaction 
responses with the paired 
importance responses. 
Multiply the recoded satisfaction response by the raw importance 
for each pair of satisfaction and importance items.  This is exactly 
the same step as #2 above. 
3. Obtain preliminary sum 
for the subscale score. 
Add together the weighted responses obtained in step 2 for the 
items that compose the subscale. 
4. Obtain final subscale 
score. 
 
To prevent bias due to missing data, divide each sum obtained in 
step 3 by the number of items answered in that subscale for that 
individual.  (At this point the possible range for score is -15 to +15.  
This is the possible range for all four of the subscales and for the 
overall (total) score.  The possible range is the same for all five 
scores even though they have different numbers of items, because 
we have divided the preliminary sum by the number of items 
answered for each one.)  Next, to eliminate negative numbers for 
the final score, add 15 to every score.  It is always the number 15 
that is added, regardless of which subscale score is being 
calculated.  This will produce the final subscale score.  (Possible 
range for the final scores = 0 to 30.)  The possible range for the 
final scores is the same for all four subscales and for the overall 
(total) score. 
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Health-Promoting Lifestyle Profile-II 
 
 
 
 
 
Directions: This questionnaire contains statements about your present 
way of life or personal habits. Please respond to each item as accurately 
as possible, and try not to skip any item. Indicate the frequency with 
which you engage in each behavior by circling the number under 
Never, Sometimes, Often, or Routinely: 
 
 
 
 
N 
E 
V 
E 
R 
S 
O 
M 
E 
T 
I 
M 
E 
S 
 
 
 
O 
F 
T 
E 
N 
R 
O 
U 
T 
I  
N 
E 
L 
Y 
1.  Discuss my problems and concerns with people close to me. 1 2 3 4 
2.  Choose a diet low in fat, saturated fat, and cholesterol. 1 2 3 4 
3.  Report any unusual signs or symptoms to a physician or other health 
professional. 
 
1 
 
2 
 
3 
 
4 
4. . Follow a planned exercise program. 1 2 3 4 
5.  Get enough sleep. 1 2 3 4 
6.  Feel I am growing and changing in positive ways. 1 2 3 4 
7.  Praise other people easily for their achievements. 1 2 3 4 
8.  Limit use of sugars and food containing sugar (sweets). 1 2 3 4 
9.  Read or watch TV programs about improving health. 1 2 3 4 
10.  Exercise vigorously for 20 or more minutes at least three times a 
week (such as brisk walking, bicycling, aerobic dancing, using a 
stair climber). 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
11.  Take time for relaxation each day. 1 2 3 4 
12.  Believe that my life has purpose. 1 2 3 4 
13.  Maintain meaningful and fulfilling relationships with others. 1 2 3 4 
14.  Eat 6 – 11 servings of bread, cereal, rice, and pasta each day. 1 2 3 4 
15.  Question health professionals in order to understand their 
instructions. 
 
1 
 
2 
 
3 
 
4 
16.  Take part in light to moderate physical activity (such as sustained 
walking 30-40 minutes 5 or more times a week). 
 
1 
 
2 
 
3 
 
4 
17.  Accept those things in my life which I cannot change. 1 2 3 4 
18.  Look forward to the future. 1 2 3 4 
19.  Spend time with close friends. 1 2 3 4 
20.  Eat 2 – 4 servings of fruit each day. 1 2 3 4 
21.  Get a second opinion when I question my health care provider‘s 
advice. 
 
1 
 
2 
 
3 
 
4 
22.  Take part in leisure-time (recreational) physical activities (such as 
swimming, dancing, bicycling). 
 
1 
 
2 
 
3 
 
4 
23.  Concentrate on pleasant thoughts at bedtime. 1 2 3 4 
24.  Feel content and at peace with myself. 1 2 3 4 
25.  Find it easy to show concern, love, and warmth to others. 1 2 3 4 
26.  Eat 3 – 5 servings of vegetables each day. 1 2 3 4 
27.  Discuss my health concerns with health professionals. 1 2 3 4 
Continued on next page. 
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Health-Promoting Lifestyle Profile-II (Continued) 
 
 
 
 
Directions: This questionnaire contains statements about your present 
way of life or personal habits. Please respond to each item as accurately 
as possible, and try not to skip any item. Indicate the frequency with 
which you engage in each behavior by circling the number under 
Never, Sometimes, Often, or Routinely: 
 
 
 
 
N 
E 
V 
E 
R 
S 
O 
M 
E 
T 
I 
M 
E 
S 
 
 
 
O 
F 
T 
E 
N 
R 
O 
U 
T 
I  
N 
E 
L 
Y 
28.  Do stretching exercises at least 3 times per week. 1 2 3 4 
29.  Use specific methods to control my stress 1 2 3 4 
30.  Work toward long-term goals in my life. 1 2 3 4 
31.  Touch and am touched by people I care about. 1 2 3 4 
32.  Eat 2 – 3 servings of milk, yogurt, or cheese each day. 1 2 3 4 
33. . Inspect my body at least monthly for physical changes/danger signs. 1 2 3 4 
34.  Get exercise during usual daily activities (such as walking during 
lunch, using stairs instead of elevators, parking car away from 
destination and walking). 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
35.  Balance time between work and play. 1 2 3 4 
36.  Find each day interesting and challenging. 1 2 3 4 
37.  Find ways to meet my needs for intimacy. 1 2 3 4 
38.  Eat only 2 -3 servings from the meat, poultry, fish, dried beans, 
eggs, and nut group each day. 
 
1 
 
2 
 
3 
 
4 
39.  Ask for information from health professionals about how to take 
good care of myself. 
 
1 
 
2 
 
3 
 
4 
40.  Check my pulse rate when exercising. 1 2 3 4 
41.  Practice relaxation or meditation for 15 – 20 minutes daily. 1 2 3 4 
42.  Am aware of what is important to me in life. 1 2 3 4 
43.  Get support from a network of caring people. 1 2 3 4 
44.  Read labels to identify nutrients, fats, and sodium content in 
packaged foods. 
 
1 
 
2 
 
3 
 
4 
45.  Attend educational programs on personal health care. 1 2 3 4 
46.  Reach my target heart rate when exercising. 1 2 3 4 
47.  Pace myself to prevent tiredness. 1 2 3 4 
48.  Feel connected with some force greater than myself. 1 2 3 4 
49.  Settle conflicts with others through discussion and compromise. 1 2 3 4 
50.  Eat breakfast. 1 2 3 4 
51.  Seek guidance or counseling when necessary. 1 2 3 4 
52.  Expose myself to new experiences and challenges. 1 2 3 4 
 
Permission has been granted by Susan Walker, PhD, RN (College of Nursing, University of 
Nebraska Medical Center, Omaha, NE 68198-5330) to use this instrument in a research study.  
 S. N. Walker, K. Sechrist, N. Pender, 1995.  
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Health-Promoting Lifestyle Profile-II – Scoring Instructions 
 
 
A score for overall health-promoting lifestyle is obtained by calculating a mean of the 
individual‘s responses to all 52 items; six subscale scores are obtained similarly by 
calculating a mean of the responses to subscale items. The use of means rather than 
sums of scale items is recommended to retain the 1 to 4 metric of item responses and to 
allow meaningful comparisons of scores across subscales. The items included on each 
scale are as follows: 
 Health-Promoting Lifestyle  1 to 52 
 Health Responsibility   3, 9, 15, 21, 27, 33, 39, 45, 51 
 Physical Activity   4, 10, 16, 22, 28, 34, 40, 46 
 Nutrition    2, 8, 14, 20, 26, 32, 38, 44, 50 
 Spiritual Growth   6, 12, 18, 24, 30, 36, 42, 48, 52 
 Interpersonal Relations  1, 7, 13, 19, 25, 31, 37, 43, 49 
 Stress Management   5, 11, 17, 23, 29, 35, 41, 47  
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ASSESSING DEPRESSIVE SYMPTOMS IMPROVES THE KNOWLEDGE OF CVD 
RISK: THE ASK STUDY QUESTIONS
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  Assessing Depressive  
  Symptoms Improves the 
  Knowledge of CVD Risk (The ASK Study) 
 
Dear Participant, 
 Thank you for your willingness to participate in this study about the experience 
of depressive symptoms and quality of life. Would you kindly complete this booklet of 
questions? Remember, all your information will be kept totally confidential and no 
information in this booklet will be connected with you as an individual in any way.  
 When you complete this booklet you will be given a $10.00 gift card to the 
Fashion Square Mall in appreciation for your time. 
 If you have any questions regarding the questions in this booklet or anything 
else about the study, please feel free to ask me. 
 
Suzanne Savoy, MN, RN. PhD in Nursing Student, Loyola University of Chicago; 
Assistant Professor of Nursing, Saginaw Valley State University. 
Phone: 989-964-7026. 
 
What is your ethnicity? 
  Hispanic origin 
  Not of Hispanic origin 
What is your race? 
  American Indian or Alaskan Native 
  Asian or Pacific Islander 
  Black or African-American 
  White 
Please check your highest level of education: 
  Less than 9th grade 
  9th to 12th grade, no diploma 
  High school graduate (includes equivalency) 
  Some college, no degree 
  Associate degree 
  Bachelor‘s degree 
  Graduate or professional degree 
Please indicate your total family income: 
  Less than $15,000 
  $15,000-$24,999 
  $25,000-$49,999 
  More than $50,000 
What is your marital status? 
   Never Married 
   Now Married 
   Separated 
   Divorced 
   Widowed 
What is your employment status? 
   Employed full-time 
   Employed part-time 
   Unemployed 
   Not seeking employment 
Mental Health 
 Is there a family history of  
       depression?            Yes      No 
 Have your ever been told you 
have depression?   Yes      No 
 Have your ever been treated for 
depression?            Yes      No 
 Are you taking any medication 
for depression?      Yes      No 
  
 Please continue to the next page. 
 
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Which of the following medical 
problems do you have? Check off those 
that apply to you. 
 Arthritis (rheumatoid and osteoarthritis) 
 Osteoporosis 
 Asthma 
 Chronic obstructive pulmonary disease  
(COPD), acquired respiratory distress 
syndrome (ARDS), or emphysema 
 Angina 
 Congestive heart failure (or heart 
disease) 
 Heart attack (myocardial infarction) 
 Neurological disease (such as multiple 
sclerosis or Parkinson‘s) 
 Stroke or Transient Ischemic attack 
(TIA) 
 Peripheral vascular disease 
 Diabetes types 1 and 2 
 Upper gastrointestinal disease (ulcer, 
hernia, reflux) 
 Depression 
 Anxiety 
 Panic disorder 
 Visual impairment (such as cataracts, 
glaucoma, macular degeneration) 
 Hearing impairment (very hard of 
hearing, even with hearing aids) 
 Degenerative disc disease (back disease, 
spinal stenosis or severe chronic back 
pain) 
 [Functional Comorbidity Index] 
Heart Disease 
Did you know your chances/risk of getting 
heart disease before this screening? 
                      Yes      No 
Did you learn about your heart disease risk 
from your primary healthcare provider?
                     Yes      No 
Did you know that all women should be 
evaluated for their chances/risk of getting 
heart disease?                     Yes      No 
 
Did you learn about heart disease in 
women from information you have 
received from being a member of the 
Women‘s Heart Advantage program or 
coverage on television, radio, or in the 
newspaper?           Yes      No 
 
Have you ever had a Stress test/ Exercise 
stress test?              Yes       No 
  
Do you snore?         Yes       No 
 
Have you ever been diagnosed with sleep 
apnea?               Yes       No 
 
Please list the medications you are 
taking: 
 _________________________ 
 _________________________ 
 _________________________ 
 _________________________ 
 _________________________ 
 _________________________ 
 _________________________ 
Continue on the reverse side if necessary. 
 
 
Please continue with the rest of the questions in this booklet.
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APPENDIX R 
LETTER OF ORGANIZATION COOPERATION FROM COVENANT 
HEALTHCARE WOMEN‘S HEART ADVANTAGE 
[Original signed copy submitted to Loyola IRB.] 
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March 7, 2008 
 
 
Suzanne M Savoy 
4039 Parsons Walk 
Saginaw, MI 48603 
 
Dear Ms. Savoy, 
 I have reviewed the purpose of your proposed study, ―Depressive Symptoms in 
Women Being Screened for Cardiovascular Disease‖, and the research procedures 
(recruitment, consent, and data collection) outlined in your research protocol. I 
understand that you are asking to recruit women to participate in your research study 
when they come to a Women‘s Heart Advantage screening program. I also understand 
that you are asking for copies of the women‘s Heart Health questions and the results of 
their Heart Health Profile. The information from each woman will be released with their 
name so that you can match this information with each woman‘s research study data 
collection booklet. Furthermore, I understand that once these data sets have been 
matched, all personal identifying information will be removed or blocked out. 
 We look forward to you beginning your study once you have obtained the 
approval from the following Institutional Review Boards: Loyola University Chicago, 
Covenant HealthCare, and Saginaw Valley State University. 
 
Sincerely, 
 
Kevin Birchmeier 
Director, Cardiovascular Services 
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